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Q U I L L  O N  S C A L P E L  This section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
THE CANADIAN CARDIOVASCULAR SOCIETY
This is the third time that the Canadian 
Journal of Surgery has published a large 
proportion of papers presented at the 
annual meetings of the Canadian Cardio­
vascular Society. When I approached the 
potential contributors on the second occa­
sion, in 1973, several were reluctant to 
publish their material in a journal with 
a circulation of less than 1600; but by 1975 
the circulation had exceeded 7000 and the 
advantages of rapid publication (5 months 
separate the date of the oral presentations 
and the date of this issue) and the avail­
ability of a journal that reaches all Cana­
dian surgeons led to an excellent response.
Six of the eight papers in this issue of 
the Journal relate to surgical aspects of 
coronary artery atherosclerosis. This disease 
has been recognized as the commonest 
cause of morbidity and mortality in 
Canadians over the age of 40 and many 
of its manifestations are uniquely relieved 
by operation. Since its introduction in 
1968, the operation of aortocoronary by­
pass has greatly increased in popularity.
THE ABC OF GOOD
That medical writing is not easy is a 
truism, but physicians can take comfort in 
realizing that all great writers put much ef­
fort into preparing their work. It is also a 
truism that the quality of much medical 
writing is poor; but again, it is comforting 
to know that good medical writing depends 
on three simple principles only: accuracy, 
brevity and clarity.
The need for accuracy should not surprise 
any physician, for “truth” is an essential 
quality of all good scientific work. More 
practically, accuracy aids clarity, for pre-
During 1970 this operation was performed 
on almost 1000 Canadians and by the end 
of 1975 over 13 000 Canadians had bene­
fited from this operation— 4000 in the 
last year alone. Its proven ability to alleviate 
the symptoms of angina pectoris and its 
expected ability to diminish the subsequent 
incidence of infarction and to prolong life 
have led to a demand for treatment that is 
straining our present facilities. The indica­
tions and benefits of this procedure will be 
widened by the advances in surgical tech­
nique, myocardial protection and circula­
tion-assist devices detailed in the papers of 
the contributing authors.
The Canadian Cardiovascular Society 
appreciates the cooperation of the coeditors 
and editorial staff of the Canadian Journal 
of Surgery in the rapid processing of the 
manuscripts and in devoting a special issue 
to cardiovascular surgery.
R. J. Baird, MD, MS, FRCS[C]
Vice-president,
Canadian Cardiovascular Society.
MEDICAL WRITING
cisely the right word helps the author com­
municate his message clearly. But there are 
more pragmatic reasons for a writer to be 
accurate: he gains the respect of his col­
leagues thereby; he assists other workers by 
reporting accurately what he did and what 
he found; and he certainly makes it easier 
for journal editors and reviewers to react 
favourably to the manuscript he submits.
With respect to brevity, the adage “Half 
as long is twice as good” is a good one to 
follow. But why is brevity important?
Brevity makes a writer use simple and
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direct language, which cuts through the 
tangled undergrowth of opaqueness caused 
by unnecessary jargon, redundancy, circum­
locution and complexity. The need for 
brevity forces one to eschew the lack-lustre 
passive voice and the abstract noun and to 
use instead the active voice and concrete 
noun. The writing becomes clearer, even 
more accurate, but also stronger and more 
effective — and more interesting.
Finally, clarity, the sine qua non of good 
writing. To get the message across it 
must be clear— and to have expended time 
and effort on a cherished manuscript that 
is unclear is unfortunate, if not folly. Lack 
of clarity breeds numerous hobgoblins— 
from the reader’s becoming irritated and 
frustrated because his time is wasted in 
trying to understand the author to the read­
er’s misinterpreting the author, perhaps, in 
medicine, with unfortunate results. More­
over, the first objective reader of a manu­
script submitted may be the journal editor 
or reviewer; each abhors lack of clarity and 
reacts accordingly.
Nor must one forget the reader whose 
native language is not English, and the fact 
that English more and more is the language 
of science. Clarity then becomes doubly im­
portant.
If authors knew what they wanted to say 
if they do not they should not be writing 
— and they could then be accurate, brief 
and clear, many of the problems with 
medical writing would become resolved. 
True, some effort will always be necessary 
in practising a skill; but medical writing 
would no longer be a chore and it might 
even be a pleasure for both writer and 
reader.
D. A . E . Sh e p h a r d , MB, FRCP[C]
Scientific Editor,
Canadian Medical Association Journal.
S E L F - A S S E S S M E N T
SESAP II QUESTION
404. indications for coronary artery bypass grafting include
(1) disabling angina pectoris which is not relieved by medical therapy
(2) lesions demonstrated by arteriography that suggest a threat to life because of 
their location or extensiveness
(3) coronary artery stenosis associated with surgically correctable valvular heart 
disease or ventricular aneurysm
(4) severe ventricular dysfunction (ejection fraction of 35 per cent) associated with 
coronary artery disease
For this question one or more of the answers given above is correct. Your answer should 
be:
A if only 1, 2 and 3 are correct,
B if only 1 and 3 are correct,
C if only 2 and 4 are correct,
D if only 4 is correct,
E if all are correct.
For the critique of Item 404 see page 126 of this issue.
(Reproduced by permission of the American College of Surgeons from SESAP II Syllabus: 
Surgical Education and Self-assessment Program No. 2.)
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PROGNOSTIC SIGNIFICANCE OF ENDOCARDIAL VIABILITY 
RATIO IN AORTOCORONARY BYPASS SURGERY*
] GUNSTENSEN, MB, ChB, FRCS(Edin), FRCS[C],t HUGH E. SCULLY, MD, 
MSc(Med) FRCS[C], THEODORE KELLY, DP, ALLAN G. ADELMAN, MD, FRCP[C], 
WILLIAM G. WILLIAMS, MD, FRCS[C], E. DOUGLAS WIGLE, MD, FRCP[C], 
FACP and BERNARD S. GOLDMAN, MD, BSc(Med), FRCS[C]
Although aortocoronary bypass (ACB) for pa­
tients with stable angina carries a low mortality, 
some unexpected deaths do occur. Since in 
patients with normal coronary arteries the endo­
cardial viability ratio (EVR) can be correlated 
with subendocardial perfusion, with a ratio of 0.7 
or less indicating ischemia of the left ventricular 
subendocardium, and since the EVR postoperati- 
vely is useful in determining the need for intra­
aortic balloon pump assist (IABPA), it was de­
cided to ascertain whether the EVR might have 
prognostic value in patients with stable angina 
scheduled for standard ACB. Three groups of 
patients were studied: 50 with stable angina, 24 
who had died after ACB, and 18 who required 
IABPA for cardiogenic shock after surgery for 
stable angina. No significant differences were 
found for cardiac index, left ventricular end- 
diastolic pressure, left ventricular ejection frac­
tion and pre- and postoperative artery scores, 
but there were significant differences in the EVR 
between the first and second groups and be­
tween the first and third groups (P <  0.01 in 
each instance). These findings suggest that the 
left ventricular EVR may indeed be of prognostic 
value in patients scheduled to undergo ACB and 
that use of IABPA, which produces an increase 
in EVR, may be useful in patients with EVRs of 
less than 0.7, even if other parameters of cardiac 
function are normal.
Bien que le pontage aortocoronarien soit asso- 
cie a un faible taux de mortalite chez les pa­
tients ayant une angine stable, quelques deces 
imprevus surviennent. Comme il existe une cor­
relation chez les patients ayant des arteres coro- 
naires normales, entre I’indice de viabilite endo- 
cardiaque et la perfusion subendocardiaque, alors 
qu'un indice de 0.7 ou moins indique une ische- 
mie du subendocarde ventriculaire gauche, et
*From the departments of surgery and medicine, 
University of Toronto, and the division of cardio­
vascular surgery, Toronto General Hospital, 
Toronto, Ont.
Presented at the annual meeting of the Canadian 
Cardiovascular Society, Montreal, Que., Oct. 23- 
25, 1975.
fSupported by the Ontario Heart Foundation.
Reprint requests to: Dr. J. Gunstensen, 8th floor, 
University wing, Toronto General Hospital, 
Toronto, ON M5G 1L7.
comme la mesure de I'indice de viabilite endo- 
cardiaque pendant la periode post-operatoire 
aide a determiner la necessity d'une pompe a 
ballonnets intra-aortique d'appoint (destinee a 
augmenter le debit sanguin au coeur et a dimi- 
nuer le travail cardiaque) il a ete decide de ve­
rifier si le rapport de viabilite endocardiaque 
pouvait avoir une valeur pronostique chez les 
patients ayant une angine stable et destines a 
recevoir un pontage aortocoronarien classique. 
On a etudie trois groupes de patients: 50 pa­
tients avec une angine stable, 24 qui sont d ec i­
des apres une operation de pontage aortocoro­
narien et 18 qui ont requis une pompe a bal­
lonnets intra-aortique d’appoint pour un choc 
cardiogenique apres un pontage aortocoronarien 
pour une angine stable. Aucune difference si­
gnificative n'a ete observee en ce qui a trait 
a I’index cardiaque, la pression diastolique ven­
triculaire gauche finale, la fraction d'ejection 
ventriculaire gauche et les scores pre- et post- 
operatoires des arteres coronaires, mais on a 
note des differences significatives entre les 
indices de viabilite endocardiaque du premier 
et du second groupe et ceux du premier et du 
troisieme groupe (P <  0.01 dans chaque cas). 
Ces constatations suggerent que I’indice de 
viabilite endocardiaque ventriculaire gauche 
peut effectivement avoir une valeur pronostique 
pour les patients devant recevoir un pontage 
aortocoronarien et que I'emploi de la pompe a 
ballonnets intra-aortique d'appoint, qui produit 
une augmentation de I’indice de viabilite endo­
cardiaque, peut etre utile chez les patients 
ayant un indice inferieur a 0.7, meme lorsque 
les autres parametres de fonction cardiaque 
sont normaux.
A ortocoronary  bypass surgery for pa­
tients with stable angina is now an accept­
able surgical procedure and in most centres 
carries a low mortality. In October 1973 
this centre acquired an AVCO intra-aortic 
balloon pump and since then patients with 
stable angina who had evidence of severe 
left ventricular dysfunction, severe left main 
coronary artery disease or severe triple­
vessel disease have undergone aortocoronary 
bypass with prophylactic preoperative intra­
aortic balloon pump assist (IABPA) with 
95% survival.1’ 2 A further 352 patients
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with stable angina underwent surgery in the 
normal manner but 18 (5.1%) have required 
IABPA for the control of cardiogenic shock 
in the postoperative period and of these 12 
(67%) have survived. That cardiogenic shock 
should have developed in so many patients 
was somewhat disconcerting, since routine 
preoperative investigations should have 
identified those who would benefit from 
prophylactic IABPA. Preliminary investiga­
tion of the 18 patients revealed that 11 
(61%) had a low endocardial viability ra­
tio (EVR) as the only gross hemodynamic 
abnormality.
The EVR (obtained by dividing the dia­
stolic pressure time index by the tension 
time index [DPTI/TTI]) is correlated with 
subendocardial perfusion in patients with 
normal coronary arteries,;i and a ratio of 
0.7 or less indicates ischemia of the left ven­
tricular subendocardium. The postoperative 
estimation of the EVR is of value in deter­
mining whether patients with low cardiac 
output postoperatively will benefit from 
IABPA,4 which improves the EVR (Fig. 1) 
and thus improves the circulation to the left 
ventricular endocardium.
A precise estimation of the true EVR is 
not possible in patients with coronary artery 
disease because the decrease in pressure 
across an individual area of stenosis in a
coronary artery can not as yet be measured. 
As use of IABPA increases the EVR and 
as, prophylactically, it results in improved 
survival when compared with its use for 
postoperative cardiogenic shock, it seems 
pertinent to ascertain whether the EVR has 
any prognostic value in patients with stable 
angina who are scheduled for standard aor­
tocoronary bypass.
Patients and M ethods
The patients in this series were of three 
groups: group 1 comprised 50 randomly 
selected patients with stable angina who 
survived an aortocoronary bypass proce­
dure in 1971 and 1972; group 2 included 24 
patients who died after aortocoronary by­
pass from June 1969 to October 1973, dur­
ing which period the total number of patients 
thus treated was 475; and group 3 com­
prised 18 patients who required IABPA 
for postoperative cardiogenic shock after 
aortocoronary bypass for stable angina.
Variables reflecting left ventricular func­
tion and coronary artery disease that were 
examined were the coronary artery score, 
cardiac index (Cl), left ventricular ejection 
fraction (LVEF) and EVR. The coronary 
artery score was estimated for each vessel 
as a modification of the Friesinger tech 
nique" as follows: a score of 1 was recorded
I '
■ 4
'
4
100r ------  L V PRESSURE
H 3  T T I  (SYSTOLE) 
D P T I  (D IA ST O LE )
EVR = 0-67
IABP OFF IABP ON
S J E H S  m y o c ard K ly g en
t -  ■
4
*
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for multiple, 50% occlusions; 2, for proxi­
mal occlusion of 50 to 75%; 3, for proxi­
mal occlusion of 75 to 95% or for multiple 
occlusions of 50 to 75%; 4, for proximal 
occlusion of 90 to 99% or for multiple oc­
clusions of 75 to 95%; and 5, for proximal 
occlusion of 100%. These scores were then 
summed to provide a total preoperative 
score; bypass into a vessel diminished the 
score appropriately and the total postoper­
ative score was also added. The Cl was 
calculated by the Fick technique and the 
left ventricular end-diastolic pressure 
(LVDEP) was recorded during left heart 
catheterization. The LVEF was calculated 
by an estimation of the difference between 
the end-diastolic volume and end-systolic 
volume in a single-plane right anterior 
oblique projection. The EVR was calculated 
from the tracings obtained from withdrawal 
of the catheter from the left ventricular ca­
vity into the aorta after left ventricular an­
giography.
R esu l t s
Mean values for coronary artery score, 
cr, LVEDP and LVEF for the three groups 
are given in Table I. No significant differ­
ences were noted between the groups for 
any of the variables.
The mean values for EVR are presented 
in Table II, together with statistical find­
ings. An EVR of less than 0.7 was not nec­
essarily associated with other abnormalities. 
The values for coronary artery score, Cl, 
LVEDP and LVEF for patients with an 
EVR of 0.7 or less (mean, 0.59) and those 
with an EVR of greater than 0.7 (mean, 
1.03) are displayed in Table III. None of 
the differences in these values are signifi­
cant.
TABLE I.—H emodynamic D ata for Groups 1, 2 
and 3
Group
~1 2 3
Variable (n = 50) (m = 24) (n = 18)
Coronary artery 
score (mean)
Preoperative. . . .  9
Postoperative. . .  3.2
Cl, I/min-m2.........  2.8
LVEDP, mm Hg. . 10.4
LVEF, % ............... 60.9
TABLE II.—Comparison of EVR in  G roups 1, 2 
and 3
Group
1 2  3 
{n = 50) (n =  24) (n = 18)
Mean EVR*..........
No. of patients 
with EVR < 0.7
0.98 0.78 0.82 
6 11 11
*Differences between groups were significant for 1 
v. 2 (P < 0.01) for 1 v. 3 (P <  0.01); difference be­
tween 2 and 3 was not significant (P <  0.7).
TABLE III.—C omparison of H emodynamic D ata 
for P atients w ith  EVR Below  0.7 and Above 0.7
E V R
Variable
< 0.7 > 0.7 
(mean, 0.59) (mean, 1.03)
Coronary artery
score....................
CI, I/min-m2..........
LVEDP, mm Hg . . 
LVEF, % ...............
10.4 9.6 
3.07 2.71 
12.0 11.2 
56.2 60.2
D iscussio n
Evolving indications for the prophylactic 
use of IABPA include relief of ischemia 
in acute coronary artery insufficiency0 and 
cardiovascular support of patients undergo­
ing aortocoronary bypass or valve replace­
ment in the presence of poor left ventricu­
lar function,2 patients with left main-stem 
lesions, or patients with both valve dis­
ease and coronary artery disease requiring 
a concomitant surgical procedure. Never­
theless, in spite of all these precautions, 
cardiogenic shock occasionally develops at 
the end of what should have been a straight­
forward saphenous vein bypass graft pro­
cedure. The results of our study show that a 
low preoperative value for left ventricular 
EVR will be recorded for an undue num­
ber of these patients. It therefore seems 
logical that the estimation of the EVR 
should be part of routine preoperative in­
vestigation of the patient undergoing an 
aortocoronary bypass procedure. When in­
vestigation reveals a low EVR the prophy­
lactic use of IABPA should be considered.
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TRIPLE-VESSEL CORONARY ARTERY DISEASE: EFFECT OF 
REVASCULARIZATION ON LATE SURVIVAL*
W. J. KEON, MD, FRCS[C], P. BEDARD, MD, FRCS[C], Y. AKYUREKLI MD 
FRCS[C], M. P. BRAIS, MD, FRCS[C] and J. PORTER, MD *
Of the first 600 patients to receive aorto­
coronary bypass grafts 383 had three dis­
eased vessels, and of them 36 ( 9 % )  have died: 
20 (5 % ) in hospital and 16 (4 % ) late. In 10 of 
those who died, ventricular function was normal, 
class I or class II and in the other 26 function 
was class III or class IV. For all ventricular 
classes except class IV, improvement in myo­
cardial blood flow with operation was consider­
ably lower than average in those who died. The 
leading cause of late death was congestive heart 
failure followed by myocardial infarction, and 
then by other cardiac complications. Of patients 
with good (normal, classes I or II) ventricular 
function, 3.5%  died during a mean follow-up 
period of 27 months; and since, according to 
published reports, 1%  of patients with triple­
vessel disease without surgical intervention die 
each month, the data from this study suggest 
that survival in this group is improved by 23.5%. 
This study also shows that in patients with triple­
vessel disease and good ventricular function, 
adequate coronary artery bypass operations (i.e., 
placement of three grafts or more) improves sur­
vival.
I ou classe II, et les 26 autres appartenaient aux 
classes III et IV. Pour toutes les classes ventricu- 
laire, sauf pour la classe IV, (’amelioration du 
debit sanguin myocardique qui suivit I’operation 
fut considerable merit inferieure a la moyenne 
chez ceux qui moururent. La principale cause des 
deces survenant tardivement fut I'insuffisance 
cardiaque suivie d'un infarctus du myocarde, et 
ensuite d'autres complications cardiaques. Chez 
les patients presentant une bonne fonction ven- 
triculaire (normale, classe I ou II), 3.5% mou­
rurent pendant une periode de post-observation 
moyenne de 27 mois; et comme, d'apres les 
observations publiees, 1% des patients qui ont 
une atteinte de trois vaisseaux et qui ne subis- 
sent pas d’intervention chirurgicale meurent 
chaque mois, les donnees de cette etude sugge- 
rent que la survie de ce groupe a ete amelioree 
de 23.5%. Cette etude montre aussi que chez 
les patients ayant une atteinte de trois vais­
seaux et possedant une bonne fonction ventri- 
culaire, une operation de pontage aortocorona- 
rien adequate (i.e. la pose de trois greffons ou 
plus) ameliore la survie.
Des 600 premiers patients a recevoir un 
pontage aortocoronarien, 383 avaient une at­
teinte de trois vaisseaux, et de ceux-ci 36 ( 9 % )  
moururent: 20 ( 5 % )  a I'hopital et 16 ( 4 % )  ulte- 
rieurement. Dix de ceux qui sont morts presen- 
taient une fonction ventriculaire normale, classe
*From the University of Ottawa cardiac unit, 
Ottawa Civic Hospital, Ottawa, Ont.
Presented at the annual meeting of the Canadian 
Cardiovascular Society, Montreal, Que., Oct 23- 
25, 1975.
Supported by the Ontario Heart Foundation.
Reprint requests to: Dr. W. J. Keon, University of 
Ottawa cardiac unit, Ottawa Civic Hospital 1053 
Carling Ave., Ottawa, ON K1Y 4E9
Coronary artery bypass grafting, a rela­
tively new operative technique that has 
gained popularity, is now the most widely 
used surgical form of treatment for ischemic 
heart disease.1 Bypass grafting operations 
have not been performed for long enough 
to permit reliable assessment of their ef­
fectiveness to be made and, at present, car­
diac surgeons can only present their past 
experience and theorize that this experi­
ence indicates future trends.
The use of bypass grafts for triple coro­
nary vessel disease has been little investi­
gated. Results in a large series have been 
analyzed by workers from the Cleveland 
Clinic, where, of 397 patients with three
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diseased vessels and who received three by­
pass grafts, 10 died in hospital and 11 died 
later (mortality, 5.2% ).2 Others have re­
ported hospital mortalities of 5.4% and 
8% ,:!- 4 and one group, using life-table 
analysis, estimated a survival of 96% over 
4 years in patients who did not have con­
gestive heart failure preoperatively or who 
did not undergo auxiliary procedures such 
as valve replacements.'' And for a group of 
patients evaluated 2 years after operation, 
survival was 88% in patients with normal 
ventricles and 71% in those with abnormal 
ventricular function.6
In this paper we report the results of by­
pass grafts for triple-vessel disease in our 
first 383 consecutive patients.
Patients and O perative  Procedures
Between April 1970 and March 1974, 
600 patients underwent operations in the 
University of Ottawa cardiac unit. Of these
TABLE I.—Condition of P atients who Under­
went E mergency Operation
Preoperative condition
No. of 
patients
No. of 
deaths
Cardiogenic shock......... 3 2
Acute myocardial
infarction................... 13 2
Preinfarction angina. . . 26 2
Angiographic
emergency.................. 2 0
Total....................... 44 6
patients 383 were defined as having triple 
coronary vessel disease— that is, occlu­
sion or stenosis of at least 70% in the right, 
anterior descending and circumflex arteries. 
There were 25 women and 358 men; their 
mean age was 49 years.
Before operation 40 of these patients 
were asymptomatic, 105 had class II an­
gina, 140 were considered to have class III 
angina and 98 were graded as having class 
IV angina.
An operation was performed under 
emergency circumstances in 44 patients. 
The preoperative condition of these patients 
and the mortality is given in Table I. Re­
sults of operation in these patients and in 
those who underwent operation electively 
are summarized in Table II.
The types of procedures performed and 
the associated mortalities are set forth in 
Table III. The 383 patients received a to­
tal of 1009 bypass grafts. A single graft 
was placed in 49 patients, double grafts in 
87, triple in 205, quadruple in 39 and quin­
tuple in 3. In 220 patients all three diseased 
vessels were grafted, in 111 two vessels 
were grafted, and in 52 only one vessel was 
grafted.
R esults
Of the 383 patients who were operated on 
for triple-vessel disease, 36 had died by 
March 1974, 20 (5%) at operation or in
TABLE II.—M ortality of E lective and E mergency Procedures
No. (and %) of deaths
Urgency of operation
IV U . UJ
patients Hospital Late Total
Elective............................................................. 339 16 (4.7) 14 (4.1) 30 (8.8)
Emergency....................................................... 44 4 (9.1) 2 (4.5) 6 (13.6)
Total......................................................... 383 20 (5.2) 16 (4.2) 36 (9.4)
TABLE III.—T ypes of Procedures and Associated M ortality
No. of No. (and %)
patients of deaths
Grafts alone............................................................. 199 18 ( 9)
Grafts and implants................................................ 138 11 ( 8)
Grafts and aneurysmectomies.............................. 22 4 ( 18)
Grafts and valve replacements............................. 7 2 ( 28)
Grafts, implants and aneurysmectomies............. 15 0 (  0)
Grafts and repair of ventricular septal defects. . 1 1 (100)
Grafts, implant and valve replacements............. 1 0 (  0)
Total................................................................. 383 36
M
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Fig. 1.—Increase in mortality (in percent) ac­
cording to decrease in ventricular function.
hospital and 16 (4%) after discharge from 
hospital.
Mortality was correlated with preoper­
ative ventricular function (Fig. 1). Among 
the 137 patients with normal ventricular 
function 4 died, but otherwise mortality was 
correlated with poor ventricular function. 
None of the 61 patients with class I ventri­
cular function died, either in hospital or 
after discharge. Six of the 107 patients 
with class II function died, 3 in hos­
pital and 3 later. Among the 43 patients 
with class III ventricular function 8 (20%) 
have died, 6 early and 2 late. The highest 
number of deaths was among patients with 
class IV function, of whom 18 of 40 pa­
tients have died (10 of whom died late).
Late death occurred at an average of 9 
months after operation. The causes are listed 
in Table IV. The most frequent causes of 
late death were congestive heart failure, 
in 5 of the 16 patients, and myocardial in­
farction in 4 patients; the cause of death
was unknown in 3 patients and varied in 
the remainder. The number of bypass grafts 
received was calculated (Table IV) and it 
was found that only 3 of the 16 patients 
received three grafts. The total increase in 
myocardial flow was also determined: in the 
majority of patients the increase was much 
below the normal increase in myocardial 
blood flow. We also calculated that for our 
100 most recent patients, the average in­
crease in myocardial flow was 175 ml and 
we found that in only 3 of the patients who 
died late was this average exceeded and 
that they were all patients with class IV 
ventricular function.
Class of angina was determined I year 
after operation. Analysis showed that 249 
patients had become asymptomatic and that 
80 had class II angina. There were 21 pa­
tients in whom serious angina persisted — 
14 with class III angina and 7 with class IV. 
At 1 year, 33 patients had died; the other 
3 died later.
D iscussion
One of the primary causes of death in 
triple-vessel disease among surgical patients 
appears to be inadequacy of the operation. 
We believe that for an operation to be con­
sidered adequate three or more bypass grafts 
should be performed and that myocardial 
blood flow should increase by at least 150 
ml. With respect to the patients who died 
in hospital, an average of 2.5 grafts were 
placed, whereas with respect to the patients 
who died late an average of only 1.84 grafts 
were placed. The majority of patients who 
received fewer than three grafts were oper­
ated on during the first 2 years of our ex-
Ventricular 
function class
Normal
I
II
III
IV
TABLE IV.—F indings Associated with Late Deaths
N°- of Average no. Total increase in
patients____________ Cause of death of grafts myocardical flow, ml
Unknown 2 64
0
1 Myocardial infarction 1 ND*
2 Congestive heart failure 1.5 60
1 Myocardial infarction 1 ND1 Unknown 2 ND3 Congestive heart failure 2 1002 Myocardial infarction 1.5 95I Arrhythmia 1 751 Pulmonary embolism 2 3301 Cardiorespiratory failure 3 ND
1 Cardiac arrest 3 1801 Unknown 3 225
*ND = not determined.
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perience in performing bypass grafts, when 
we were more cautious about doing multi­
ple grafting. We now do as many bypass 
grafts as we believe to be needed; in the 
most recent 50 patients with triple-vessel 
disease treated surgically an average of four 
grafts were performed and among them 
there were no early or late deaths.
Calculation of increase in myocardial 
blood flow revealed that the average ranged 
from 141.54 ml/min in patients with class 
I ventricular function to 178.66 ml/min 
in patients with class IV function. A com­
parison of average graft flows in the sur­
viving and deceased patients (Table V) 
showed notable differences: in all but those 
with class IV ventricular function the blood 
flow was considerably higher in the sur­
vivors than in the nonsurvivors. These find­
ings indicate that an inadequate operation, 
as evidenced by a low increase in blood 
flow or grafting of fewer than three vessels, 
is a prognostic indicator of mortality in 
triple-vessel disease.
Ventricular function is also a determin­
ant of mortality. As Fig. 1 illustrates, mor­
tality increases according to the decrease in 
ventricular function; the curve rises much 
more sharply with the class of ventricular 
function: 20% of patients with class III 
function and 45% of those with class IV 
function have died. Six of the patients with 
class III function underwent emergency 
operations; three died at operation and three 
survived.
There have been several reports on med­
ical treatment of patients with triple-vessel 
disease that have disclosed a resulting mor­
tality of 10 to 20% per year depending on 
the medical condition of the patients at the 
time of angiography. The poorest results 
were in a group studied by Slagle and asso­
ciates :7 all the patients had congestive heart
TABLE V.—Average Increases of Myocardial 
Blood F low in Survivors and Nonsurvivors
Increase in myocardial 
blood flow, ml/min
V e n t r i c u l a r ----------------------------------
function Non­
class Survivors survivors
Normal.....................  176.16 112.50
I  ..................  141.54 (No deaths)
II ..................  168.81 51.40
III ..................  167.59 91.25
IV ..................  173.40 193.12
failure and previous myocardial infarction, 
and an annual mortality of 20% was found 
in this group. Bruschke, Proudfit and 
Soness and Lichtlen and Moccetti0 studied 
a randomized group that included patients 
with congestive heart failure and both re­
ported annual mortalities of 10 to 11%. 
Webster, Moberg and Rincon10 excluded 
patients with congestive heart failure from 
angiographic study. In spite of this exclu­
sion, the annual mortality rate remained 
at 10 to 11%. Oberman and associates11 
divided their patients into a group of those 
with congestive heart failure and those 
without and reported a 24% annual mor­
tality in the first group and 12% in the 
second.
Our patients with good ventricular func­
tion (i.e., normal function or class I or II 
function) could most clearly be compared 
with the group without congestive heart fail­
ure reported by Oberman and associates11 
for whom there was a 12% annual mortali­
ty rate. At a mean time of 27 months after 
operation, 6 (1.5%) of our patients with 
good ventricular function had died in hos­
pital and 8 (2%) later. Since 1% of the 
patients in the nonsurgical group of Ober­
man and associates died each month, 27% 
of them would be dead at 27 months, in 
contrast with only 3.5% of our surgical 
patients (Fig. 2). We believe that coronary 
artery bypass grafting offers a better prog­
nosis for patients with triple-vessel disease 
than does medical treatment alone.
To learn whether revascularization im- 
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Fig. 2.—Prognosis of patients with triple-vessel 
disease: surgical and nonsurgical patients. Morta­
lity for patients with good ventricular function 
treated surgically for triple coronary artery disease 
was 3.5% at mean time of 27 months after oper­
ation; for nonsurgical patients in group studied by 
Oberman and associates11 mortality was 1% per 
month.
100 THE CANADIAN JOURNAL OF SURGERY Vol. 19
an em erging problem
“Bacteroides species are often over­
looked as a cause of serious infec­
tion both by clinicians and micro­
biologists. They are most commonly 
associated with intra-abdominal 
and pelvic sepsis following gastro­
intestinal surgery.”
“Our experience with this series of seriously 
ill patients provides clinical confirmation toA 
complement recent in vitro evidence that 
clindamycin is the antibiotic of choice for 
use in bacteroides infections. Not only was*' 
the response in 17 of the 18 patients favour­
able, but in several it was dramatic.” ''
Tracy, 0 .,e t  al.(29 Jan.’72). 
Brit. med. J.,p. 280.
Haldane, E.V. and van Rooyen.C.E. (1972). 
C.M.A.J.,p. 1177.
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.bacteroides infection
•  I.M. injection or I.V. infusion 
achieves prompt and high peak
r serum levels of active clindamycin
•  well tolerated locally and sys- 
•^tem ically following I.M. injection
„ jor I.V. infusion
'  ’  \ PRODUCT o f  j
U p jo h n
ANTIBIOTIC
r e s e a r c h  , prescribing information on page
DaladnC
pnosonaie S.S.a new solution
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Daiacinc Phosphate s.s.
in anaerobic infections
Indications: Dalacin C Phosphate has been found effective in the 
treatment of certain infections due to anaerobic bacteria, including 
Bacteroides species, Peptostreptococcus, anaerobic streptococci, 
Clostridium species and microaerophilic streptococci. It is also in­
dicated in infections due to sensitive Gram-positive organisms, par­
ticularly staphylococci, streptococci and pneumococci. As with all 
antibiotics, in vitro susceptibility studies should be performed.
DOSAGE AND ADMINISTRATION 
Adults:
Intramuscular-600 to 2400 mg*/day in 2, 3, or 4 equal doses. In­
tramuscular injections of more than 600 mg in a single site are not 
recommended.
Intravenous-900 to 4800 mgVday by continuous drip or in 3 or 
4 equal doses, each infused over 20 minutes or longer. Administration 
o f more than 1200 mg in a single one hour infusion not recom­
mended.**
Children (over one month of age):
Intramuscular-10 to 30 mg*/kg/day in 2, 3, or 4 equal doses. 
Intravenous-15 to 40 mg*/kg/day by continuous drip or in 3 or 
4 equal doses, each infused over 20 minutes or longer.** 
•Depending on the severity o f the infection.
**Dalacin C Phosphate Sterile Solution should not be given un­
diluted intravenously; always administer in an infusion. See product 
monograph supplied with each package for complete dosage infor­
mation and infusion rates.
Cautions: Generally well tolerated. Known and usual antibiotic 
administration route side effects have been reported. Pain at the 
injection site, induration and sterile abscess have been reported 
following intram uscular injection. Throm bophlebitis, erythema, 
swelling and pain at the infusion site have been observed following 
intravenous infusion.
Warning: Some cases o f severe and persistent diarrhea have been 
reported during or after therapy with clindamycin. This diarrhea 
has been occasionally associated with blood and mucus in the stools 
and has at times resulted in acute colitis. When endoscopy has been 
performed, some of these cases have shown pseudomembrane for­
mation.
If significant diarrhea occurs during therapy, this drug should be 
discontinued or, if necessary, continued only with close observation. 
Significant diarrheaoccurringuptoseveral weeks post-therapy should 
be managed as if antibiotic-associated.
If colitis is suspected, endoscopy is recommended. Mild cases showing 
minimal mucosal changes may respond to simple drug discontin­
uance. Moderate to severe cases, including those showing ulceration 
or pseudomembrane formation, should be managed with fluid, elec­
trolyte, and protein supplementation as indicated. Corticoid retention 
enemas and systemic corticoids may be o f help in persistent cases. 
Anticholinergics and antiperistaltic agents may worsen the condition. 
Other causes o f colitis should be considered.
Abnormalities in liver function tests have been reported occasionally. 
Usual antibiotic side-effects-rash, urticaria, pruritus, fever, leukocy­
tosis, nausea, diarrhea, changes in blood pressure, shortness of breath 
and bad or bitter taste in mouth have been reported.
Not indicated in patients who have demonstrated sensitivity to clin­
damycin or Iincomycin. Safety in infants below 30 days of age or 
in pregnant women not established. Use with caution in patients 
with a history o f asthma and other allergies. As with other antibiotics, 
periodic liver function tests and blood counts should be performed 
during prolonged therapy.
Detailed information available upon request.
Availability:
Dalacin C Phosphate Sterile Solution-E ach ml contains clindamy- 
cin-2-phosphate equivalent to clindamycin base 150 mg in 2 ml and 
1 ml paediatric ampoules.
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proved the patients’ quality of life as well 
as increasing their chances of survival, we 
assessed the level of rehabilitation 1 year 
after operation. Information was obtained 
on 321 of the 383 patients; 70% were work­
ing, 10% were not working, 3% were 
working part-time, 5% had retired, and 
12% were dead. We hold that surgical in­
tervention rehabilitates a large number of 
patients with triple-vessel disease so they 
can lead a productive life.
Conclusions
Surgical treatment appears to be a more 
effective means of therapy than medical 
treatment, as evidenced by our experience. 
Of our patients, 3.5% died during a period 
in which 27% would have been expected to 
die with medical management alone. Qual­
ity of life of these patients is greatly im­
proved by myocardial revascularization; 
70% of them were working 1 year after 
operation. The major prognostic indicators 
in determining survival are the quality of 
ventricular function preoperatively, the de­
gree of improvement in total myocardial 
blood flow, and the distribution of flow 
achieved by operation. Intraoperative meas­
urement of improved myocardial blood flow 
with operation should be an essential part of 
the procedure. Patients with normal ventri­
cular function and triple-vessel disease have 
a low operative mortality and excellent late 
survival.
We thank Mrs. Elizabeth Masson for her help 
in preparation of this manuscript.
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USE OF A MEMBRANE OXYGENATOR 
FOR OPEN-HEART SURGERY IN INFANTS*
D. A. MURPHY, MD, FRCS[C], D. A. GILLIS, MD, FRCS[C], FACS 
and H. LAU MD, FRCS[C]
Because use of the bubble oxygenator during 
open-heart surgery is associated with com­
plications such as hemolysis, pulmonary in­
sufficiency and oliguria, a membrane oxygenator 
was used in conjunction with hypothermia in 37 
infants. The main features of the oxygenator are 
gravitational blood flow, oxygenation into an air­
less, collapsible blood reservoir, low-flow roller 
pump flow back to the patient, accurate deter­
mination of flows and careful use of a heat ex­
changer. Gas flow (98% oxygen, 2% carbon 
dioxide) for the unit of 2 m is maintained at 3 
to 4 //m in. Specific precautions are taken to 
ensure absence of bubbles. Three prime solu­
tions are used, the final one having an osmola­
lity of 381 mOsmol and containing 129.9 meq of 
sodium, 3.8 of potassium and 94.0 of chloride 
and 2001 mg/dl of glucose. Six patients died, but 
none of the deaths could be directly related to 
the use of the oxygenator. Respiratory complica­
tions were minimal, as were other complications. 
The technique is reliable in oxygenating blood 
in an extracorporeal circulation, but further fami­
liarity with the membrane oxygenator for use in 
open-heart surgery in infants is desirable before 
firm conclusions can be drawn as to its value.
Parce que I’emploi de I'oxygenateur a bulle 
pendant les operations a coeur ouvert est asso- 
cie a des complications telles que I’hemolyse, 
I'insuffisance pulmonaire et I’oligurie, un oxy- 
genateur a membrane a ete utilise en associa­
tion avec I'hypothermie chez 37 nourrissons. Les 
caracteristiques principales de cet oxygena- 
teur sont un ecoulement du sang par gravita­
tion, I’oxygenation dans un reservoir a sang 
compressible, sans air, un retour du sang 
au patient au moyen d’une pompe peristal- 
tique a faible debit, une determination pre­
cise des debits et ('utilisation soigneuse d'un 
echangeur de chaleur. Le courant de gaz (oxy- 
gene 98% et gaz carbonique 2% ) pour I'unite 
de 2 m est maintenu a 3 a 4 //min. Des pre-
*From the department of surgery, division of 
cardiovascular surgery, Dalhousie University, 
Halifax, NS.
Presented at the annual meeting of the Canadian 
Cardiovascular Society, Montreal, Que., Oct. 23- 
25, 1975.
Supported by the Nova Scotia Heart Foundation.
Reprint requests to: Dr. D. A. Murphy, Division 
of cardiovascular surgery, The Izaak Walton 
Killam Hospital for Children, 5850 University 
Ave., Halifax, NS B3J 3J6.
cautions particulieres sont prises afin de s'as- 
surer de I'absence de bulles. Trois solutions 
d’amorpage sont utilisees dont la derniere a 
une osmolalite de 381 m osmole et contient 
129.9 meq de sodium, 3.8 de potassium et 94.0 
de chlorure et 2001 mg/dl de glucose. Six 
patients sont morts, mais aucun deces n’a pu 
etre relie directement a I’emploi de I’oxyge- 
nateur. Les complications respiratoires ou au- 
tres furent sans importance. Pour I'oxygena- 
tion du sang en circulation extracorporelle, la 
technique demeure fiable mais il est souhai- 
table qu'une plus grande experience soit 
acquise dans (’utilisation de I’oxygenateur a 
membrane en chirurgie a coeur ouvert chez les 
nourrissons avant que des conclusions defi­
nitives puissent etre tirees sur sa valeur.
A variable degree and incidence of hemo­
lysis, pulmonary insufficiency and oliguria 
is accepted by most surgeons as the price of 
extracorporeal circulation in small infants. 
These complications have been largely mini­
mized by using a shorter extracorporeal 
circulation time and techniques of moderate 
surface hypothermia, profound hypother­
mia and circulatory arrest, and lower bypass 
flow rates. In most centres the bubble oxy­
genator is an integral part of the extracorpo­
real circuit and these complications persist. 
We have recently seen two cases of lethal 
hyperkalemic cardiac arrest occurring with­
in the first 24 postoperative hours result­
ing from hemolysis, and because of this ex­
perience we decided to substitute a mem­
brane oxygenator in the extracorporeal 
circuit in all patients weighing less than 10 
kg in an attempt to minimize these com­
plications. The purpose of this communica­
tion is to describe our experience with such 
an oxygenator.
Patients and Methods
The membrane oxygenator was used in 
37 patients, whose average age was 9.4 
months (range, 3 days to 24 months) and 
average weight was 6.01 kg (range, 2.6 to 
9.8 kg). The perfusion time averaged 82 
minutes (range, 14 minutes to 4 hours 11 
minutes). The diagnoses and results of opera­
tion are listed in Table I.
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^ PA TIEN T-..,
TA B LE I.— D iagnoses and R esults of Open -
H eart Surgery U sing M embrane Oxygenator
No. of
No. of 
hospital
Diagnosis patients deaths
Ventricular septal defect 12 0
Tetralogy of Fallot and 
complex.......................... 4 1
Transposition.................... 6 1
Primum atrial septal 
defect.............................. 4 0
Atrioventricular canal. . . . 2 0
Pulmonary stenosis.......... 1 0
Aortic stenosis................... 2 0
Truncus arteriosus............ 2 2
Hypoplastic left h ea rt.. . . 1 1
Miscellaneous.................... 3 1
Some form of induced hypothermia was 
used in all patients. In most, anesthesia was 
begun with ketamine to facilitate insertion 
of arterial and venous pressure monitoring 
catheters, after which either halothane or 
nitrous oxide (50%) and curare were ad­
ministered. Surface hypothermia was in­
duced either by placing small ice packs 
around the patient or by floating the pa­
tient on an ice bath while the surgeon was 
scrubbing. In three infants with complicated 
lesions surface cooling alone was used to 
obtain a sufficiently low core temperature 
for circulatory arrest without bypass, but 
in 17 of the 37 infants varying periods of 
cardiopulmonary bypass were instituted in 
order to control the circulation and allow 
surgical repair to be done under optimal 
conditions.
Priming and Bypass Technique
Circuit components.— The circuitry is 
demonstrated in Fig. 1. The membrane oxy­
genator rests 7.5 cm off the floor on a low, 
operating-room foot platform. Blood flow 
through the membrane is gravitational and 
the oxygenated blood rises into an airless, 
Edwards collapsible blood reservoir.* This 
reservoir is approximately 30 cm above the 
top of the oxygenator so that there is a suf­
ficient resistance in the membrane blood 
outlet to distend the sandwiched membranes 
and prevent blood streaming between the 
membrane sheets; it is supported by a sim­
ple, but accurate, tension-spring scale so 
that the volume of blood within it can be 
monitored. A low-flow roller pump (max-
Fig. 1.—Circuitry for membrane oxygenator. 
Venous and cardiotomy tubing is indicated by 
dotted lines.
imum flow, 1 //min)* returns the blood to 
the patient via an aortic root cannulation. 
Precise flows are determined with the aid 
of a Statham electromagnetic flow probe 
(0.625 x 0.625 cm) in the circuit. The tub­
ing throughout is of Tygon (internal diame­
ter, 0.625 cm). A Sarnsf miniprime heat 
exchanger is placed on the venous outflow 
from the patient so that, should bubbles 
form because of excessive temperature 
changes, they are likely to be trapped in the 
oxygenator or the reservoir; similarly, any 
air coming down the venous line would be 
trapped in the heat exchanger. The Travenol 
disposable oxygenator was used initially; 
however, the Sarns metal heat exchanger has 
now been substituted because of its superior 
efficiency.
The cardiotomy suction return enters the 
circuit through a 0.625-cm T-piece at a 
point just before the membrane oxygenator. 
All prime solutions enter via this system. 
Connectors in the circuit are plastic or 
metal. A coil of the sterile tubing, which will 
become the arterial and venous lines, is 
placed on a sterile side table, adjacent to 
the operating room table, and is covered 
with double drapes. This allows the per­
fusionist to rinse, debubble and fully prime 
all the membrane and tubing while the sur­
geon is preparing the surgical field. The 
former procedure takes time (up to 1 hour) 
and should not be rushed.
Operation of bypass.— The gas flow for
* American Optical Co., Spring Garden Rd., 
Halifax, NS.
fErika Laboratories, 53 Rancliffe Rd., Oakville, 
ON.Edwards Laboratory, Santa Ana, CA.
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a unit of 2 m2, consisting of 98% oxygen 
and 2% carbon dioxide, is started and 
maintained at 3 to 4 //min. A first prime 
of 1500 ml of 5% dextrose and water, con­
taining 15 000 units of heparin, is added 
through the Bentley reservoir. The roller 
pump is operated at the maximum rate (1 
//min) while most of the large bubbles are 
evacuated from the membrane by tilting 
the unit in all directions and gently thump­
ing the unit with the open palm. This takes 
approximately 20 to 25 minutes.
The rinse is then drained out of the arte­
rial Edwards reservoir with the pump still 
in operation. This rinse is slowly pushed out 
by a second rinse that comprises 1500 ml of 
5% dextrose and water without heparin, 
with 100 ml sodium-free human albumin. 
The latter coats the plastic surfaces and 
diminishes platelet adherence. The recir­
culation is continued and tiny bubbles will 
be evacuated at this time. Another 20 min­
utes is required for this step.
The pump is decreased and as much of 
the second prime is drained from the reser­
voir as possible without letting in any air. 
Then the final prime, which helps push out 
the second liquid rinse, is added, consist­
ing of 2 units of fresh (3 days) citrate- 
phosphate-dextrose reconstituted whole 
blood, to which has been added 1.5 ml of 
1% magnesium sulfate and 20 ml of 20% 
mannitol. This blood prime is slowly recir­
culated and the membrane is now left un­
disturbed for the duration of the case. The 
final prime constituents are listed in Table 
II.
TABLE II.—Constituents of F inal Prime
Constituent Content
Sodium, meq...................................... 129.9
Potassium, meq................................. 3.8
Chloride, meq....................................  94.0
Osmolality, mOsmol.........................  381
Glucose, m g/dl..................................  2001
Uric acid, m g..................................... 2,78
Hemoglobin, g /d l.............................. 9.1
Hematocrit, % ..................................  24
Two observations were made from these 
measurements. The sodium concentration 
in the final prime is very variable and prob­
ably represents the size of the membrane 
and the volumes of the rinse. It was never 
greater than 144 meq, but on three occa­
sions was less than 118 meq, though no 
ill effects resulted. On occasion also, the 
prime plasma hemoglobin concentration was 
greater than the postbypass value. The total 
volume of the circuit of 2 m'-’ is approxi­
mately 1000 ml.
Once the infant has been prepared and 
draped, the sterile covering over the arterial 
line is removed and brought to the operat­
ing room table, where it can be divided in 
preparation for bypass.
R e s u l t s
Deaths
There were six deaths in this group of 
patients. One patient with a tetralogy of 
Fallot and Ebstein’s anomaly had previous­
ly undergone three operations—a left Bla­
lock shunt, a Waterston shunt and an open 
infundibulectomy in the first 12 months of 
life. At 24 months of age, severe cardio- 
megaly and tricuspid regurgitation devel­
oped, and total correction was urgently re­
quired. She underwent closure of atrial and 
ventricular septal defects, infundibulectomy, 
tricuspid valvular annuloplasty and closure 
of the Waterston shunt. The early part of 
the operation was complicated by hypo­
tension and bradycardia, necessitating rapid 
commencement of cardiopulmonary bypass 
via the right atrium and the right common 
iliac artery. Bradycardia and hypotension 
at approximately 20 minutes after cessation 
of bypass were treated successfully, but she 
died approximately 1 hour later, in the in­
tensive care unit, of low cardiac output. 
Despite more than 4 hours of bypass time 
and 22 minutes of circulatory arrest, the 
patient’s plasma hemoglobin concentration 
was 100 mg/dl at the end of operation.
One infant died 24 hours after a Mustard 
repair. This patient underwent a Dacron 
patch enlargement of her new left atrium. 
However, it was not preclotted and as by­
pass was being discontinued it was neces­
sary to transfuse 3 units of old acid-citrate- 
dextrose blood without the use of a Micro­
pore transfusion filter. The pulmonary in­
sufficiency and terminal supraventricular 
tachycardia in this patient could have been 
related to use of the membrane oxygenator, 
but it is more likely that they were related to 
the sequelae of controlling the bleeding
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from the patch and the episode of hypoten­
sion.
Two infants underwent total correction 
of type 1 truncus arteriosus. The first, a 
6-week-old infant, died approximately 6 
hours after correction, of pulmonary ede­
ma, pulmonary hemorrhage and low car­
diac output. The second, a 2-month-old in­
fant, underwent total correction, consisting 
of closure of ventricular and atrial septal 
defects with insertion of a nonvalved, 10- 
mm Dacron graft from the right ventricle to 
the divided pulmonary artery. Extubation 
was effected shortly after arrival in the in­
tensive care unit and an excellent cardio­
pulmonary status was maintained, with nor­
mal blood-gas and biochemical values prior 
to sudden cardiac arrest approximately 10 
hours after surgery. The autopsy revealed 
no particular cause for the cardiac arrest.
One critically ill infant, in whom cardiac 
arrest had occurred in the cardiology lab­
oratory, underwent total correction of a 
long, preductal coarctation and closure of 
atrial and ventricular septal defects. This in­
fant could not support an adequate circula­
tion following termination of bypass.
The last infant, with hypoplastic left 
heart syndrome, died 36 hours after opera­
tion with low aortic pressure and anuria. 
The operation had consisted of creation of 
a large window between ascending aorta 
and main pulmonary artery, distal main 
pulmonary artery banding, duct ligation and 
atrial septectomy.
Respiratory Complications
Apart from these six patients, the remain­
der had minimal respiratory problems. Most 
(18) were either extubated in the operating 
room or on arrival in the intensive care unit; 
11 were extubated within 24 hours, 2 with­
in 48 hours, and 1 at 3 days. Late pul­
monary complications, such as increased 
secretions and lobe collapse, developed in 
six patients, but none required reintubation 
or tracheostomy.
Renal Function
Not one infant had hemoglobinuria and 
only one had oliguria, attributable to poor 
distal aortic perfusion (hypoplastic left 
heart). All other infants initially voided 
large quantities of clear urine.
Blood Values
Platelet counts were initially performed 
routinely, but discontinued as the mean for 
a group of 14 patients was 138.5 x 10s*// 
(range, 57 to 289 x 10,J/0- Bleeding aver­
aged 29 ml/kg body weight for a 48-hour 
period, though this was extremely variable 
depending on the complexity of the opera­
tion. In three infants re-exploration was re­
quired for bleeding; specific bleeding points 
were found in all.
Mean plasma hemoglobin concentrations 
measured from the pump at the end of by­
pass were 30.3 mg/dl (n =  33).
D iscussion
The evidence that membrane oxygenators 
are superior to bubble oxygenators for short­
term, extracorporeal circulation, remains 
scant. This can largely be attributed to our 
inability to identify specific alterations in 
the blood that could be blamed for the mor­
bid and clinical changes observed in pa­
tients following cardiopulmonary bypass 
with bubble oxygenators. Although many 
alterations in blood composition have been 
observed, the identification of a single fac­
tor, or of several factors, that might clearly 
be the cause of diminished pulmonary sur­
factant, for example, has yet to be made.
Changes have been observed in the 
plasma of blood exposed directly to a gas 
phase,1'8 but whether these changes speci­
fically cause the clinical picture of oliguria 
or pulmonary insufficiency is not known. 
Dobell and colleagues,3 in an ingenious ex­
periment, demonstrated the lethal effect of 
perfusing small dogs with plasma that had 
been recirculated in a screen oxygenator 
circuit. The protective effect of interposing 
a Teflon membrane oxygenator was demon­
strated in another experimental model that 
was similar except that whole blood was 
used. The specific alteration in the plasma 
causing the animals’ deaths and the exact 
physiologic sequelae were not identified. 
This observation needs further investiga­
tion.
Not having a specific change to look for, 
most investigators measure the traumatic 
effect on erythrocytes and platelets. Plate­
let counts and function have been compared 
in membrane and bubble oxygenators,4- 5
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and it is clear that both red cell and platelet 
function are better preserved' in a mem­
brane system. Particle counts0-8 in the arte­
rial inflow line of patients undergoing car­
diopulmonary bypass have been greatly 
diminished in membrane oxygenators, and 
cerebral function is said to be superior. Pul­
monary function, on the other hand, as 
measured experimentally in animals, is not 
significantly different9 between the two 
types of oxygenators.
No one could argue that the observed 
hematologic changes are useful to the body, 
but their clinical importance to the cellular 
and subcellular systems of the body is not 
clear. It is just not known how much whole 
blood damage is clinically tolerable. The 
problem has been summarized by Peirce:10 
“standard tests [for measurements of these 
changes] are not available and there is 
much room for improvement in methods”.
Without specific measurements, evalua­
tions must be based on testimonials4’ 11-13 
such as this one and on observations14, 15 
that bubble oxygenators cannot safely oxy­
genate patients for extended periods, as can 
be done with membrane oxygenators.
Bearing this in mind, this presentation 
is only witness to our results of open-heart 
surgery in infants using the membrane 
oxygenator among several other modifica­
tions in cardiopulmonary bypass technique. 
It is a reliable method of oxygenating 
blood in an extracorporeal circuit. Target 
organs such as the lungs and kidneys, 
which are commonly compromised by the 
sequelae of bypass using a bubble oxy­
genator, were not affected appreciably in 
this group of patients. The total material 
cost of bypass using this circuit is $231.00,* 
compared with the total cost of using a con­
ventional Bentley pediatric oxygenator of 
$204.00. The other small benefit of the 
membrane oxygenator is that the perfusion­
ists and the nursing personnel become so 
thoroughly familiar with the routine use of 
such a device that the psychologic barrier to 
its use in prolonged extracorporeal mem-
*For a 2-m2 Lane membrane, Bentley cardiotomy 
reservoir, Lande reservoir, transfusion filter, prime, 
tubing and suction tips.
brane oxygenation for respiratory insuffi­
ciency is not present.
We acknowledge the help given by Drs. A. V. 
Krause and A. J. Stewart and perfusionists C. 
Power, R. Ricketts, P. Pike, J. MacDonald, and 
R. Leadon.
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For prophylactic 
security during 
indwelling _ 
catheterization...
Neosporin 
Irrigating 
Solution
(Sterile)
neomycin sulphate 
polymyxin B sulphate
• helps prevent bacteriuria and Gram-negative 
rod bacteremia associated with indwelling 
catheters
• wide antibacterial activity against susceptible 
Gram-negative and Gram-positive organisms 
including most strains of Proteus and 
Pseudomonas
• low index of allergenicity —  low incidence of 
irritation —  low absorption from mucosa
• recommended in diluted solution for 
continuous bladder irrigation in short-term 
therapy (up to 10 days). NOT FOR INJECTION.
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PERICARDIECTOMY FOR UREMIC TAMPONADE*
J. E. MORIN, MD, FRCS[C], D. S. MULDER, MD, MSc, FRCSfC] and
R. LONG. MD
Pericardial tamponade developed in 29 patients 
with uremia. The clinical presentation varied, 
some patients having no symptoms whereas 
others sustained circulatory collapse. Peri­
cardial friction rub, elevated central venous 
pressure and a paradoxical pulse were the most 
common physical findings. Serial chest radio­
graphy and echocardiography were most useful 
procedures in confirming this diagnosis. Two 
patients were treated conservatively and died 
despite repeated pericardiocentesis. The re­
maining 27 patients underwent partial pericar- 
diectomy. One patient died of cardiorespiratory 
failure and a second from brain damage related 
to cardiac arrest before pericardiectomy. The 
other 25 patients reported immediate relief of 
symptoms and no recurrence of pericarditis.
Pericardiectomy is the treatment of choice in 
uremic pericardial tamponade.
Une tamponade pericardique est apparue chez 
29 patients souffrant d’uremie. Le tableau Cli­
nique etait variable: quelques patients ne pre- 
sentait aucun symptome alors que d'autres 
avaient subi un collapsus circulatoire. A  I'exa- 
men physique, les observations les plus fre- 
quentes ont ete un frottement pericardique, une 
pression veineuse centrale elevee et un pouls 
paradoxal. Des radiographies et des echocardio­
graphies seriees ont ete un moyen tres utile 
de confirmer le diagnostic. Deux patients ont 
recu un traitement conservateur et sont morts 
en depit de pericardiocenteses repetees. Les 27 
autres patients ont subi une pericardiectomie 
partielle. Un patient est mort d'insuffisance 
cardiorespiratoire alors qu'un deuxieme a suc- 
combe aux dommages cerebraux consecutifs a 
un arret cardiaque survenu avant la pericardiec­
tomie. Chez les 25 autres patients, on a signale 
un soulagement immediat des symptomes et 
aucune recurrence de la pericardite n'est sur- 
venue.
La pericardiectomie est le traitement de choix 
dans les cas de tamponade pericardique ure- 
mique.
*From the division of cardiovascular and thoracic 
surgery, McGill University, the Royal Victoria 
Hospital and the Montreal General Hospital, 
Montreal, Que.
Presented at the annual meeting of the Canadian 
Cardiovascular Society, Montreal, Que., Oct. 23- 
25, 1975.
Reprint requests to: Dr. J. E. Morin, Department 
of surgery, Royal Victoria Hospital, 687 Pine Ave. 
W, Montreal, PQ H3A 1A1.
S in c e  the introduction of hemodialysis, 
survival of patients with uremia has in­
creased and the occurrence of uremic peri­
carditis with effusion is recognized more 
frequently. The management of these pa­
tients, however, is still controversial. While 
in the past the appearance of pericarditis 
was almost always a sign of imminent death, 
most patients with pericarditis now can be 
treated successfully and continue their pro­
gram of renal dialysis or kidney transplanta­
tion.
P a t ie n t s , C l in ic a l  F e a t u r e s  a n d
R e s u l t s  o f  In v e st ig a t io n
From 1968 through 1974, 29 cases of 
uremic pericardial tamponade were recorded 
at the Royal Victoria Hospital and the 
Montreal General Hospital (Table I). Of the 
29 patients, 18 were male and 11 were fe­
male; their ages ranged from 15 to 70 years, 
but 13 of the 29 patients were under 30 
years of age. Most of the patients had been 
hospitalized for reasons other than their 
cardiac condition, including chronic hemo­
dialysis or pretransplant evaluation.
The severity of their subjective symptoms 
ranged from little acknowledgement of dif­
ficulty to severe circulatory collapse; the 
symptoms included fatigue, chest pain, short­
ness of breath and peripheral edema. There 
was little correlation between subjective 
symptoms and the actual degree of peri­
cardial effusion.
The physical findings are presented in 
Table II and the results of diagnostic studies 
are listed in Table III.
Of the diagnostic studies used to confirm 
the clinical impression of tamponade the 
most reliable was chest radiography, which 
demonstrated in all 29 patients a recent and 
progressively enlarging cardiac silhouette 
suggestive of pericardial effusion. Echocar­
diography also was reliable; in the 12 pa­
tients in whom it was used, effusion was 
demonstrated in each. The isotope scan 
findings were compatible with pericardial 
effusion in eight of nine patients, but the 
electrocardiogram was characteristic in on-
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TABLE I.—Details of 29 Uremic P atients Concerning Blood Values, Dialysis
and Pericardiocentesis
Patient no. Age, yr BUN,mg/dl
Serumcreatinine,mg/dl
Length of dialysis before pericardiec­tomy, mo Pericardiocen­tesis Outcome
* 1............................. ........ 15 33 5.4 21 Yes Died2 ............................. ........ 20 153 4.8 16 No Alive3 ............................. ........ 22 68 11.6 0.1 No Alive4 ............................. ........ 22 153 19.2 0.6 Yes Died5 ............................. ........ 23 90 13.5 0.25 No Alive6 ............................. ........ 23 118 5.2 36 No Alive7 ............................. ........ 24 111 5.8 17 No Alive8 .............................. ........ 24 160 8.2 11 No Alive9 ............................. ........ 24 97 10.2 48 No Died10............................. ........ 25 128 6.8 2.5 No Alive11............................. ........ 28 76 4.4 24 No Alive12............................. ........ 29 60 14.4 12 Yes Alive13............................. ........ 29 136 6.2 37 No Alive14 ........................ ........ 35 120 6.0 24 No Alive15............................. ........ 35 88 4.6 3 No Alive*16............................. ........ 36 40 6.4 Yes Died17............................. ........ 37 56 9.5 4 Yes Alive18............................. ........ 38 164 6.7 48 No Alive19............................. ........ 39 114 8.8 36 Yes Alive20............................. ........ 40 156 12.7 No Alive21............................. ........ 42 74 6.2 28 Yes Alive22 ........................ ........ 42 106 5.8 24 No Alive23............................. ........ 44 87.4 10.0 25 No Alive24............................. ........ 48 140 6.9 6 Yes Died25............................. ........ 52 104 4.9 28 No Alive26............................. ........ 52 20 6.0 17 No Alive27 ........................... ........ 63 165 9.8 1 Yes Died28............................. ........ 67 141 11.0 — No Alive29............................. ........ 70 132 5.9 3 No Died
*Did not have pericardiectomy.
TABLE I I — P hysical F indings in 29 P atients 
with Uremic Pericardial T amponade
No. ofFinding patients
Elevated central venous pressure... 25Pericardial friction rub*.................... 23Paradoxical pulsef............................  17Systemic hypotension (<  100mm H g)..........................................  12Peripheral edema..............................  9
*In some patients, pleuropericardial.(Associated with a decrease in arterial pressure of 10 to 46 mm Hg with inspiration.
TABLE III.—Results of D iagnostic 
Procedures
Investigation No. of patients
No. ofpatients with positive findings
Serial chestradiography........... 29 29Echocardiography. . . 12 12Electrocardiography . 29 9Isotope scanning....... 9 8
ly nine (the other 20 manifested nonspecific 
ST-T wave changes).
All the patients in this series had renal 
failure, blood urea nitrogen (BUN) concen­
trations ranging from 20 to 165 mg/dl and 
creatinine concentrations from 4.6 to 19.2 
mg/dl.
Results of Treatment
Pericardiocentesis was performed in 9 of 
the 29 patients for relief of their symptoms, 
but this was only of temporary benefit. The 
effusion recurred rapidly and the symptoms 
reappeared with increased severity.
Anterolateral pericardiectomy, through 
left thoracotomy, was performed in 27 pa­
tients. Two of these patients died. One pa­
tient died from massive gastrointestinal 
hemorrhage and aspiration that preceded 
renal failure and pericarditis; the second 
died from profound irreversible brain dam­
age 11 days after cardiac arrest had devel­
oped on the ward following pericardiocen-
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tesis and before pericardiectomy. The im­
mediate postoperative course in the other 
25 patients was uneventful, though 3 died 
later. One died after 6 weeks from myocar­
dial infarction, another died after 18 months 
from acute hemorrhagic pancreatitis, and 
the third died after 3 years from subarach­
noid hemorrhage.
Two patients did not undergo pericar­
diectomy; in them progressive tamponade 
led to cardiac arrest despite repeated peri­
cardiocentesis, and resuscitation was unsuc­
cessful.
D iscussion
With the longer survival of uremic pa­
tients, uremic pericarditis is becoming recog­
nized more frequently, especially in the 
younger patients. Bailey and colleagues1 
reported an incidence of 41% and others 
have put it as high as 50% .2 Although peri­
carditis seems to occur with greater fre­
quency within the 1st year of dialysis, it 
may occur at any time.
The cause of this entity is largely un­
known. Viruses, uremic toxins and chemical 
abnormalities all have been incriminated as 
etiologic agents.1- 2 Compty, Cohen and 
Shapiro2 have postulated that pericarditis 
is an indication of poor control of uremia, 
yet pericarditis develops in 16% of those 
on dialysis programs at some time in the 
course of the disease. Obviously, in not all 
of these patients do effusions accompany 
the inflammatory process in the pericardium, 
and the prognosis for most patients with 
uremic pericarditis is good if proper treat­
ment is instituted.2
The inflammatory process in the uremic 
patient is not limited to the pericardium but 
seems to affect serous membranes through­
out the body.1- 4 Thus, the characteristic 
friction rub is often not simply pericardial 
but has a pleural component as well. In 
many patients the chest radiograph shows 
evidence of pleural effusions before the 
pericardial effusion becomes manifest. Ali- 
Regiaba and colleagues0 have speculated 
that in uremia the serous membranes under­
go a subacute inflammatory process with 
the formation of vascular adhesions between 
visceral and parietal pericardium. Cardiac 
pulsations engender shearing forces that may
rupture these vascular adhesions and pro­
duce the characteristic hemorrhagic effusion.
Progressive pericardial effusion or tam­
ponade was diagnosed most often by evi­
dence of elevated venous pressure, often 
accompanied by a friction rub. Although a 
paradoxical pulse was present in one-half of 
our cases, according to Alfrey and col­
leagues*’ it is not a reliable sign. Ascites and 
edema were infrequently found in patients 
presenting with this acute complication of 
their uremia although hepatomegaly was 
found in several. Ali-Regiaba and asso­
ciates5 have reported that 80% of those 
with uremic pericarditis will have fever and 
60% will have leukocytosis, while 54% 
will become hypotensive during a dialysis 
program.
Concerning substantiation of the diag­
nosis, Collins and associates2 agreed that 
the regular chest radiograph gives the most 
consistently positive results, showing the en­
larged, globular cardiac silhouette in 100% 
of cases. Constrictive pericarditis is rare in 
uremia7- s so that the presence of these 
symptoms with a small cardiac silhouette is 
infrequent. Echocardiography is a relatively 
new procedure and gives reliable results 
quickly and easily, and so seems ideal for 
use in these patients who, at the time of 
diagnosis, are often critically ill.9 Although 
the electrocardiogram is almost always ab­
normal in these patients, it rarely shows the 
concave ST elevation and T-wave inversion 
characteristic of pericarditis.2 Usually the 
electrocardiogram shows nonspecific changes 
and low voltages.
The fluid in uremic effusions is almost 
always bloody2- G- 10- 11 and Merikas, Sa- 
martzis and Marketos12 have used pericar­
diocentesis as the treatment of choice for 
tamponade. But because the fluid in the 
pericardial cavity contains large fibrin clots 
and is often loculated,2 each pericardial tap 
removes only a small portion of the fluid. 
Most agree that, even when symptomatic 
improvement follows pericardiocentesis the 
improvement is short-lived as the fluid ra­
pidly reaccumulates.2- 3 Collins and col­
leagues2 have advocated one attempt at peri­
cardiocentesis before pericardiectomy, but 
beyond this is not justified. In our series the 
two patients who died without operation
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each had undergone several pericardiocen­
teses and in all patients the fluid reaccumu­
lated with progression of their symptoms.
Although all these patients have severe 
renal disease, it is not possible to identify 
those in whom pericarditis and tamponade 
will eventually develop. The BUN and se­
rum creatinine values are almost always ab­
normal but there is no correlation between 
the values and the development of pericar­
dial effusion.3’ 4- 10
Bailey and colleagues1 have reported a 
72% cure rate of uremic pericarditis with 
intensive hemodialysis. However, cardiac 
tamponade is a lethal complication and is 
not amenable to prolonged therapy. In 
Hager’s13 view dialysis, by mobilizing the 
intravascular fluid faster than the extra- 
vascular fluid and thus compromising an 
already marginal venous return, may worsen 
the patient’s condition rather than improve 
it.
The mortality from uremic pericarditis 
is said to be 12% .3 The mortality and mor­
bidity of pericardiectomy is negligible and 
improvement after operation is manifested 
by a decreased venous pressure and im­
provement of cardiac output. Because of 
the initial two deaths in our series and the 
rapidity with which acute, pericardial tam­
ponade and death can supervene, we now 
follow a specific program in treating all pa­
tients with uremic pericarditis.
At the first sign of pericarditis all patients 
are assessed clinically regarding pulsus para- 
doxicus, Kussmaul’s sign, venous pressure 
and hypotension. After the initial chest ra­
diographs and echocardiograms have been 
obtained, dialysis is performed on at least 
every 2nd day, with regional heparinization. 
This form of therapy is continued as long as 
there are signs of improvement or there is 
no increase in heart size or echocardio- 
graphic evidence of increasing pericardial 
fluid. The development of a significant 
effusion either clinically or even symptoma­
tically as shown by echocardiography is suf­
ficient justification for immediate anterior 
pericardiectomy. This approach has been
associated with no mortality and little mor­
bidity. We do not give corticosteroids, 
though the study of Eliasson and Murphy14 
suggests that steroid therapy may be a use­
ful alternative in the high-risk patient. We 
reserve pericardiocentesis for emergency 
use only, and usually it is performed with 
the patient in the operating room. Pericar­
diectomy prevents recurrence of this com­
plication.4
Uremic pericarditis, therefore, should be 
treated by a specific program that includes 
pericardiectomy if tamponade has been 
diagnosed.
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A NEW MODEL FOR ASSESSMENT OF MYOCARDIAL FUNCTION: 
I. DESCRIPTION AND PERFORMANCE NORMS*
COLIN E. BAYLISS, MD, FRCS[C],t FLORA B. CRAWFORD, RN and 
BAFFOUR NSAFOAH, BSc
Use of a new isometric rabbit-heart model, a 
modification of Langer's original preparation, has 
permitted independent assessment of myocardial 
perfusability in addition to contractility and re­
laxation. In this model an isolated, paced, inter­
ventricular septum contracts against a tension 
transducer and is perfused from another awake 
rabbit. Heparinized, diluted arterial blood is 
warmed and pumped at 1 ml/g*min. Perfusion 
pressure is measured by transducer. Each pre­
paration serves as its own control.
This model was used in determining perform­
ance norms for 68 preparations. Contractility was 
measured by maximum active tension, maximum 
rate of increase of tension and time to peak 
tension; relaxation by resting tension, maximum 
rate of relaxation and relaxation time; and per­
fusability by mean perfusion pressure and mean 
conductance. The status of the parabiotic rabbit 
was closely monitored. These studies have shown 
that the model is relatively simple, clearly de­
fined and adaptable to a variety of experimental 
protocols.
L'emploi d'un nouveau dispositif isometrique du 
coeur de lapin, une modification de la prepara­
tion originelle de Langer, a permis de mesurer 
la capacite de perfusion du myocarde en plus 
de la contractilite et de la relaxation. Dans ce 
dispositif, un septum interventriculaire isole et 
stimule se contracte contre un transducteur de 
tension et est perfuse a partir d'un autre lapin 
eveille. Le sang arteriel dilue et heparine est 
rechauffe et pompe a raison de 1 ml/g .min. 
La pression de perfusion est mesuree a I'aide 
du transducteur. Chaque preparation sert de 
propre temoin.
Ce dispositif a servi a determiner les normes 
de performance de 68 preparations. La contrac­
tilite a ete mesuree par la tension active maxi­
mum, le taux maximum d'augmentation de la 
tension et le temps necessaire pour atteindre
*From the department of surgery, University of 
Toronto, Toronto, Ont.
Supported by a grant from the Ontario Heart 
Foundation.
Presented in part at the annual meeting of the 
Canadian Cardiovascular Society, Montreal, Que., 
Oct. 23-25, 1975.
fScholar of the Medical Research Council of 
Canada.
Reprint requests to: Dr. C. E. Bayliss, Depart­
ment of surgery, Medical Sciences Building, Uni­
versity of Toronto, Toronto, ON M5S 1A8.
la tension maximum; la relaxation, par la tension 
au repos, le taux maximum de relaxation et le 
temps de relaxation; et la capacite de perfusion, 
par la pression de perfusion moyenne et la con­
ductance moyenne. L'etat du lapin en parabiose 
a ete constamment surveille. Ces etudes ont 
montre que le dispositif est relativement sim­
ple, clairement defini et qu'il peut s’adapter a 
une diversity de protocoles experimentaux.
T h e r e  has, in the 1970s, been increasing 
interest in the physiologic correlates of myo­
cardial ischemia, interest that has been 
stimulated by new possibilities for medical 
and surgical treatment of coronary artery 
disease. Direct measurements of the subtle 
changes in myocardial contractility, relaxa­
tion and perfusability have been a continu­
ing challenge.1
Whole-heart models, despite physiologic 
perfusion and ingenious methods of instru­
mentation, provide hemodynamic data that 
require complex conversion to the basic 
units of force provided by isolated muscle 
models. Isolated preparations, on the other 
hand, depend on oxygen diffusion from a 
water bath and have the disadvantage of a 
potentially hypoxic central core. Isometric 
models are attractive because they eliminate 
the variables of changing active state and 
afterload that alter performance in shorten­
ing muscle fibres.1' 2
Attempts to combine the advantages of 
isolated, isometric function and physiologic 
perfusion in a working heart model have not 
been entirely successful. Improvements3’ 4 
on the classic Langendorff model5 convert 
it to a working preparation but retain the 
disadvantage of an anoxic washout perfu­
sion using Krebs-Henseleit bicarbonate buf­
fer; models using partially isolated, perfused 
ventricular segments6' 7 present difficulties 
in measuring perfusion and muscle force; 
and a perfused papillary muscle preparation, 
tried by Langer and Brady8 in 1963, be­
cause of technical difficulty in cannulation, 
was found less satisfactory than rabbit in­
terventricular septum.9 This last model was 
used in much of the classic work on ionic 
flux by Langer;10 its only inadequacy is a
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relatively unsophisticated perfusion system, 
consisting of an unmonitored, controlled- 
flow, single passage of heterologous red cells 
in balanced electrolyte solution.
The purpose of this communication is to 
describe a new model that modifies Langer’s 
original preparation by introducing moni­
tored parabiotic perfusion. The possibility 
of assessing myocardial perfusability is thus 
added to the model’s already well-estab­
lished capacity to measure directly con­
tractility and relaxation.
M eth o d s
Septal Preparation and Mounting
A 3-kg male New Zealand white rabbit 
is heparinized and then anesthetized with 
an intravenous injection of sodium pento- 
thal. The heart is excised through a median 
sternotomy and placed in warm Normosol-R 
(pH, 7.4) before it is dissected.
The preparation and mounting of a trian-
r igh t  ventric le  
pu lm onary artery 
righ t atrium
septal artery
exc ise  righ t ven tric le  and a tria  
transect abrta  expo sing  
left corona ry  artery
tricusp id  p a p illa ry  muscle 
deroof le ft coronary  artery
gular segment of interventricular septum are 
illustrated in Fig. 1. Perfusion is established 
within 2 to 5 minutes of excision. Dissection 
is facilitated by pinning the heart to a flat 
wax surface, by using optical loupes (mag­
nification power, 2.5) and by ensuring good 
illumination. The perfusion cannula is made 
from polyethylene-50 tubing and has a small 
bulb 4 mm proximal to a finely drawn tip; 
it is held in place by a 6-0 suture. The stump 
of tricuspid papillary muscle marks the best 
position for the apical suspending suture 
and the most distal point of septal artery 
perfusion. The atrioventricular node is ex­
cised to remove any tendency for rapid 
spontaneous rhythm. Before the base clamps 
are applied the septum is suspended from 
the strain gauge and weighed to determine 
the tissue perfusion flow of 1 ml/g-min. The 
output from a Grass SD-9 stimulator is 
delivered through the base clamps or 28- 
gauge platinum electrodes inserted in the 
myocardium (Fig. 2). Perfusate drips from 
the double endocardial surface of the sep­
tum and keeps the tissue moist. A 24- 
gauge Yellow Springs thermistor needle is 
inserted into the tissue to monitor septal 
temperature.
The mounting system is an aluminum 
yoke, detachable from a vertical plastic 
frame. The two base clamps are controlled 
by Palmer micromanipulators so as to exert 
slight lateral tension. The suspending suture 
is linked to a Statham UC-4 silver cell ten­
sion transducer by a detachable metal hook. 
The transducer can be moved in all direc-
excise left ventricle
- 5 -0  suspending suture
- trim to remove all 
>n-perfused tissue
excise aortic root 
and A-V node
P E “ 5 0  septal 
a rtery cannu la
perfusion
Fig. la
suspend from strain gauge at 
stable resting 
tension of 5-10 g
course of septal artery
pacer stimulus 
con be delivered
small toothed clamps under 
slight lateral tension
Fig. lb
Fig. 1.—(a) Stages in septal preparation, (b) 
Septal preparation and mounting.
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Fig. 2.—Model for assessment of myocardial 
circuit stippled.
tions by means of a Narishige micromanipu­
lator permanently mounted on the plastic 
frame. For applications requiring a signi­
ficant period of organ storage, the hook is 
clamped to the yoke and the yoke and sep­
tum are removed from the frame to the 
storage environment. The unit is reassem­
bled for direct measurement of contracture 
(i.e., level of resting tension) and reperfu­
sion following storage.
The Parabiotic Rabbit
A 3-kg male New Zealand white rabbit 
is lightly restrained in a metal rabbit-holder. 
Warmth, from an electric heating pad, re­
laxes the animal and promotes vasodilation. 
Two 22-gauge plastic cannulas are inserted 
into an ear artery and opposite ear vein un­
der local anesthesia. A small transverse cut- 
down aids positive identification of the 
artery in the median neurovascular bundle. 
Through the venous cannula the animal 
then receives a slow infusion of 2000 units 
of heparin, 10 ml of Normosol-R (pH, 7.4) 
and 10 ml of “flow-promoting cocktail” 
(consisting of 150 ml Normosol-R, 10 g 
dextran 40, and 1.5 g Pluronic F-68, filtered 
to exclude bacteria and stored at 4°C).
Under restraint, calm but awake rabbits 
manifest a tendency to spontaneous and 
lethal hyperventilation. For this reason, a 
low flow of carbon dioxide (C 02) (500 
ml/min) is directed to the area of the ani­
mal’s nose and adjusted to maintain normal 
arterial C 0 2 tension (Pco2). Fluid deficits 
are corrected with Normosol-R, and meta­
function. Arterial circuit black; venous return
bolic acidosis is reversed with 7.5% sodium 
bicarbonate solution. With careful manage­
ment the parabiotic rabbit remains stable 
for up to 3 hours of recirculation.
The Perfusion Circuit
Fig. 2 illustrates the central components 
of the model. Tubing consists of Silastic 
rubber segments joined by 14-gauge needle 
adapters at connections. The system is 
primed with 30 ml of Normosol-R and 1000 
units of heparin. Diluted blood is slowly 
recirculated for 10 minutes before septal 
mounting. Flow is controlled by a calibrated 
Holter pump.
The rabbit’s arterial pressure is monitored 
just distal to the ear cannula by a Micron 
MP-15 transducer. A 20-ml collapsible rub­
ber reservoir is inserted in parallel with the 
arterial line between the rabbit and pump 
head. If arterial spasm interrupts smooth 
perfusion, back pressure of the distended 
reservoir tends to break the spasm. If ob­
struction persists, the reservoir provides 
enough fluid for a further 10 to 20 minutes 
of perfusion. When closed, the arteriovenous 
shunt at the level of the ear cannulas directs 
circulation through the parabiotic rabbit; 
when open the shunt excludes the animal 
from the circuit and perfusion can be main­
tained despite arterial spasm or instability 
of the rabbit’s condition.
The arterial manifold is the core of the 
perfusion monitoring system. Arterial Pco2 
is measured continually by a General Elec­
tric electrode with its tip positioned adjacent
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to a Yellow Springs thermistor probe in the 
distal portion of the manifold. The Pcoa 
electrode is calibrated periodically and acid- 
base balance determined in arterial blood 
by a conventional Radiometer bench-top 
electrode system. The perfusate is heated to 
40°C by a circumferential in-line heater 
controlled by a variable power supply. A 
Micron MP-15 pressure transducer measures 
mean and phasic pressure in the slightly 
pulsatile system. A resistance artifact of 20 
to 25 mm Hg is determined for each septal 
cannula and applied as a correction factor. 
The side arm in the distal manifold is used 
to inject drugs or to introduce a different 
perfusate, if desired. Optimal position for 
the septal cannula is maintained by clamp­
ing the entire manifold in a Narishige micro­
manipulator. Perfusate dripping from the 
surface of the septum is collected in a fun­
nel-reservoir and returned to the rabbit via 
the venous line.
Assessment of Myocardial Function
The mounted septum is paced at 60 beats 
per minute. The stimulus blip is recorded 
on the first channel of a four-channel Brush 
recorder and simultaneously displayed on a 
storage oscilloscope in the variable persist­
ence mode. The stimulus voltage is adjusted 
to remain just above capture (5 to 10 V) 
and the duration of the square wave is ad­
justed to 2 ms. A photographic record of 
the stimulus variables is made with a Pola­
roid oscilloscope camera.
Tension recordings are made by the 
weight-calibrated tension transducer and 
displayed on the second channel of the 
Brush recorder. Resting tension is adjusted 
to a level between 5 and 10 g and allowed 
to stabilize for 30 minutes. If the septum 
has been damaged during preparation, loss 
of contractility leads to progressive diminu­
tion of maximum active tension and con­
tracture results in progressive increase in 
the resting tension. Septa are discarded if 
either eventuality is noted during the 30- 
minute stabilization period. Measurements 
taken directly from the tension tracing are 
maximum active tension (total tension minus 
resting tension), resting tension, time to peak 
tension and relaxation time.
The differential of tension is displayed on 
the third channel of the Brush recorder. Ex­
cellent vibration-free mounting of the ap­
paratus is essential to obtain clear differen­
tial tracings. A mechanical function gen­
erator is used to calibrate the differentiator; 
this is thought to have the advantage of test­
ing the transducer circuit. Measurements 
taken directly from the differential tracing 
are maximum rate of increase in tension and 
maximum rate of relaxation.
The manifold perfusion pressure at con­
stant flow is displayed on the fourth channel 
of the Brush recorder. The pressure trans­
ducer is calibrated by mercury manometer 
and zero levels are checked periodically 
throughout the perfusion. The pressure is 
slightly pulsatile (pulse pressure, 10 to 15 
mm Hg) owing to the action of the Holter 
pump, so that mean pressure is used to cal­
culate conductance (flow per unit pressure) 
in assessing perfusability. If control pres­
sures exceed 150 mm Hg (indicating ex­
cessive resistance) the septum is rejected.
During use of the model for testing 
an experimental hypothesis, each septum 
would act as its own control, with baseline 
recordings taken after 30 minutes of stable 
function. These measurements would then 
be compared with similar measurements 
taken after the experimental intervention.
Results
Septal Function
A typical tracing from a stable septum 
after 30 minutes of perfusion is shown in 
Fig. 3. There is no discernible effect of 
contraction on the pressure tracing. Despite 
the slight compliance of the system, the 
model is essentially isometric.
A summary of the performance norms
STIMULUS
20 rvolts 10 L
q! _LL 1 L L L L L L L 1 I I I I I 1 I I 111 1 L 1
30 r  
2 0 -
grams 1Q _ 
0  -
100 r  
50 - 
g /s  0  -  
50 
100
i m m j u i t
dF/dt
150 PRESSURE 
0
Fig. 3.—Typical tracing from stable septum 
after 30 minutes of perfusion.
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TABLE I.—Performance Norms for 68 Per­
fused Septa
Norm (mean ±  
SD) after 30 min 
of stable
Performance* function
Contractility
T m a x ,  g .................................... 14.3 ±  7.2
dF/dtmax, g/S......................... 100 ±  67
TPT, m s................................. 261 ±  82
Relaxation
Tr,.«. g ................................ 6.7 +  1.7
—dF/dtmax, g /s .............. 70 ±  51
RT, ms............................... 549 ±  167
Perfusability
P, mm H g.......................... 97 ±  24
C, td/g- min- mm H g. . . . 11.1 ±  3.3
* Abbreviations: Tmsx, maximum active tension; 
dF/dtm.„, maximum rate of rise of tension; TPT, 
time to peak tension; Tr(,st, resting tension; — dF/ 
dtmnl, maximum rate of relaxation^ RT, relaxation 
time; P, mean perfusion pressure; C, mean conduct­
ance (flow per unit mean pressure).
for 68 preparations after 30 minutes of 
stable function is presented in Table I.
The Parabiotic Rabbit 
Details concerning the status of the para­
biotic rabbit in 68 preparations are set forth 
in Table II. These values were obtained at 
the beginning of perfusion and maintained 
for 30 minutes. They emphasize that, by 
human standards, normal acid-base status 
for a rabbit is a mild state of respiratory and 
metabolic alkalosis. It is only possible to 
maintain a constant Pco2 in the presence 
of the inevitable spontaneous hyperventila­
tion by administering small quantities of 
C 0 2 in the inspired air. The proportion 
of CO-2 in the mixture must be varied in 
response to continuous arterial Pco2 moni­
toring.
The hematocrit dilution attributable to 
use of priming fluid and “flow-promoting 
cocktail” is 15%. Hemodilution of this or­
der has no effect on the adequacy and dis­
tribution of coronary blood flow.11
TABLE II.—Status of 68 Parabiotic Rabbits
Value
Variable* (mean ±  SD)
pH ...............................................  7.45 ±  0.05
PCO2, mm H g............................  37 ±  4
Base excess, m mol/1................  +2.3 ±  2.7
PO2, mm H g..............................  89 A 6
Hematocrit, %
Normal...............................  37.2 ±  2.9
Diluted...............................  31.6 ±  2.8
Arterial pressure (mean),
mm Hg...................................   87 ±  10
*Blood-gas values are for arterial blood.
D iscussion
In the intact animal or human, the heart 
is inaccessible for direct measurement of 
muscle function. Direct access requires that 
a surgical procedure be combined with 
mechanical intervention that frequently al­
ters function. At best, the data are either in­
direct or approximate. Although whole 
hearts can be artificially perfused, dither the 
perfusate or the perfusion system is rela­
tively unphysiologic and may be difficult to 
control or quantitate. Isolated papillary 
muscle preparations are unperfused, and, 
although they permit one to measure rela­
tively pure functional variables, they may 
have an anoxic central core that splints con­
traction or impedes tension development. 
Isometric function, though desirable, is dif­
ficult to achieve in a physiologic setting 
where independent variables can be con­
trolled or measured. There is still no simple 
and precise method for quantitating and dif­
ferentiating between contracture and edema 
without destroying the tissue by the analysis. 
Langer’s perfused-septum model approaches 
the ideal but lacks a sophisticated perfusion 
system. Because the simultaneous assessment 
of contractility, relaxation and perfusability 
might be useful in solving problems of car­
diology and cardiac surgery, it seems worth­
while to adapt Langer’s model to incorporate 
this capability.
The reasons for choosing the rabbit as an 
experimental animal are important. This 
species is available in unlimited quantities at 
reasonable prices. Physiologically, though in 
a delicate state of balance, basic data are 
well documented and resemble those of the 
human in many respects. The size of its 
heart is ideal for instrumentation. Particu­
larly fortuitous is the fact that the ear vessels 
are large in relation to animal size, making 
vascular access possible without the need 
for general anesthesia.
The model can be used to simulate vari­
ous conditions of cardiopulmonary bypass. 
This is achieved by permutations and com­
binations of temperature, perfusate composi­
tion, ischemia, pacemaking and resting ten­
sion. For example, a vented heart with the 
aorta clamped at room temperature would 
be simulated by lowering the resting tension 
to zero, stopping perfusion and turning off
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the stimulator. Similarly, an unvented, 
fibril lating heart with coronary artery per­
fusion at 30°C would be simulated by in­
creasing the resting tension to 20 g, applying 
a fibrillating current from the stimulator and 
perfusing with unheated blood at a pressure 
of 80 mm Hg.
Metabolic studies can be carried out on 
the perfusate entering and leaving the sep­
tum. This capability is well illustrated by 
Langer’s studies of cation kinetics.10 Meta­
bolic and morphologic studies can be car­
ried out on the tissue itself, if destruction 
is acceptable in an experimental design. The 
method of perfusion, which incorporates an 
option to exclude the parabiotic animal from 
the circuit, permits the testing of drugs or 
perfusates on the isolated heart or on the 
whole animal in addition to the heart.
There are a number of deficiencies in the 
model that do not detract from its usefulness. 
The triangulated septum probably has a 
centripetal contraction pattern, with all 
forces vectored upward to the tension trans­
ducer except those at right angles to the 
suspending suture. A low, flat triangle dis­
sipates a good deal of force against the base 
clamps; a high, peaked triangle vectors most 
of its force upwards. This is a systematic 
variable that is compensated for by having 
each preparation, regardless of geometric 
factors, act as its own control.
The process of isolating any muscle pre­
paration implies an ischemic interval. The 
interval varies from 2 to 5 minutes in this 
model and results in septa that deteriorate 
with reperfusion if damage is appreciable. 
Any septum that does not remain stable in 
all respects for 30 minutes of control perfu­
sion must be rejected from further study.
Whether the double endocardial surface 
of the septum is a benefit or a liability is 
not known. It probably results in fairly uni­
form perfusion but may not typify free 
ventricular myocardium. Its main advantage 
is that thebesian venous leakage keeps all 
surfaces wet, a situation that would not 
occur if one of the surfaces was epicardial. 
The deleterious effects of a blood-gas inter­
face12 appear to be largely nullified by the 
parabiotic animal in the circuit and this may 
be the major advantage of the system.
The model is, of course, purely an acute 
denervated preparation. It cannot provide
answers to questions involving the long-term 
effects of metabolic injury but it may identi­
fy minor short-term abnormalities that form 
the basis for later problems. To test any 
hypothesis involving innervated myocar­
dium, the experimental stress would have to 
be applied to the intact donor prior to septal 
harvest or simulated in the control septum.
This communication describes and docu­
ments performance norms of a new model 
for assessing myocardial function. Testing 
and further speculation on its applicability 
will be the subject of future reports.
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GLIMPSES OF SURGICAL HISTORY:
H FOR HEMOSTASIS
D. A. E. SHEPHARD
The stanching of blood from wounds has
always been of fundamental importance to 
man’s health, and it is not surprising that 
the history of HEMOSTASIS is lost in the 
mists of time. Blood, too, has always had 
magical and religious meaning, and, in the 
history of hemostasis, factors that are clear­
ly not surgical are not easy to separate from 
those that are. But one’s glimpse has sharper 
focus if one notes that hemostasis has but six 
main bases: compression, cautery, the tour- 
niquet, the ligature, and blood fractions and 
absorbable hemostatics.
One group of hemostatic remedies did not 
presuppose any knowledge of anatomy and 
physiology. Digital pressure and local rem­
edies of plant origin had primitive roots, and 
cautery is nearly as old as man’s use of fire. 
Chemical agents, too, have a long history: 
the Egyptians, for example, used lead sul­
fate, antimony and copper sulfate, the “hemo­
static button”. Their remedies were effective 
but, with a mainly surface action, their ef­
fect was transient.
Specific, permanent remedies came later. 
One reason was that in certain eras— the 
post-Galenic, the Saracen, and the pre- 
Renascent particularly—dissemination of 
knowledge was slow or impeded. Then a 
fundamental invention, printing, made basic 
knowledge available to all permanently; the 
best of the knowledge of the great classical 
writers spread, no longer obscured by the 
formalism and mysticism that had stifled 
surgical science. The great discovery of the 
circulation was publicized, without delay, 
as were the second group of hemostatic 
remedies.
One such remedy was the ligature, and 
the catgut ligature especially shows how 
much surgery owes to human endeavour in 
\o ther fields. Catgut long had had many 
\nonmedical uses and thus was well known 
w>hen Lister carbolized it and used it in 
preference to silk for suturing. In so doing 
a great surgeon applied ancient knowledge 
in a modern manner and perfected the tech­
nical management of a surgical problem that 
had taken thousands of years to overcome.
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Large r doses (up  to  1 g q6h in ad u lts  or up to  25 m g /k g  q6h in  ch ild re n ) may be g iven 
fo r severe or c h ro n ic  in fe c tion s : maximum da ily  do se  sho u ld  no t exceed 4 g Therapy 
s h o u ld  be c o n tin u e d  fo r  a m in im u m  of 48 to  72 h o u rs  a f te r  th e  p a tie n t becom es 
asym ptom atic  or ev idence o f bacte ria l e ra d ica tio n  has been ob ta in ed In in fections 
ca u s e d  by h e m o ly tic  s tre p to c o c c i,  a m in im u m  1 0 -d a y -tre a tm e n t p e rio d  is  re co m ­
m ended S tubbo rn  in fe c tio n s  m ay require tre a tm e n t fo r several w eeks w ith  frequent bac­
te rio lo g ica l and c lin ica l appra isa l
A  m od ified  dosage sche du le  in pa tien ts w ith  de creased re n a l fu n c tio n  is necessary 
Each patien t should be con s ide re d  ind ividually: th e  fo llo w in g  sche du le  is recom m ended 
as a gu ide line. In it ia l load ing  dose: 750 mg. M a in ten an ce  dose: 500 m g at th e  tim e in te r­
va ls  lis ted  below:
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(m l/m in /1 .7 3 m 2 )
> 20 m i/m in  
15-19 m l/m in  
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<  5 m l/m in
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Coronary artery bypass grafting is a new 
procedure which has not been completely 
evaluated. The long-term results of grafting 
procedures utilizing the autogenous veins or 
the internal mammary artery for bypassing 
the occluded portions of the proximal coro­
nary artery are continually being reevalu­
ated. There is agreement that the risk of the 
operative procedure is related to the ex­
tensiveness of the arterial changes and the 
impairment of ventricular function which 
may be due to factors other than ischemia. 
Evaluation of ventricular function is a con­
sideration in the choice of patients. Those 
with severe dysfunction are found to have 
poor tolerance for the operation; higher 
mortality is incurred in this group of patients.
The indications for coronary artery re­
vascularization are slightly enlarged in the 
case of patients on whom the open-heart 
procedure is done for other lesions, such as 
valvular heart disease or ventricular aneur­
ysm, as in answer (3). Certain lesions, be­
cause of their location, such as the main left 
coronary artery, are more life-threatening 
than similar degrees of stenosis in more 
peripheral vessels. The indication for opera­
tion in this group seems more urgent, as 
represented in answer (2). The evaluation 
of angina pectoris remains somewhat less 
well defined since patients with progressive 
angina with impending coronary occlusion 
would be a logical group for whom the op­
eration should be considered. Selection with­
in this group requires somewhat greater 
skill and more sophisticated methods for 
evaluating the condition of these patients. 
Those with disabling angina are given some 
priority if arteriographic studies show that 
their situation is favorable for grafting.
A
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IN TRA-AORTIC BALLOON PUMP ASSIST: ADJUNCT TO SURGERY 
FOR LEFT VENTRICULAR DYSFUNCTION*
BERNARD S. GOLDMAN, MD, BSc(Med), FRCS[C], PAUL WALKER MD 
JOHN GUNSTENSEN, MB, ChB, FRCS(Edin) FRCSfC], HUGH E SCULLY MD 
MSc(Med), FRCS[C] and ALLAN G. ADELMAN, MD, FRCT[C] ’
Intra-aortic balloon pump assist (IABPA) was 
used intraoperatively and postoperatively in 
34 patients with severe left ventricular dysfunc­
tion: the mean ejection fraction was 0.29 and 
all patients had angiographic grade IV left 
ventricular contractility. There were three groups 
of patients: 11 patients with acute coronary 
artery insufficiency— 10 of whom survived vein 
bypass surgery (group 1); 16 patients with 
crescendo-type unstable angina— of whom 15 
survived surgery (group 2); 7 patients with sin­
gle (6) or multi valvular (1) replacement (com­
bined with vein bypass in 3)— of whom 5 sur­
vived (group 3). Overall survival was 88%. The 
mean duration of 1:1 IABPA was 40 hours. Ino­
tropic support was not required, hemolysis was 
insignificant and hemostasis remained secure. 
Two patients required tracheostomy and one re­
quired dialysis. One patient had a peripheral 
embolus in the leg used for IABPA.
IABPA improves subendocardial perfusion dur­
ing induction of anesthesia, during cardiopul­
monary bypass and into the postoperative pe­
riod; left ventricular work is decreased with a 
concomitant increase in coronary artery and vein 
graft blood flow. Use of IABPA may also improve 
survival and lessen morbidity in patients with 
left ventricular dysfunction due to the benefi­
cial effects on myocardial performance and is 
thus a valuable adjunct to cardiac surgery in 
high-risk patients.
ration de pontage veineux (groupe 1); 16 pa­
tients ayant une angine instable devolution 
rapide parmi lesquels 15 survecurent a la chi- 
rurgie (groupe 2); 7 patients ayant subi des 
valvuloplasties simples (6) ou multiples (1) 
(associees a un pontage veineux dans 3 cas), 
parmi lesquels 5 survecurent (groupe 3). Le 
taux de survie a ete de 88%. La duree moyenne 
de (’assistance 1:1 de la PBIA a ete de 40 
heures. Aucune therapeutique inotrope d’ap- 
point n'a ete necessaire. L’hemolyse a ete peu 
importante et I'hemostase est demeuree ade­
quate. Deux patients eurent besoin d'une tra- 
cheostomie et un eut besoin de dialyse. Un 
patient a eut une embolie peripherique loca- 
lisee dans la jambe utilisee pour la PBIA.
L assistance de la PBIA ameliore la perfusion 
sous-endocardiaque durant I’induction de I’anes- 
thesie, pendant la derivation cardiopulmonaire 
et pendant la periode post-operatoire. Le travail 
ventriculaire gauche est diminue alors que le 
debit sanguin est augmente dans les arteres 
coronaires et le pontage veineux. L'emploi de la 
PBIA peut aussi ameliorer la survie et dimi- 
nuer la morbidity chez les patients ayant une 
insuffisance ventriculaire gauche, grace a ses 
effets favorables sur la fonction du myocarde; 
cette technique constitue de la sorte un traite- 
ment d'appoint valable a la chirurgie cardiaque 
chez les patients presentant un risque eleve.
L assistance d'une pompe a ballonnets intra- 
aortique (PBIA) a ete mise a profit durant 
la periode pre- et post-operatoire chez 34 pa­
tients presentant une insuffisance ventriculaire 
gauche grave: la fraction d’ejection moyenne 
etait de 0.29 et tous les patients presentaient 
a I angiographie une contractilite ventriculaire 
gauche de grade IV. On comptait trois groupes 
de patients: 11 patients avec insuffisance coro- 
narienne aigue dont 10 survecurent a une ope-
*From  the departments of surgery and medicine, 
University of Toronto, and the division of cardio­
vascular surgery, Toronto General Hospital, To­
ronto, Ont.
Presented at the annual meeting of the Canadian 
Cardiovascular Society, Montreal, Oue., Oct 23- 
25, 1975.
Reprint requests to: Dr. B. S. Goldman, Division 
of cardiovascular surgery, Toronto General Hos­
pital, 101 College St., Toronto, ON M5G 1L7
Abbreviations
AVR A ortic valve replacem ent
C l C ardiac index
IABPA Intra-aortic balloon pum p
assist
LVA Left ventricular aneurysm
LVEDP L eft ventricular end-diastolic
pressure
LV EF Left ventricular ejection
fraction
MVR M itral valve replacem ent
RCA Right coronary artery
SVG Saphenous vein graft
TEA T hrom boendarterectom y
TVR Tricuspid valve replacem ent
L e f t  v en tricu lar dysfu n ctio n  com plicating 
ischem ic o r v alvular h e a rt d isease, o r both , 
m ay increase surgical risk  and  m orbidity , i-*
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TABLE I.—Details of P atients
Group
Variable
1
(n =  16)
2
(:n =  11)
3
(n = 7)
Age, yr
Average.................................................. 53 53 55
Range...................................................... 41 — 63 42 — 64 52 — 57
LVEF
Average.................................................. 0.29 0.30 0.24
Range...................................................... 0.08 — 0.40 0.13 — 0.40 0.10 — 0.40
Mean LVEDP (rest to postangiography,
mm Hg).................................................. 19.4 — 24.7 18.0 — 27.0 22.6 — 35.0
Cl./ min in2 .................................................. 2.4 2.6 1.9
Left ventricular angiographic grade.......... IV IV IV
Coronary artery score.................................. 12.8 14.0 7.0*
*Score obtained in only 4 patients.
and even may be a contraindication to oper­
ation because of the high risk and uncertain 
functional improvement. Recent reports, 
however, have demonstrated decreasing op­
erative mortality and increased longevity.4'9 
We believe that patients with angina and 
poor left ventricular function should not be 
denied operation if there is potential for 
adequate direct repair. This paper describes 
our experience with surgery and intra-aortic 
balloon pump assist (IABPA) in 34 patients 
with significant left ventricular dysfunction.
C linical Material
During a 22-month period (Oct. 1, 1973 
to Aug. 1, 1975) 34 patients with left ven­
tricular dysfunction underwent operation 
with IABPA for ischemic or valvular heart 
disease or both. (During the same period, 
945 open-heart operations were performed 
and 125 patients received IABPA.)
The 34 patients made up three groups. 
In group 1, 3 of the 16 patients with typical 
crescendo angina had significant main-stem 
left coronary artery stenosis. One patient 
had symptoms of congestive failure as well 
as ischemic pain. In group 2, 2 of the 11
patients with acute coronary artery insuffi­
ciency had main-stem left coronary artery 
stenosis; despite adequate medical manage­
ment with analgesics, nitrites and propra­
nolol, these patients had severe, recurrent, 
prolonged pain at rest, often accompanied 
by electrocardiographic changes of acute 
myocardial ischemia. In group 3, four of the 
seven patients with valvular heart disease 
(six, aortic; one, multivalvular) also had 
ischemic heart disease. One patient, with 
end-stage aortic stenosis, was operated upon 
in extremis.
All patients had a left ventricular ejection 
fraction (LVEF) of 0.4 or less (calculated 
from a single-plane right anterior oblique 
ventriculogram) grade IV impairment of left 
ventricular contractility, and elevated left 
ventricular end-diastolic pressures (LVEDP) 
(Table I).
Surgical Procedures
The surgical procedures, duration of 1:1 
assist and results in terms of operative 
survival are summarized in Table II.
The AVCO intra-aortic balloon catheter 
was inserted via a common femoral artery
TABLE II.—Operative P rocedures, Duration of IABPA and Survival
Group
1 2  3
(n = 16) (« = 11) (n =  7)
No. of SVGs/patient................................  1.9 2.2 1.5*
Other operations performed....................  Repair of LVA x 3, Repair of AVR x 6,
RCA TEA x 2 LVA x 2 AVT, MVR, TVR x 1
Duration 1:1 IABPA (hr)
Average..............................................  46.7 40.9 25.0f
Range.................................................. 18 — 96 6 — 92 15 — 48
Operative survival....................................  15 10 5
*3 patients. 
)5 patients.
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under local anesthesia before induction of 
general anesthesia or endotracheal intuba­
tion. In group 2 (acute coronary artery in­
sufficiency) IABPA was instituted before or 
during hemodynamic evaluation in five pa­
tients; in one extremely agitated patient we 
unwisely elected to proceed with induction 
of anesthesia before instituting IABPA. Af­
ter intubation this patient suffered an acute 
myocardial infarction with cardiac arrest 
and could not be resuscitated despite 
IABPA and coronary artery bypass.
IABPA was maintained during cardiopul­
monary bypass, the console being triggered 
by a signal from an external pacemaker,10 13 
and into the postoperative period. After 
cessation of 1:1 assist, weaning was usually 
rapid and balloon removal was accomplished 
whenever operation schedules permitted.
R esults
Group 1
Despite triple saphenous vein bypass 
grafts and successful weaning from balloon 
support within 96 hours, one patient, who 
had predominant symptoms of congestive 
heart failure, died in hospital 4 weeks after 
operation of respiratory and renal failure 
aggravated by sternal dehiscence. This pa­
tient would not now be considered a can­
didate for direct revascularization.
Group 2
In the one patient in group 2 who died, 
rapid institution of IABPA after induction 
of general anesthesia resulted in cardiac 
arrest. The balloon catheter should have 
been inserted before general anesthesia to 
obtain an optimal balance between oxygen 
supply and demand in this seriously ill pa­
tient.
Group 3
In this group two patients died: in one, 
a paravalvular aortic prosthetic leak resulted 
in massive left ventricular distension due to 
balloon counterpulsation during cardiopul­
monary bypass, which was unrecognized 
during construction of the proximal bypass- 
graft anastomoses; the patient could not be 
weaned from cardiopulmonary bypass. The 
other patient, who had been in extremis 
(cardiac index [Cl], 0.7 Z/min-m2; LVEF, 
0.01), could not be weaned from cardio­
pulmonary bypass after aortic valve replace­
ment. His condition would not now be con­
sidered operable.
One patient sustained a popliteal embol­
ism just before discharge, presumably from 
the site of balloon insertion; despite em- 
bolectomy he has mild claudication. No in­
stances of arterial perforation, aortic dissec­
tion or sepsis at the Dacron sleeve were 
noted in the series.
Morbidity was minimal: two patients re­
quired tracheostomy and one, dialysis (one 
of these patients died). Inotropic agents 
were not used. Occasionally, peripheral re­
sistance was augmented by vasopressor to 
improve proximal aortic root counterpulsa­
tion and, similarly, a peripheral vasodilator 
was occasionally used to decrease a hyper­
tensive balloon pulse pressure. No unusual 
rhythm disturbances or hemostatic problems 
were related to either counterpulsation or 
the use of low-molecular-weight dextran in 
these patients.
D iscussion
The assessment of left ventricular func­
tion is essential for the prognosis of patients 
with ischemic or valvular heart disease, or 
both. The mortality over 3 to 5 years for 
the patient with triple-vessel occlusive dis­
ease and a markedly depressed ejection 
fraction from severe diffuse impairment of 
left ventricular function ranges from 71 to 
88% .14’ 15 Thus, if surgery for acquired 
heart disease is restricted to those with good 
left ventricular function, those most in need 
of definitive therapy are excluded.
Clinically, left ventricular function is as­
sessed by the Cl, LVEDP, LVEF (calcu­
lated either from angiographic or echocar- 
diographic findings) and the impression of 
contractility afforded by the left ventriculo­
gram. Subjective review of the ventriculo­
gram and the LVEF are probably the most 
accurate of these parameters since others 
may vary with the physiologic state of after­
load, preload, heart rate and wall com­
pliance. All patients in this series had grade 
IV impairment of left ventricular con­
tractility and an LVEF of less than 0.4.16
Patients with impaired left ventricular 
function face a high operative risk, which 
has varied from 5 to 55%. The operative
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mortality and hospital morbidity are in in­
verse relation to the calculated LVEF.17"19 
When diffuse left ventricular hypokinesia is 
present without angina, operation is con­
traindicated, but the presence of angina or 
anginal-equivalent congestive episodes, or 
congestion associated with mechanical le­
sions that can be repaired, such as mitral 
valve dysfunction or localized aneurysm, all 
suggest a possible benefit from operation 
despite a poor LVEF.
Recent reports have indicated that im­
proved surgical techniques result in accept­
able operative mortality rates.7’ 2°, 21 If 
revascularization or other reparative proce­
dure can be performed without injury to an 
already compromised myocardium, then the 
5-year prognosis may be better than the na­
tural history alone. Indeed, Isom7' 8 has 
demonstrated 83% survival at 2 years. Al­
though there is little evidence suggesting that 
enhanced longevity is associated with im­
provement in total left ventricular function, 
local improvement of segmental contractility 
has been demonstrated.22 There has been 
renewed interest in intraoperative myocar­
dial preservation and, in particular, in the 
maintenance of subendocardial flow.16 Ob­
viously preservation of existing left ventri­
cular function in the severely impaired heart 
is essential in order to decrease operative 
risk and improve later survival. Operative 
mortality has been reduced in patients with 
poor left ventricular function by avoiding 
severe hemodilution and air embolism of 
the coronary artery graft, by using systemic 
and topical hypothermia, by limiting or 
avoiding ischemic periods, by maintaining 
a high mean intra-aortic perfusion pressure 
and adequate left ventricular decompression 
and by periodic defibrillation.
Intra-aortic balloon pump counterpulsa­
tion has been proven effective in the man­
agement of patients with acute myocardial 
ischemia.20’ 21 It re-established an optimal 
oxygen supply/demand balance with physio­
logic effects of particular benefit to those 
patients with left ventricular dysfunction; 
reduction of ventricular afterload may re­
duce LVEDP and enhance subendocardial 
perfusion, while diastolic counterpulsation 
increases coronary artery perfusion pressure 
and vein bypass graft flow, and may cause
redistribution of coronary artery blood flow 
in favour of ischemic areas by opening 
dormant collaterals with maximal vasodila­
tation. 12
IABPA temporarily corrects hemodyna­
mic and electrocardiographic instability in 
patients with acute myocardial ischemia,23 
facilitating diagnostic catheterization, induc­
tion of general anesthesia and cannulation 
for bypass. Pulsatile extracorporeal perfusion 
is achieved during cardiopulmonary bypass 
by balloon inflation from a pacemaker sig­
nal.13 Early postoperative LVEFs improve 
after pulsatile cardiopulmonary bypass com­
pared with mean perfusion, with a signifi­
cantly decreased incidence of perioperative 
infarction.11 Postoperative balloon support 
has been free of arrhythmias or low-output 
states, thus obviating the need for inotropic 
agents.
Support with the intra-aortic balloon 
pump is a valuable adjunct to other meas­
ures for intraoperative myocardial protec­
tion; the preservation of myocardial tissue 
of borderline viability in the presence of 
irreversibly scarred muscle may improve 
operative risk, hospital morbidity, long-term 
survival and perhaps, net left ventricular 
flmction.
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when shock 
threatens 
the lung
Abstract v isua liza tion of lung tissue
• preserves 
lysosome and 
cell membranes, 
thereby preventing 
the release of destruc­
tive lysosomal enzymes3
• preserves platelets 
thereby reducing the risk
of intravascular coagulation1
• preserves leukocyte in­
tegrity thereby helping to main­
tain the pulmonary architecture
soiu-Medroi
helps reduce 
pulmonary 
damage 
and increase 
survival rates
The recovery of patients in shock 
is often complicated by a pattern of 
deteriorating pulmonary function. 
This pulmonary insufficiency pro­
gresses despite restoration of haemo­
dynamic balance and apparent stabili­
zation of the acute episode.
Under conditions of prolonged shock, 
lack of oxygen at the cellular level 
causes alterations in the oxygen-carbon 
dioxide exchange mechanism. These 
changes in cell metabolism lead ultimately 
to interstitial oedema and perivascular 
haemorrhage.1 Polymorphonuclear leuko­
cytes aggregate in the pulmonary capillaries 
and obstruct the pulmonary vascular bed. 
As these trapped cells break down, they 
release lysosomes, tiny subcellular par­
ticles containing proteolytic enzymes.1 
These enzymes attack their host cell and 
go on to dapiage or destroy other cells.2 
The resulting tissue damage may not 
readily repair itself even if the shock 
patient survives.
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In the treatment 
of shock and its 
pulmonary 
complications
Solu-Medrol
soon enough, 
often enough, 
in pharmacologic 
doses
Dosage and Administration:
in treating severe shock, there is a tendency 
in current medical practice to use massive 
(pharmacologic) dosesof corticosteroids. (The 
anti-inflammatory activity of 1 mg of Solu- 
Medrol is equal to 4 mg or more of hydrocor­
tisone.)
The suggested dosage of Solu-Medrol for se­
vere shock is 30 mg/kg stat and repeated in 
four hours, if necessary.
Therapy is initiated by administering Solu- 
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tinued only until the patient’s condition has 
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In patients known to have esophageal 
varices it can be difficult to determine the 
site of bleeding within the gastrointestinal 
tract. To distinguish variceal hemorrhage 
from hemorrhage elsewhere in the upper 
gastrointestinal tract in such patients, Rosen­
berg and Harken (Surg Gynecol Obstet 142: 
241, 1976) have used a test based on the 
differential affinity for oxygen of blood shed 
into the gastrointestinal tract and of saline 
instilled into the stomach.
The oxygen tension of saline solution used 
for instillation is 150 mm Hg; its oxygen 
content is 0.4 vol% . Hemoglobin in blood 
lost into the stomach is desaturated, and any 
desaturated hemoglobin in venous blood in 
the vicinity of oxygenated saline will cause 
oxygen to leave this saline solution. Variceal 
bleeding and bleeding from gastritis or ulcer 
can therefore be distinguished by deter­
mining the oxygen tension of blood-stained 
saline that was irrigated the stomach.
Rosenberg and Harken first administered 
oxygen (8 l/min) by face mask for 3 to 5 
minutes before making any tests. The sto­
mach was lavaged free of clots through a 
nasogastric tube. A saline solution (100 ml) 
was instilled into the stomach, and samples 
of arterial and venous blood taken for 
oxygen tension and hemoglobin concentra­
tion analyses. Gastric saline solution was 
then withdrawn into a 50-ml syringe and, 
when the gastric solution was obviously 
bood-stained, 5 ml was withdrawn into a 
syringe previously connected to the naso­
gastric tube. Oxygen tension and hemoglo­
bin concentration were determined.
Rosenberg and Harken found that in all 
nine patients with bleeding caused by gas­
tritis or ulcer the oxygen tension of gastric 
aspirate was 122 mm Hg or higher, and that 
in four of five patients with bleeding from esophageal varices the Poi of gastric as­
pirate was less than 100 mm Hg.
Although this test was used in few pa­
tients it may prove to be a useful non- 
invasive test to differentiate variceal bleed­
ing from bleeding resulting from gastritis or ulceration.
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MYOCARDIAL INFARCTION AFTER AORTOCORONARY BYPASS:
ETIOLOGIC FACTORS*
) R ALLARD, MD, FRCS[C], C. A. MILNE, MD, FRCS[C], N. L. POIRIER, MD, FRCS[C], 
A. SNIDERMAN, MD, FRCP[C] and J. E. MORIN, MD, FRCS[C]
To ascertain the frequency and probable 
determinants of myocardial infarction after 
aortocoronary bypass, two groups of patients 
were studied: a group of 20 patients who under­
went valve replacement or repair of congenital 
anomalies and a group of 24 patients who un­
derwent aortocoronary bypass. Postoperative 
myocardial infarction was diagnosed by an in­
crease in serum creatine phosphokinase con­
centration to a minimum of 1200 IU in two con­
secutive samples.
The frequency of myocardial infarction dif­
fered between the groups, being only 5%  in 
group 1 but 20.4% in group 2. In the patients 
undergoing coronary artery surgery, the duration 
of bypass, the aortic cross-clamp time and the 
vent site did not influence the rate of infarction. 
However, the incidence of myocardial necrosis 
did correlate with the number of vessels by­
passed. In no case was the clinical course in­
fluenced by the infarction.
Our results suggest that the frequency of 
perioperative infarction is higher in coronary 
artery surgery than in other adult cardiac sur­
gery, and that the most important determining 
factor is the number of diseased vessels.
Nous avons evalue la frequence et les fac- 
teurs qui peuvent predisposer a I'infarctus du 
myocarde apres les pontages aortocoronariens. 
Deux groupes furent etudies: le premier grou- 
pe (20 patients) a subi soit des remplacements 
valvulaires soit des corrections d’anomalies con- 
genitales. Le deuxieme groupe (24 patients) 
a subi des pontages aortocoronariens. Le dia­
gnostic d’infarctus du myocarde a ete pose, 
lorsqu'il y avait une elevation anormale de la 
CPK.
L’incidence des infarctus du myocarde differe 
dans les deux groupes. Elle est de 5% dans le 
premier groupe mais de 20.4% dans le second. 
Chez les patients ayant subi un pontage aorto- 
coronarien, la duree de la circulation extracor- 
porelle, le temps de pincement de I’aorte et la 
localisation de la ligne de decompression ven-
*From the division of cardiovascular and thoracic 
surgery, McGill University and Royal Victoria 
Hospital, Montreal, Que.
Presented at the annual meeting of the Canadian 
Cardiovascular Society, Montreal, Que., Oct. 23- 
25, 1975.
Reprint requests to: Dr. Jean E. Morin, Depart­
ment of surgery, Royal Victoria Hospital, 687 
Pine Ave. W, Montreal, PQ H3A 1A1.
triculaire gauche n'ont pas influence I'incidence 
d'infarctus. Cependant, la frequence de necrose 
myocardique etait proportionnelle au nombre de 
pontages pratiques. Devolution clinique des pa­
tients en periode post-operatoire n'a pas ete 
influencee par la presence de ces infarctus.
Nos resultats suggerent que la frequence de 
I'infarctus du myocarde peri-operatoire est plus 
grande chez les patients subissant des pontages 
aortocoronariens que chez les patients adultes 
operes pour d'autres pathologies cardiaques, et 
le facteur qui influence le plus I’incidence des 
infarctus du myocarde est le nombre de vais- 
seaux atteints de facon significative par le pro­
cessus artherosclerotique.
T he postoperative diagnosis of myocardial 
infarction (MI) may be difficult.1 Chest 
pain, a cardinal symptom of infarction, may 
be obscured by concomitant incisional pain 
or obtunded by analgesics, and elevation of 
serum enzymes may result from surgical 
trauma.- Detection of myocardial necrosis 
is particularly difficult after cardiac surgery, 
because direct manipulation of the heart 
and pericardium can produce an epimyope- 
ricarditis, which may cause pain, and elec­
trocardiographic changes suggesting MI.
The aim of coronary artery surgery is to 
preserve myocardial tissue, and one indica­
tor of its success is the incidence of MI 
following surgery. We therefore set out to 
determine the incidence of MI after aorto­
coronary bypass, noting particularly whether 
the conduct of the operation altered the 
frequency of infarction.
Patients and M ethods
Forty-four patients (22 men, 22 women) 
undergoing cardiopulmonary bypass were 
divided into two groups according to the 
nature of the surgical procedure: The 20 
patients in group 1 (mean age, 48 years) in­
cluded all those undergoing either valve 
replacement, open mitral commissurotomy 
or repair of a congenital anomaly. The 24 
patients in group 2 (mean age, 50 years) 
had coronary artery disease; at least one 
aortocoronary bypass procedure was per­
formed in each patient. The diagnosis and
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TABLE I.—D iagnoses and Operative Proce­
dures P erformed in 44 P atients Undergoing 
Cardiopulmonary Bypass
Group
1
{n = 20)
2
0n = 24)
Diagnosis
Mitral valve disease... . 9
Aortic valve disease.. . . 7 —
Atrial septal defect. . . . 4 —
Coronary artery disease — 24
Procedures 
Mitral valve replace­
ment ............................ 6
Aortic valve replace­
m ent............................ 6
Double valve replace­
ment ............................ 1
Open mitral commisu- 
rotomy........................ 3
Repair of atrial septal 
defect.......................... 4
Aortocoronary bypass 
x 1................................ 4
Aortocoronary bypass 
x 2 ................................ 7
Aortocoronary bypass
x 3 ............................... — 9
Aortocoronary bypass 
x 4 ............................... 3
Internal mammary ar­
tery to left anterior 
descending coronary 
artery .......................... 1
details of various operative procedures are 
listed in Table I.
Serum enzyme concentrations and elec­
trocardiograms (ECG) were obtained in the 
48 hours before operation and at the fol­
lowing times after operation: immediately 
the patient reached the recovery room, 10 
hours later and on days 1, 2, 3, 5, 7 and 10. 
On each serum sample, serum glutamic oxa­
loacetic transaminase (SGOT), lactic dehy­
drogenase (LDH) and creatine phosphoki- 
nase (CPK) values were determined by 
standard automated techniques. The anal­
yses of the ECGs were made independently 
of results of the enzyme studies.
The major criterion for infarction in this 
study was an elevation of CPK to a mini­
mum of 1200 IU on at least two consecu­
tive determinations.'* The ECG was con­
sidered diagnostic of transmural infarction 
if it showed new persistent Q waves, and 
was considered compatible with ischemic in­
jury if localized, characteristic, ST-segment 
deflections were recorded. Pericarditis was 
diagnosed if classical evolution of ST-T 
segments was documented.
Results
Incidence of Infarction
In group 1 (patients undergoing valvular 
surgery or repair of congenital anomalies) 
only 1 of the 20 patients sustained MI. 
In contrast, in group 2, 5 of 24 pa­
tients receiving aortocoronary bypass sus­
tained MI. None of the patients with post­
operative infarction died, nor did they suffer 
from a low cardiac output state or conges­
tive heart failure. Clinical recovery in the 
immediate postoperative period was evi­
dently not affected by infarction.
Enzyme and ECG Results
The CPK concentration was elevated in 
all six patients with infarction to at least 
1200 IU on 2 consecutive determinations. 
Only one patient had associated ECG evi­
dence of transmural infarction.
Changes in SGOT and LDH did not pa­
rallel those of CPK. For SGOT 100 IU was 
taken as the upper limit of normal follow­
ing cardiac surgery.4 Only three of the six 
patients with infarction had elevated SGOT 
levels, but 7 of the 38 patients without in­
farction had abnormally elevated levels. 
Similarly an LDH value less than 500 IU 
was not accepted as evidence of necrosis.4’ 5 
In only two patients with infarction was the 
LDH elevated; again 7 patients without 
other evidence of infarction had an elevated 
LDH.''- ‘
The ECG findings are summarized in 
Table II. In the preoperative ECG the fre­
quency of old MI was 10% in group 1 and 
40% in group 2. The ECG findings in the 
six patients with MI, diagnosed by CPK, 
varied. In only one patient did definite evi­
dence of transmural infarction develop. 
Another had an ST current of injury. The 
dominant finding in the rest was ST-T 
changes that, although indicating ischemia, 
were not sufficiently specific that subendo­
cardial infarction could be diagnosed by 
conventional criteria.
Two noteworthy findings were that some 
patients with similar ECG changes did not 
manifest sustained rises in serum CPK, and 
that the incidence of postoperative pericar­
ditis following coronary artery surgery is 
high compared with other forms of cardiac 
surgery.
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TABLE II.—Electrocardiographic Changes
Abnormality
Group
1 2
(n =  20) (n = 24)
Preoperative:
Old myocardial
infarction................... 2 10
Postoperative:
QRS changes (Q 
waves)*...................... 0 1
QRS changes (bundle 
branch block)............ 4 0
ST-T changes of injury* 0 2
ST-T changes of 
ischemia).................... 3 7
ST-T changes of peri­
carditis* ...................... 4 9
Nonspecific ST-T 
changes*..................... 9 1
*One patient in this category had an infarct. 
(Two patients in this category had an infarct.
Factors Relating to Incidence of M l in
Aortocoronary Bypass
Duration of bypass.—It appears that 
cardiopulmonary bypass beyond 2 hours 
may increase the risk of infarction (Table 
III). Indeed, of 11 patients on bypass longer 
than 2 hours, 4 sustained infarctions; of 13 
with bypass for shorter time periods, only 
1 had an infarct. Yet the duration of bypass 
was clearly related to the complexity of the 
peration. Of the 11 patients with pump 
times exceeding 2 hours, 7 had at least three 
vessels bypassed. Conversely eight patients 
with pump times of less than 2 hours re­
quired at most two bypasses. When the 
mean duration of cardiopulmonary bypass 
in both groups was compared, we noted no 
significant difference: 115 ±  15 min in pa­
tients without infarction and 138 ± 2 7  min 
in those with infarction (P > 0.50).
Aortic cross-clamp time.— There was no 
significant difference in the mean, total,
aortic, cross-clamp time in patients with 
infarction (28 ±  8 min) and those without 
infarction (27 ±  4 min) (P >  0.50). Again, 
comparison of cross-clamps exceeding 15 
minutes revealed no significant difference 
between the two groups; in four patients 
with infarction no period of cross-clamping 
exceeded 15 minutes while four patients 
without infarction had two periods of cross­
clamping for more than 15 minutes.
Vent site during cardiopulmonary bypass. 
— In only 4 of the 24 patients was a vent 
not placed and none of these had MI. In 
the remainder the location of the vent 
varied, being either in the apex of the left 
ventricle (12 patients) or through the left 
atrium (8). The number of infarctions was 
evenly distributed—three in the former 
and two in the latter— making the vent 
location an unlikely determinant of infarc­
tion.
When the actual increase in serum CPK 
concentration was compared in patients 
whose heart was vented through the apex 
of the left ventricle and in the others, there 
was no significant difference (P >  0.20). 
In 16 of the 20 patients in group 1 a vent 
was also placed through the apex of the left 
ventricle and their serum CPK concentra­
tion was not abnormally elevated.
Number of bypasses performed.— There 
was a clear relation between the frequency 
of infarction and the number of bypasses 
performed. In the five patients with a single 
bypass no infarctions occurred. The inci­
dence of MI increased with the number of 
bypasses constructed. One of seven patients 
with two bypasses sustained an infarction 
whereas this complication occurred in three 
of nine patients with three bypasses and in 
one of three patients with four bypasses.
TABLE I II .—Duration of Bypass v. Incidence of Myocardial Infarction
Duration, min
No. of 
patients
No. of vessels grafted
1 2 O 4 M I
1 — 60 ........................ ........  4 4 0
61 — 120........................ ........ 9 1 3 5 (3)*
121 — 180........................ ........  7 4 1 2 (4), (2), (2)
181 — 240........................ ........  3 3 (3)
241 — 300........................ ........  1 1 0
*Each set of parentheses represents one myocardial infarction; the number within each set of parentheses re­
presents the number of vessels grafted in that patient.
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D isc u ssio n
This study indicates a definite risk of 
MI after aortocoronary bypass surgery. 
The risk is clearly higher in these circum­
stances than in other types of cardiac sur­
gery. Yet the clinical importance of our find­
ings is not clear. Certain reservations must 
be stated before reaching such conclusions.
We recognize that the diagnosis of MI 
after cardiac surgery is difficult.2 Cases 
in which classical ECG changes of localized 
transmural infarction appear, present no 
difficulty. Fortunately in our experience 
this was relatively rare. The criterion relied 
on in this study was a serum CPK con­
centration greater than 1200 1U on two 
consecutive determinations. This cutoff 
point is based on the study of Bolooki 
and associates,2 who demonstrated that all 
such patients had occluded vessels or new 
areas of hypokinesis on follow-up examina­
tion.
In our study only total serum CPK was 
measured. Skeletal muscle necrosis liberates 
CPK into the serum,2 yet the measurement 
of the myocardial isoenzymes may not sub­
stantially improve the diagnosis of postoper­
ative infarction.8 The additional sophistica­
tion may be illusory because such surgery 
involves direct manipulation of the heart.11 
The pericarditis so often seen testifies to 
probable epicardial damage.
Patients who did not have coronary artery 
surgery rarely had a diagnostic increase in 
the serum CPK concentration. Such patients 
did not have coronary artery disease so a 
relatively low incidence of infarction would 
be anticipated. It suggests that a CPK con­
centration greater than 1200 IU probably 
indicates myocardial necrosis and would not 
be anticipated on the basis of the surgical 
procedure alone.
The bias of this study is pessimistic. The 
ECG confirmed MI in only one of the six 
cases. If anything, therefore, we may over 
rather than underestimate our frequency 
of infarction. The incidence of infarction 
considering the rather small numbers in 
each group is compatible with that reported 
by others.3'8' 10‘13
Opinions have differed as to the impor­
tance of bypass time longer than 120 min­
utes.8' 10 We found no indication that this
was an independent determinant. The clear­
est factor that influenced the risk of infarc­
tion was the most obvious: the number of 
bypasses performed is related to diffuse­
ness of disease, and as the extent of disease 
increases so does the risk of infarction.r)-
1 0 , 14
In our series MI did not influence the 
clinical outcome, contrary to the findings 
noted after other forms of surgery.3- 5' 7- 8' 
1;{. 14 This does not mean that MI is 
unimportant, but that there is no serious 
risk in the immediate postoperative period.
C o n c l u sio n s
The incidence of MI after aortocoronary 
surgery is greater than that after noncoro­
nary cardiac surgery. Of all the possible 
contributing factors analyzed, only the num­
ber of vessels bypassed had a direct correla­
tion with the incidence of MI. In patients 
with infarction, there was no discernible 
effect on recovery, so the clinical importance 
of infarction in this period is not clear. Our 
understanding would be improved by more 
sensitive and specific tests to recognize myo­
cardial necrosis in the postoperative period.
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SURGICAL REPAIR OF ACUTE VENTRICULAR SEPTAL DEFECT 
COMPLICATING MYOCARDIAL INFARCTION*
JOHN C. COLES, MD, FRCSjC], FACS, W. G. SANDOVAL, MD, A. DOCTOR, MD, 
FRCS(Edin), FRCSjC] and C. MULLANGI, MD
Ventricular septal defect complicating myo­
cardial infarction was repaired surgically in 
seven patients between 1965 and 1974. In four, 
the septal defect had developed in the lower 
portion of the septum and in three, high in the 
septum, above the origin of the papillary muscle. 
Concomitant operations included mitral valve re­
placement and infarctectomy, in one patient, and 
triple aortocoronary bypass in another. The com­
moner low defect was repaired either by ampu­
tating the lower portion of the heart or patch­
repairing through a left ventriculotomy incision. 
The higher defects, more difficult to repair, were 
repaired through a high posterior left ventricu­
lotomy. Complete pre- and postoperative hemo­
dynamic studies were carried out and follow-up 
information was available for all patients.
Recognition of the high defect is essential. 
Pathologically, the coronary artery lesion is 
more complicated and extensive and a different 
surgical approach is necessary. A classification 
of high and low ventricular septal defects de­
veloping after myocardial infarction is recom­
mended. The natural history of the disease and 
the reasonable surgical results support an active 
surgical approach in both types of postinfarction 
septal perforation.
^'Presented at the annual meeting of the Cana­
dian Cardiovascular Society, Montreal, Que., 
Oct. 23-25, 1975.
Reprint requests to: Dr. J. C. Coles, Chief, Car­
diac surgery, Victoria Hospital, 391 South St., 
London. ON N6A 4G5.
Entre 1965 et 1974, on a fait chez sept patients 
la refection chirurgicale de communications 
interventriculaires survenant en cours d’in- 
farctus du myocarde. Dans quatre cas, la com­
munication interventriculaire est apparue dans 
la partie basse du septum et dans trois cas, elle 
etait haute, au-dessus de I'origine du muscle 
papillaire. Les operations concomitantes ont 
compris le remplacement de la valvule mitrale 
et une infarctectomie chez un patient, et un 
triple pontage aortocoronarien dans un autre 
cas. La communication interventriculaire basse, 
plus frequente, a ete corrigee soit en ampu- 
tant la partie inferieure du coeur, soit par 
occlusion en passant par I'incision d'une ventri- 
culotomie gauche. Les communications inter­
ventriculaires hautes, plus difficiles a reparer, 
ont ete corrigees par une ventriculotomie poste- 
rieure gauche haute. Des etudes hemodynami- 
ques completes ont ete realisees dans la pe- 
riode pre- et post-operatoire et I'information de 
post-observation a ete obtenue pour tous les 
patients.
La reconnaissance des communications inter­
ventriculaires hautes est essentielle. Patholo- 
giquement, la lesion de I'artere coronaire est 
plus compliquee et plus etendue et elle requiert 
une approche chirurgicale differente. II est 
recommande qu'on fasse la classification des 
communications interventriculaires hautes et 
basses consecutives a un infarctus du myo­
carde. L'evolution normale de la maladie et les 
resultats chirurgicaux satisfaisants obtenus 
vont a I'appui d'un traitement chirurgical actif 
dans les deux types de perforations septales 
consecutives a un infarctus.
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Septal perforation, first described by La­
tham1 in 1845, is an uncommon but sinister 
complication of myocardial infarction that 
occurs in approximately 0.5% of all cases 
of infarction and is responsible for 2% of 
all fatal cases.2- 3 The true incidence, how­
ever, may be higher because the lesion may 
be missed, even at autopsy with the heart 
in an agonal state. This is particularly ap ­
plicable to the high defect.
The natural history of postinfarction 
septal perforation suggests an extremely 
poor prognosis in patients treated medical­
ly, for 65% are dead within 2 weeks and 
80% within 1 month, and only occasional 
patients survive for 1 year.4 This survival 
is in sharp contrast to that for patients 
treated surgically: Javid and associates,5 for 
example, reported that 60% were alive and 
well at 1 month and 32% alive after 1 year.
Since the first reported surgical closure 
by Cooley and colleagues6 in 1957, there 
have been numerous case reports of surgi­
cal repair, but no one institution has accu­
mulated a large experience. Useful contribu­
tions are those of Kitamura, Mendez and 
Kay,7 Shumacker,8 Donahoo and asso­
ciates6 and Shumway.10 According to most 
of these authors, including Shumacker8 and 
Donahoo’s group,0 early operation mitigates 
against success. This, however, has not been 
the experience of Shumway10 nor of our­
selves in a small series of patients.
Diagnosis is made when a loud systolic 
murmur develops early in the course of 
acute myocardial infarction. This is almost 
invariably associated with congestive heart 
failure. Papillary muscle rupture may pre­
sent difficulty in the differential diagnosis 
but the echocardiogram will readily dif­
ferentiate this.11 The clinical diagnosis is 
confirmed by a catheter-angiographic study 
demonstrating the site and location of the 
usually large left-to-right shunt.
In this paper we present our experience 
at the University of Western Ontario with 
the surgical treatment of postinfarction sep­
tal perforation, propose a classification of 
such defects, bring attention to the high de­
fect occurring above the origin of the pa­
pillary muscle, and describe a surgical ap­
proach to this latter type of defect.
Patients and Methods
During a 13-year period (1962 through 
1974), seven patients with septal perfora­
tion complicating myocardial infarction un­
derwent operation for surgical repair. Cer­
tain details of the patients, their condition 
and the outcome are presented in Table I.
TABLE I.—Details of Seven Patients with 
Ventricular Septal Perforation Complicating 
M yocardial Infarction
Sex, age (yr)
Interval, 
diagnosis 
to operation
(4)
Type of 
defect Outcome
M ,48 8 — 89 Low Died at 6 yr
F , 56 11 — 19 Low Well at 1 yr
M , 77 4 — 34 Low Died at 29 d
M , 64 5 — 21 High Well at 2 yr
M , 67 10 — 12 High Well at 18 mo
F , 79 2 — 4 High Died at 11 d
M , 67 7 — 11 Low Died at 24 h
The ages of the five men and two women 
ranged from 48 to 79 years. The diagnosis 
was made 2 to 11 days after the myocardial 
infarction and operation was performed be­
tween 4 and 89 days after the infarction. 
In three patients the defect was a high one 
and in four, a low one.
Surgical Technique
Since Cooley and colleagues6 described 
their procedure in 1957, the conventional 
approach has been through an anterior 
right ventriculotomy. Kitamura, Mendez 
and Kay,7 noting the frequency of antero­
lateral aneurysm or infarct, suggested a left 
anteroapical ventriculotomy, a second ad­
vantage being the distinct marginal defini­
tion unobstructed by the heavily trabecu- 
lated right ventricle; Javid and colleagues5 
suggested a similar approach. Shumacker,8 
who noted the difficulty in repairing the 
most posterior defects, suggested a posterior 
right ventriculotomy approach.
We have used the following technique: 
The low or conventional defect was ap­
proached through a right ventriculotomy in 
one patient, a left ventriculotomy in two 
and resection of the apex of the heart in 
one. The high defects were all approached 
through a high posterior left ventriculotomy, 
gentle forward retraction of the chordae 
tendinae giving a clear visualization of the
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Fig. 1.—Exposure of high ventricular septal 
defect.
edge of the defect (Fig. 1), which would 
otherwise be difficult with the more con­
ventional ventriculotomies.
Use of a generous patch of Dacron or 
Teflon and its fixation with numerous 
Teflon felt-buttressed sutures well away 
from the apparent edge of viable muscle is 
mandatory.
Associated left ventricular aneurysm or 
infarcted muscle must be excised,12 16 and 
the judicious use of an aortocoronary by­
pass graft may make the difference between 
success and failure in patients whose con­
dition is borderline.
The high ventricular septal defect pre­
sents certain peculiarities that require em­
phasis. These peculiarities are as follows: 
The high defect is funnel-shaped and trans- 
verses the septum obliquely, presenting on 
the right ventricular side at a lower level 
(Fig. 2). It lies above the papillary muscle, 
in contrast to the conventional defect. In 
our three patients, all had evidence of pre­
vious myocardial infarction high in the 
posterior wall of the left ventricle; this is 
in contradistinction to the situation in those 
with the conventional low defect, who often 
had no prior evidence of coronary artery 
disease.
Further, with respect to the pathologic 
features and compared with the low defect 
(in our experience), the coronary arteries 
manifest certain differences in cases of the 
high defect, the left anterior descending
Fig. 2. —Features of high and low types of ven­
tricular septal defects.
coronary artery being patent and both the 
right coronary artery and the circumflex be­
ing occluded or severely diseased.
Finally, there is no associated ventricular 
aneurysm, though akinesis of the upper part 
of the posterior wall of the left ventricle was 
a feature in two of our three patients. Left 
posterior hemiblock seems to be an inevit­
able complication of the high defect. Con­
comitant surgical procedures included aorto­
coronary bypass grafting, mitral valve re­
placement, aneurysmectomy and infarctec- 
tomy.
R e s u l t s
Four of the seven patients left hospital 
alive, and, when last seen, three of them 
were well at 18, 24 and 27 months; the 
fourth died suddenly 6 years after opera­
tion. Two of the others have a residual left- 
to-right shunt that does not seem hemody- 
namically important (1.2:1 and 1.3:1), and 
two have a posterior hemiblock.
The three hospital deaths occurred on the
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1st, 11th and 29th postoperative day, re­
spectively. The first patient barely survived 
the operative procedure and died within a 
few hours despite intensive respiratory, 
mechanical and pharmacologic support. 
The second was well until the 4th day, when 
congestive heart failure again became evi­
dent. A systolic murmur recurred on 
the 5th day and her condition slowly but 
progressively deteriorated. Reopening of 
the defect was suspected. Autopsy revealed 
two small openings (diameter, 1.5 and 2 
mm) at the edge of the patch.
Fresh thrombus was present in all three 
aortocoronary bypass grafts but the lumi­
nal diameter was not compromised at any 
of the anastomotic sites. Presumably this 
was an example of premortem thrombosis in 
situ without obvious main vessel occlusion.
The third patient who died had insidious 
but progressive congestive heart failure and 
low cardiac output. The defect was com­
pletely closed.
D iscussion
Ventricular septal defect as a conse­
quence of myocardial infarction is uncom­
mon. The prognosis is poor. Early diagnosis 
and surgical closure are warranted on the 
basis of all available data. Early and long­
term survival depend on the extent of mus­
cle death. Operation performed 6 weeks, 
or longer, after the diagnosis— aided by 
the process of natural selection of the fit­
test, as well as the clearly defined fibrotic 
edge of the defect—carries a lower mor­
tality and the incidence of recurrence of the 
left-to-right shunt is lessened.2' 17'21 On 
the other hand, early operation is often 
necessary as, otherwise, the majority of pa­
tients will have already died.22'29
It is important to monitor the condition 
of patients with this complication carefully. 
Should a patient’s condition be hemodyna- 
mically stable, operation is delayed for a 
minimum of 6 weeks. Should any deteriora­
tion occur, the site and size of the ventri­
cular septal defect and the state of the coro­
nary arteries is confirmed with balloon 
counterpulsation support if necessary, and 
an operation performed as an emergency. 
The ventriculotomy incision depends on the 
site of the defect.
Conclusions and Recommendations 
Ventricular septal defect following myo­
cardial infarction carries a sinister progno­
sis. The diagnosis is readily made clinically 
and confirmed by catheter-angiographic 
study. Surgical closure of the defect carries 
a high but acceptable mortality; the mor­
tality is still lower than that of patients 
treated medically.
We recommend that a classification of 
ventricular septal defect as a complication 
of myocardial infarction with high and low 
types be adopted. The high defect is a sepa­
rate entity anatomically and pathologically, 
and the patients’ best interests are served 
by a different surgical approach.
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D IR E C TIV E S A U X  C O N TR 1B U A N TS
Toute communication initiale doit etre adres- 
see au Coredacteurs, CP 8650, Ottawa, On. 
K1G 0G8 sous la mention: “Le journal cana- 
dien de chirurgie”.
Manuscrits. Les texts originaux des articles 
et des autres communications y compris un 
nombre limite de rapports sur des cas spe- 
ciaux doivent etre rediges en double exem- 
plaire, en frangais ou anglais, et accompagnes 
d’une lettre demandant leur publication dans 
le Journal. Veuillez les dactylographier sur une 
seule face d’une feuille norm al avec double 
interligne et grandes marges.
Illustrations. Les illustrations telles que des 
photographies d’appareils cliniques, des ra- 
diographies, des photomicrographies, des gra- 
phiques et des digrammes doivent etre four- 
nies sous la forme d’epreuves sur papier glace 
sans montage, les bordures intactes, d ’un format 
ne depassant pas 12 x 17 cm. Chaque illustra­
tion doit etre munie d’une legende dactylo- 
graphiee sur une page separee du texte de 
l’article. S’il s’agit d’une photomicrographie, 
expliquez le contraste et 1’echelle de l’agran- 
dissement. Les lettres qui servent a identifier 
les elements d’une illustration doivent etre d’u­
ne dimension suffisante afin de demeurer visi­
bles lorsque les necessites de l’impression im- 
posent une reduction de l’image fournie. II 
ne faut pas qu’on puisse identifier un patient 
grace a une illustration a moins qu’il n ’y ait 
expressement consenti par ecrit; faute de per­
mission les traits de sa physionomie doivent 
etre obliteres. Les illustrations en couleur ne 
seront publiees qu’aux frais de leur auteur. 
Si l’illustration provient d’une autre source que 
celle de l’auteur, il convient d ’obtenir tant de 
l’auteur que de l’editeur de l’ouvrage dont elle 
est tiree, 1’autorisation de s’en servir aux fins 
de la publication.
Tables. Il faut en les etablissant se conformer 
au format rectangulaire du Journal et les 
rediger sur des feuilles separees du texte, une 
table par feuille.
References. Celles-ci doivent etre citees dans 
le texte au moyen d’un chiffre et groupees 
dans l’ordre a la  fin de votre article en vous 
conformant a la maniere de faire adoptee par 
ce Journal. Les references a des periodiques 
doivent etre conformes a celles qu’adopte 
YIndex Medicus.
Un resume qui ne doit pas depasser 125 mots 
doit accompagner chaque article sur une page 
separee.
Une epreuve en placard sera adressee a l’au- 
teur de l’article avant sa parution; on ne peut 
autoriser que de legeres retouches. Ce n’est 
qu’au moment de restituer ces epreuves d’au- 
teur au Journal qu’il y aura lieu de passer 
commande de reimpression.
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* Results
Trasylol® was shown to reduce mortality in acute pancreatitis to a significant* 
extent:
Placebo................................................  25.0% Mortality
Trasylol®...............................................  7.5% Mortality
“ Because the number of deaths were reduced, the spectrum of the disease 
as a whole was altered.” *
Trapnell’s recent double-blind clinical trial 
involving 105 patients confirmed the 
effectiveness of Trasylol in acute 
pancreatitis. In addition to reducing 
mortality and altering the spectrum of the 
disease, Trasylol largely abolished the usual 
effect of increasing age in this condition. 
Trasylol should be given concurrently with 
usual measures for the treatment of 
pancreatitis, such as pain relief, 
fasting, gastric suction, etc. “ It 
(Trasylol) can therefore now be 
regarded as a drug which is both 
effective and beneficial in the 
treatment of acute pancreatitis.” *
*Trapnell, J.E. et al, British 
J. Surg., March 1974.
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G ro u p  A  (T ra s y lo l) G ro u p  B (P la c e b o )
No. % No. %
M ild 30 5 6 .6 22 4 2 .3
M o d e ra te 13 2 4 .5 9 17 .3
S e v e re 6 1 1 .3 8 15 .4
D ied 4 7 .5 13 2 5 .0
T o ta l 53 9 9 .9 52 1 0 0 .0
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Trasylol, in its role as an Synthetic antifibrinolytic
antifibrinolytic agent, inhibits agents inhibit only the
both plasmin and the plasminogen activator,
plasminogen activator.
is indicated for primary and generalized, secondary 
hyperfibrinolytic hemorrhages with and w ithout the shock 
syndrome. Secondary hyperfibrinolysis follow ing 
intravascular clotting may require heparin and/o r 
fibrinogen replacement in addition to Trasylol. 
With Trasylol, the antifibrinolytic agent with 
simultaneous anti-coagulant (anti-throm boplastic) 
effect, there will not be a dangerous shift 
in the equilibrium  between 
the clotting and the lysis system 
in favour of coagulation. 
Synthetic antifib rino lytics 
are contraindicated if there is 
evidence of active intravascular 
coagulation. Trasylol is indicated 
in all cases of hyperfibrinolysis, 
whether a differentia l diagnosis 
has been made or not.
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Trasylol
•  increases the chances 
of survival in acute 
pancreatitis
•  prevents the enzymatic 
release of toxic 
polypeptides and kinins
•  stops hyperfibrinolytic 
hemorrhage
Indications and Dosage
Hyperfibrinolytic Hemorrhage 
These c o n d itio n s  o ccu r in surgery , 
including open heart surgery, prostatic 
surgery and patho log ica l obste trica l 
bleeding conditions, such as in abruptio 
placentae.
Initial dosage: 200,000 — 500,000 K.I.U. 
of which 200,000 K.I.U. should be given 
by intravenous injection (a t a rate not to 
exceed 5 ml per minute), the rest if neces­
sary by slow  infusion. Adm inistration 
should  be continued up to 1,000,000 
K.I.U. per day until the hemorrhage has 
been arrested.
Pancreatitis
Initial dosage: 100,000 — 200,000 K.I.U. 
to be followed by 100,000 K.I.U. every 
six hours for a period of 4-5 days. The 
drug is administered either by intraven­
ous in jection (at a rate not to exceed 5 
ml per minute) or by slow infusion. 
Warnings and Precautions
ENZYME ANALYSIS OF 
PERITONEAL BLOOD 
IN ABDOMINAL INJURY
Analysis of peritoneal fluid is often useful 
in the differential diagnosis of abdominal 
disorders. Delaney, Moss and Carnevale 
(Surg Gynecol Obstet 142: 161, 1976) have 
used this approach in the management of 
patients who have sustained abdominal 
trauma. They determined the concentrations 
of alkaline phosphatase (AP), lactic dehy­
drogenase (LDH), glutamic oxaloacetic 
transaminase (GOT) and creatine phospho- 
kinase (CPK) in blood withdrawn from the 
peritoneal cavity and related these concen­
trations to those for peripheral blood. 
Blood samples were taken from the perito­
neal cavity at operation before irrigation or 
manipulation of injured viscera; peripheral 
blood specimens were obtained at about the 
same time. They identified differences in 
enzyme concentrations between organ- 
related peritoneal blood and related the 
findings to the final clinical diagnoses in 70 
patients.
Isolated injuries of the liver were asso­
ciated with significant increases in LDH 
values in peritoneal blood and GOT values 
in peritoneal and peripheral blood. Multiple 
intra-abdominal injuries produced increased 
LDH and GOT values in peritoneal blood. 
Isolated injury of the small intestine and 
this injury combined with injury of another 
organ were associated with significant in­
creases in GOT, LDH and AP values in 
peritoneal blood.
The elevation of AP concentration in 
peritoneal blood was associated with normal 
mean values in peripheral blood, and this 
abnormality of peritoneal blood was the 
most consistent enzyme elevation related to 
organ injury, particularly of the small in­
testine. Combined AP values in peritoneal 
and peripheral blood samples were there­
fore of value in identifying small intestine 
injuries in patients with traumatic hemo- 
peritoneum.
Trasylol is a polypeptide and thus may 
act as an antigen. Although adverse reac­
tions due to hypersensitivity have been 
described infrequently, this possibility 
should always be kept in mind. In patients 
w ith a h is to ry  of hypersensitiv ity, the 
usual precautions for the prevention and 
arrest o f a lle rg ic  reactions should be 
observed prior to the administration of 
Trasylol.
Availability
Trasylol (aprotinin) is available in 10 ml 
am puls c o n ta in in g  100,000 K.I.U . in 
boxes of 5 ampuls.
Trasylol® Product Monograph is available 
on request.
The object of
Trasylol:
Control of proteolytic enzymes.
FBA Pharmaceuticals Ltd.
Distributed by:
Boehringer Ingelheim (Canada) Ltd.
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SYNOVIAL CHONDROMETAPLASIA: REVIEW OF WORLD LITERATURE 
AND A STUDY OF 18 CANADIAN CASES*
ANTONI TRIAS, FRCS[C]f and OCTAVI QUINTAN A J
A retrospective study of synovial chondro- 
metaplasia in Canada revealed 18 well-docu­
mented cases of this condition. Review of 
these cases together with 137 cases obtained 
from the literature permitted clarification of the 
clinical, radiologic and histologic features of the 
disease. Positive histologic proof of synovial 
chondrometaplasia is necessary for a true diag­
nosis. Synovectomy with excision of loose 
bodies is the treatment of choice in symptomatic 
cases.
Une etude retrospective de la chondrometa- 
plasie synoviale au Canada a revele 18 cas 
bien documentes de cette affection. Une revue 
de ces cas et de 137 autres releves dans la litte- 
rature a permis de clarifier les caracteristiques 
cliniques, radiologiques et histologiques de cet­
te maladie. Un diagnostic exact doit reposer sur 
une preuve histologique de chondrometaplasie 
synoviale. La synovectomie accompagnee d'une 
excision des arthrophytes constituent le traite- 
ment de choix dans les cas symptomatiques.
A n u m b e r  of uncertainties affect our under­
standing of synovial chondrometaplasia. The 
condition is described under several differ­
ent terms, there is no consensus concerning 
the cause, and the clinical features vary with 
the pathologic features. We therefore re­
viewed the clinical, radiologic and pathologic 
aspects of synovial chondrometaplasia as 
described in the world literature and in a 
survey of Canadian cases.
T e r m in o l o g y  and  D iag n o stic
C r it e r io n
Because of its similarity to a number of 
other conditions arx because of the diversity 
of etiopathogenic theories, synovial chon­
drometaplasia is known by several synonyms:
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osteochondritis dissecans, well defined since 
Konig’s description1 and still reported as 
synovial chondrometaplasia; loose bod ies, 
though this is too imprecise a term; synovial 
chondrosis, sometimes used by the French 
and Italians and implying a degenerative ex­
foliative origin; and articular ecchondrosis, 
synovial chondrom atosis and osteochon dro­
matosis, all assuming a benign neoplastic 
origin. Synovial chondrom etaplasia, how­
ever, is preferred because it emphasizes cur­
rent thinking on the pathogenesis of this 
condition, that is, the form ation o f  cartilage 
from  the synovium by metaplasia.
Although the radiologic appearance of 
the joint or the postoperative examination 
may suggest synovial chondrometaplasia, 
the true diagnosis of this condition rests in 
Jaffe’s definition that histologic proof of 
cartilage production in the synovium is 
necessary.2 We used this diagnostic essen­
tial as a criterion for inclusion or exclusion 
of cases in our review.
R e v i e w  o f  W o rld  L it e r a t u r e
We reviewed more than 300 papers3 and 
classified the published cases but retained 
only those that fulfilled our diagnostic cri­
terion. There were 137 such cases. However, 
it is difficult to state with certainty that all 
were genuine cases of synovial chondrome­
taplasia as in some cases we had to rely on 
unverified information; for instance, histo­
logic formation of cartilage from the syno­
vium was reported for all 137 cases, but 
often it was impossible for us to check the 
reported observations.
R e v i e w  o f  C anadian  C a s e s
Because the international nomenclature 
used by most hospitals does not specifically 
code synovial chondrometaplasia, our only 
source of Canadian cases was the member­
ship of the Canadian Orthopaedic Associa­
tion. Of the 122 case reports submitted to 
us by members of the association, only 50 
contained adequate clinical, histologic and 
radiologic information. Of these 50 cases, 
only 18 fulfilled our diagnostic criterion of 
synovial chondrometaplasia. This does not
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mean that of the 122 cases only 18 were 
truly cases of this condition. Some appeared 
to be genuine but lacked histologic evidence; 
others were discarded because, in the ma­
terial available, no cartilage production in 
the synovium could be seen— and, because 
the whole synovium is usually not affected, 
our sample might have represented examina­
tions of unaffected areas.
Etiopathogenesis
There is still no agreement as to the cause 
of synovial chondrometaplasia. The most 
common causes considered are:
1. Infectious—Reichel4 and Rixford3 
believed that infection could stimulate 
the synovium into chondrogenesis. How­
ever, they did not observe an inflammatory 
reaction in the synovium.
2. Embryologic—Undifferentiated cells 
could differentiate into cartilaginous tissue.6 
This possibility, which is based on the meta­
plastic theory, has often been upheld. The 
fact that synovial chondrometaplasia is more 
common between 20 and 50 years of age 
does not favour this possibility.
3. Traumatic— Trauma has often been 
advanced either as the determining or as a 
predisposing factor. We found that a history 
of trauma to the affected joint was either 
denied or not reported in more than 50% 
of the world cases and that the proportion 
was 67% (12 of 18 cases) in our Canadian 
series.
4. Neoplastic—The description of Hen­
derson and Jones,7 among others, favours 
this theory, which would explain the clinical 
recurrences and the three cases only of 
malignant degeneration described in the 
literature.
5. Meta plastic—This, the most common­
ly accepted theory, was developed first by 
Freund,8 on a histologic basis. He classified 
the condition as hyperplastic metaplasia, a 
concept in between neoplasia and true meta­
plasia.
Clinical F eatures
Sex and Age Distribution
This condition is at least twice as common 
in males as in females. In the world literature 
69% of cases occurred in males and 31% 
in females; of the cases whose reports were
Fig. 1.—Bilateral chondrometaplasia of knee 
joint in two siblings, 7 and 5 years of age.
submitted from Canadian sources, the re­
spective proportions were 68 and 32%, and 
of the cases accepted as being synovial chon­
drometaplasia they were 61 and 39%. It is 
generally agreed that the disease occurs most 
commonly between 30 and 50 years of age; 
this was true for the world and Canadian 
cases, both submitted and accepted.
Familial Incidence
Of the 137 cases obtained from the litera­
ture there was a familial occurrence in only 
3 cases. In the Canadian series, three chil­
dren in one family suffered from synovial 
chondrometaplasia (Fig. 1).
Symptoms
The knee joint has been reported by all 
authors to be the most frequent site of 
synovial chondrometaplasia, followed by the 
shoulder and elbow joints, then the hip 
joint. However, synovial chondrometaplasia 
can occur in any joint and has been de­
scribed in most. In our series of Canadian 
cases a similar pattern was apparent (Fig. 
2), but the differences were not significant 
because of the small numbers involved.
JO IN T AFFECTED
Fig. 2.—Location of synovia! chondrometapla­
sia. White columns represent Canadian submitted 
cases and shaded columns Canadian accepted 
cases.
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The duration of symptoms is quite long, 
perhaps because none is specific; in more 
than 50% of the world and Canadian cases 
the duration was more than 2 years (average, 
5 years).
Pain is the most frequent symptom (85% 
in the Canadian group). Sometimes the pain 
is periodic, often it is ill defined and mild 
at the onset, gradually becoming worse and 
at times incapacitating the patient. The pain 
may occur with movement or may be inter­
mittent, lasting in some instances a few sec­
onds and in others a few weeks. In patients 
with advanced synovial chondrometaplasia 
the pain may become permanent.
If the loose bodies compress a nerve 
(generally the ulnar nerve at the elbow), 
the symptoms are those of a peripheral le­
sion in the distribution of that nerve.
Swelling and enlargement of the joint are 
common (42% of Canadian cases). This 
may be due to increased synovial fluid be­
cause of synovitis or to the accumulation of 
numerous fragments. Robineau9 counted up 
to 1200 loose bodies in one joint, and from 
one knee Nilsson10 removed 2 kg of loose 
bodies.
Limited range of motion is also charac­
teristic (55% of Canadian cases). In 5% 
of our cases actual blocking of the joint had 
occurred. The restriction of movement is 
often progressive; it may be permanent or 
may be present only during exacerbation.
Atrophy of the muscles controlling the 
joint was noted in 21% of the cases in our 
Canadian series.
The joint was tender on palpation in 20% 
of the Canadian cases; one or more frag­
ments could be palpated in another 20% 
and crepitus occurring with movement was 
often recorded.
Radiologic Aspects
Radiologic examination is perhaps the 
most important preoperative examination. 
The diagnosis of synovial chondrometaplasia 
was suggested radiologically in 85% of 
Canadian cases.
Typically, the appearance is of multiple 
loose bodies, with varying degrees of calci­
fication (Fig. 3). Cruveilhier11 stated that 
a diagnostic requirement was that the loose 
bodies must be numerous and that the joint
should be relatively healthy. Some authors 
have even established a definite number of 
loose bodies in the joint that should be 
present before a radiologic diagnosis of 
synovial chondrometaplasia can be made. 
More than five loose bodies were observed 
in 55% of Canadian cases. (Generally at 
operation many more loose bodies were 
encountered than were seen radiologically.)
Loose bodies are often found in other 
conditions such as osteochondritis dis­
secans, neuropathic joint, trauma and de­
generative arthritis; also, synovial chondro­
metaplasia can lead to degenerative arthri­
tis. Therefore, with our present knowledge 
of this condition, we cannot rely entirely 
on radiologic findings for the diagnosis.
Tomography may help locate the frag­
ments. Arthrography is also useful to visual­
ize noncalcified loose bodies. We have used 
successfully gas arthrography combined with 
tomography.
Pathologic A spects
Macroscopic Findings
In the early stages of synovial chondro­
metaplasia the articular cartilage is usually 
intact. The synovium appears congested with 
enlarged villi (11 % of our cases).
The loose bodies are round with a clear 
centre and a shell of calcification. Their 
dimension varies, sometimes reaching the 
size of a chestnut. Usually they are located
Fig. 3.—Loose bodies with varying degrees of 
calcification in knee of 37-year-old man.
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free in the joint but sometimes can be seen 
in synovial recesses. Often they appear in 
the joint in a typical “grape formation” 
(Fig. 4).
Loose bodies within the synovium can be 
palpated. Others are pedurculated or free 
within the joint. Rarely, extracapsular 
loose bodies are found in bursa (Fig. 5).
Microscopic Findings
The microscopic features of chondrometa- 
palpated. Others are pedunculated or free 
diagnostic importance.
Chondrometaplasia.—Areas of chondro- 
genesis are found in the subsynovial strata; 
that is, between the synovial cell layers and 
the fibrous outer layer (Fig. 6). In active 
disease, the synovium is hypertrophic with 
an increased number of synovial cells and
4.—“Grape formation” and fullness of 
synovial recesses by cartilaginous bodies.
Fig. 5.—Subacromial bursa with cartilaginous 
bodies.
formation of numerous, often large villi 
(Fig. 7). The stroma is not infiltrated by 
inflammatory cells.
There is striking hypervascularity (Fig. 8). 
Characteristically, normal synovium con­
tains a uniform network of anastomosing
Fig. 6.—Hypertrophic synovium with large villi 
and cartilaginous metaplasia (hematoxylin and 
eosin, reduced by 40% from x 25).
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Fig. 7.—Hypertrophic villi with increasing thick­
ness of synovial cell layer (hematoxylin and eosin, 
reduced by 40% from x 63).
Fig. 8.—Cross-section of villus demonstrates 
large central vessels surrounded by numerous sub­
synovial capillaries (hematoxylin and eosin, re­
duced by 40% from x 160).
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capillaries fed by larger terminal arterioles 
and venules. Higher magnification (Fig. 9) 
shows patency of pericapillary spaces. We 
believe the significance of this vascular 
arrangement should be the object of further 
study.
Sites of early chondrogenesis are charac­
terized by nodular infiltration of round cells 
(Fig. 10); several contiguous sites of chon­
drogenesis are usually observed (Fig. 11).
Fig. 9.—Large perivascular spaces of synovial 
cells (hematoxylin and eosin, reduced by 40% 
from x 250).
Fig. 10.—Nucleus of chondroid round cells with­
in synovial membrane (hematoxylin and eosin re­
duced by 40% from x 250).
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Fig. 11. —Two contiguous nuclei of chondroid­
forming cells (hematoxylin and eosin, reduced by 
40% from x 125).
These round cells enlarge and acquire the 
features of chondroblasts surrounded by 
ground substance with chondromucoid his- 
tochemical reaction (Fig. 12). Once the 
cartilaginous nucleus is formed, it enlarges 
by producing more chondroid matrix through 
division of the chondrocytes and by apposi- 
tional growth. The cartilaginous bodies are 
surrounded by a fibrous collagenous cap­
sule (Fig. 13).
Fig. 12.—Large chondrocytes producing chon­
droid matrix within villus (hematoxylin and eosin, 
reduced by 40% from x 50).
Fig. 13.—Cartilaginous nucleus surrounded by 
fibrous capsule (hematoxylin and eosin, reduced 
by 40% from x 125).
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Fig. 14.—Several intrasynovial cartilaginous
bodies surrounded by fibrous capsule and showing 
early signs of resorption and degeneration (hema­
toxylin and eosin, reduced by 40% from x 125).
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The cartilage becomes less cellular (Fig. 
14), often with areas of degeneration. At 
the periphery, zones of chondroclasis are 
seen. At this stage nodules of cartilage may 
extrude from the synovium into the joint 
cavity (Fig. 15). Other cartilaginous bodies 
may undergo partial endochondral ossifica­
tion resulting in intrasynovial ossicles (Fig. 
16).
Quite characteristic are large round cells 
(Fig. 17) surrounding degenerating nuclei,
Fig. 15.—Cartilaginous synovial bodies ready 
to extrude into joint cavity (hematoxylin and 
eosin, reduced by 40% from x 25).
Fig. 16.—Ossicle within synovial membrane 
(hematoxylin and eosin, reduced by 40% from 
x 63).
Fig. 17.—Degenerating cartilaginous body with 
fibrillation of its peripheral layers and liberation 
of chondrocytes (hematoxylin and eosin, reduced 
by 40% from x 250).
as if the cartilage could revert to fibrous 
tissue by the disappearance of the ground 
substance (Fig. 18), leaving the denuded 
collagenous fibres with the old chondrocytes 
represented by these large cells (Fig. 19). 
This results in a large capsule and some­
times becomes a fibrous synovial scar (Fig. 
20).
Fig. 18.—Degenerating cartilaginous body with 
large round cells within the surrounding fibrous 
capsule (hematoxylin and eosin, reduced by 40% 
from x 50).
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Fig. 19.—Collagen fibres in continuity with 
chondroid matrix; liberation of chondrocytes (he­
matoxylin and eosin, reduced by 40% from x 
400).
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Fig. 20.—Enlargement of fibrous capsule with 
large round cell (hematoxylin and eosin, reduced 
by 40% from x 400).
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Fig. 21.—Typical loose osteocartilaginous body 
within joint (hematoxylin and eosin, reduced by 
20% from x 250).
Fig. 22.—Laminar growth of loose body (hema­
toxylin and eosin, reduced by 20% from x 25).
Fig. 23.—Fibrous capsule in periphery of loose 
cartilaginous body (hematoxylin and eosin, re­
duced by 20% from x 125).
Loose bodies.— Loose bodies look similar 
to those arising from other conditions (Fig. 
21). The larger bodies are heavily calcified, 
degenerated and often are osteocartilaginous. 
Laminar growth by apposition is readily 
seen (Fig. 22).
Although the loose bodies are not gen­
erally surrounded by a true capsule, the 
cartilage degeneration into fibrous tissue is 
also seen at the periphery (Fig. 23).
Usually the whole synovial membrane is 
not involved in the chondrogenic metaplasia. 
However, chondrogenesis within the syno­
vium must be demonstrated before a true 
diagnosis of synovial chondrometaplasia can 
be established. For those who adhere to this 
strict diagnostic criterion, the disease is rare.
N atural Course
Kienbock1 - described five stages of syno­
vial chondrometaplasia:
1. Initially, formation of isolated small 
nodules, within the synovial membrane, 
which can be seen only histologically.
2. Formation of intrasynovial nodules of 
different sizes.
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3. Migration of nodules into the joint 
cavity.
4. Depletion of loose bodies in the cap­
sule with destruction of bone and articular 
cartilage.
5. Complete disintegration of the joint.
Usually the condition becomes clinically
symptomatic in the third stage and the last 
stage is rarely seen.
With the present state of our knowledge 
we cannot determine whether synovial chon- 
drometaplasia, which is often limited to a 
certain portion of the synovium, is a tem­
porary condition or whether it is permanent. 
Arguments can be put forward for each 
view.
We have found associated systemic con­
ditions with synovial chondrometaplasia, but 
only rarely. In our Canadian cases, there 
were associated vascular conditions in 
1.4%, gastrointestinal conditions in 1.4% 
and nervous conditions in 3.6%.
T r ea tm en t
Surgery was performed in all Canadian 
cases since histologic examination was essen­
tial for diagnosis of the disease. When 
chondrometaplasia was recognized at opera­
tion, synovectomy with removal of all the 
visible loose bodies was the treatment of 
choice; this was done in 12 of the 18 Cana­
dian patients. In the remaining six patients 
the loose bodies were removed and synovial 
biopsy was taken; synovectomy was per­
formed at a later date in two cases.
Radiotherapy has been advocated either 
as a form of treatment or, more commonly, 
postoperatively to prevent recurrence. To 
our knowledge, none of the patients in our 
two groups had radiotherapy.
Arthrotomy with removal of loose bodies 
and even synovectomy can lead to recur­
rence— 10.9% of reported cases. In three 
cases reported in the literature malignant 
degeneration developed. Recurrence cannot 
be confirmed unless chondrogenesis in the 
synovium, after a previous synovectomy, is 
observed, because loose bodies might remain 
after the initial operation.
C o m m e n t
As in many retrospective national surveys, 
our end results were difficult to assess be­
cause the follow-up in many patients was
inadequate. We had to discard many Cana­
dian cases that were perhaps genuine but 
for which we did not have enough data; this 
emphasizes the weaknesses of retro­
spective studies and the need to develop 
valuable prospective studies at a national 
level.
With these reservations in mind present 
knowledge suggests that the best treatment 
is surgical synovectomy. This can be per­
formed even in early childhood—in one of 
our cases, a bilateral synovectomy performed 
on a 7-year-old child resulted in excellent 
functional recovery and no sign of recur­
rence at 2-year follow-up.
To improve treatment, prospective studies 
should try to answer the following questions: 
Does chondroid metaplasia occur in the 
whole synovial membrane of a joint or only 
in a particular centre? Can the condition 
spread from these particular centres to the 
rest of the synovial membrane? Can intra- 
articular drug administration or radiation 
therapy alter the metaplastic process of the 
synovial membrane? Although it is evident 
that synovial chondrometaplasia produces 
alterations in the synovial circulation, these 
changes have not been investigated; there­
fore the role of the synovial blood vessels 
in different conditions should be clarified.
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COMPUTER-AIDED DIAGNOSIS OF GASTROENTEROLOGIC 
DISEASES IN SHERBROOKE: PRELIMINARY REPORT*
JANE C. HORROCKS,f GHISLAIN DEVROEDE, MD 
and F. T. de DOMBAL, MD
To assess the diagnostic accuracy of a 
computer-aided-diagnosis system when imple­
mented in different parts of the world, an auto­
mated system, which had established its reliabi­
lity in Leeds, England, was transferred to 
Sherbrooke, Quebec. In this preliminary study 
two retrospective series, comprising 104 pa­
tients with acute abdominal pain and 101 patients 
with dyspepsia, were drawn from the files of the 
Centre Hospitalier Universitaire in Sherbrooke. 
The history and physical-examination sheet was 
analyzed, coded and tested against the Leeds 
data base on a WANG 2200 computer, and the 
results were compared with the final Sherbrooke 
pathologic diagnosis. Overall the computer made 
a correct diagnosis in 78.8% of cases of acute 
abdominal pain and 70% of cases of dyspepsia. 
Computer diagnoses of appendicitis were correct 
in 97 %  of cases and the system recognized 91 %  
of the actual appendicitis cases. Similar figures 
for cholecystitis were 91 %  and for peptic ulcer, 
8 7 % . However, the "pick-up” rate by the com­
puter of pancreatitis was only 2 5 % . It is con­
cluded that geographical differences in disease 
presentation will probably not impair the validity 
of the computer method used in this study. A 
comparison of various diagnostic methods and 
levels of competence will await a prospective 
trial of this method.
Afin de voir si un systeme de diagnostic 
assiste de I'ordinateur garderait sa valeur 
dans differentes parties du monde, un systeme 
automatique, dont la valeur avait ete etablie a 
Leeds, Angleterre, a ete teste au Centre Hospi­
talier Universitaire, Sherbrooke, Quebec. Deux 
series retrospectives de 104 malades souffrant 
d'un abdomen aigu et de 101 malades souffrant 
de dyspepsie, ont ete etudiees. L’histoire de cas 
a I'admission a ete revue, codee, et un diagnos­
tic pose sur un ordinateur W ANG 2200, en lui 
donnant comme memoire les cas utilises a
*From the unite de recherche gastrointestinale, 
Universite de Sherbrooke, Sherbrooke, Que. and 
the department of surgery, Leeds University, Leeds, 
England.
tSupported by a grant from the Medical Research 
Council of the United Kingdom.
Request reprints to: Dr. G. Devroede, Depart­
ment of surgery, Centre Hospitalier Universitaire, 
Sherbrooke, PQ J1H 5N4.
Leeds dans ce but. Le diagnostic de I’ordinateur 
a ete compare au diagnostic pathologique de 
Sherbrooke. Le diagnostic de I'ordinateur etait 
correct dans 78.8% des cas d’abdomen aigu et 
70% de dyspepsie; 97% des appendicites dia- 
gnostiquees par I'ordinateur, etaient de fait des 
appendicites, et le systeme a reconnu 91 %  des 
cas d’appendicites histologiques. Les figures res- 
pectives pour la cholecystite et I’ulcere peptique 
sont 91% et 87%. Neanmoins I'ordinateur n'a 
reconnu que 25% des pancreatites. La difference 
geographique que les maladies ici pourraient 
avoir en mode de presentation, n’influence done 
probablement pas la validite du systeme teste 
dans cette etude. Par contre, il faudra attendre 
des etudes prospectives pour comparer la va­
leur respective des differents moyens de dia­
gnostic et determiner les differents niveaux de 
competence.
A ttempts have been made in a number 
of countries to introduce automated sys­
tems designed to facilitate clinical diagno­
sis, and indeed predicted diagnoses of such 
systems appear to be more accurate than 
those of unaided clinicians. Yet a major 
question remains in respect of computer- 
aided diagnosis: How applicable are such 
systems in different geographical areas? 
Would a system from one geographical area 
retain its diagnostic accuracy when imple­
mented in another?
In an attempt to answer this question, 
at least in part, we recently transferred a 
system of computer-aided diagnosis from 
Leeds, England, to Sherbrooke, Quebec. 
We report the methods used, detail some of 
the preliminary results, and outline further 
problems and perspectives for the future.
Materials and Methods
The methods used in implementing the 
computer-aided-diagnosis system in Sher­
brooke followed closely those already de­
lineated for the Leeds system,1' 2 but a 
brief outline and a summary of the differ­
ences between the two systems are appro­
priate.
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Computer System
We used a small desk-top computer 
(WANG 2200; central core store, 8K), 
which comprised a central processing unit, 
a video display unit and an entering key­
board. The programs were originally those 
of similar studies in England. These were 
written in BASIC language and transferred 
on magnetic tape to the Sherbrooke system. 
The turn-round time for each case varied 
from 1 to 2 minutes and the overall cost of 
the system approximated $12 000. The 
estimated cost of an individual search was 
$0.60.3
Patients Studied
Ideally, the efficiency and performance 
of any computer system can only be evalu­
ated on the basis of a prospective, unse­
lected, consecutive, real-time, real-life trial 
comparing the computer-aided system with 
various modes of “conventional” diagnosis. 
As an interim measure, however, we have 
tried to estimate the potential value of such
a system by considering two series of un­
selected real-life patients.
These two retrospective series comprised 
104 patients with acute abdominal pain and 
101 patients with dyspepsia admitted the 
Centre Hospitalier Universitaire, Sher­
brooke between 1970 and 1974. The com­
position of each series by disease is shown 
in Tables I and II. In both series, because 
almost all had an operation, most diagnoses 
were based on operative and histopathologic 
findings. Occasionally, as in eight patients 
with pancreatitis, biochemical evidence was 
accepted.
Methods of Study
Each case was studied in the following 
fashion. The case records were first scrutin­
ized, and details of the patient’s clinical 
presentation at the time of admission to hos­
pital were recorded on a special form (Fig. 
1). For the diagnosis in patients with acute 
abdominal pain the computer required data 
from the history and physical examination, 
but for patients with dyspepsia, it needed
TABLE I.—Comparison of Computer-aided D iagnosis v. “F inal” Clinical D iagnosis in  104
P atients with Acute Abdominal Pain
Computer-aided diagnosis
Acute appendicitis (AA).. 
Acute diverticular disease
(ADIT:.........................
Perforated peptic ulcer
(PPU )...............................
Nonspecific abdominal
pain (NASP)..................
Acute cholecystitis (A C).. 
Small bowel obstruction
(SBO)...............................
Acute pancreatitis (A P ). .
T otal............................
Final diagnosis
~AA ADD P P U  N A S P  AC SBO A P  Total
~  nr rr 32
-  — 1 3
2 1 1  5
-  1 2 8
i — 1 3
34 1 3 8
* Italicized numbers represent correct computer diagnoses.
TABLE II.—Comparison of Computer-Aided D iagnosis v. “F inal” Clinical D iagnosis in  101
Patients with Dyspepsia
Computer-aided diagnosis
Functional dyspepsia (FD)
Cholecystitis (C )..................
Peptic ulcer (PU )................
Gastric carcinoma (G C ). .
Total..............................
Final diagnosis
FD C P U  GC Total
1* .__ 8 2 1 12
— ---- 2 1 ____ 2 — 23
— 9 47 3 59
— 2 3 '— - 2 7
1 40 54 6 101
Italicized numbers represent correct computer diagnoses.
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CLINICAL DIAGNOSIS : ACUTE ABDOMEN
NAME J M H B
fc* H A l t JL6 SERIAL NUMBER
HMbt
0
0
3. Smrity SCV (114
4. Ajgrav fact *
s. iwmta kVitJQ K ill
4. Protreaa V J o t l t
7. Duration Jj.
»- Typo -  at oust »
9. Typo -  at praaent |
OTHER SYMPTOMS
1. Nouoo. V tS
2. Vocnitmf
3. Appotlt.
•o-h fuq utuey 
"no
UB
Dn^
GENERAL EXAMINATION 
Mood M ofcM A l 
Colour V30RMM. 
Temperature
ABDOMINAL INSPECTION
1. Movement K Jo t-H K .
2. Scan
3. Diuenskxi K30
ABDOMINAL PALPATION 
Tendemeaa R t a  
Rebound ' f H  
Guarding < / ( J
Rigidity M o
Swelling! MO 
Murphy t lC C M l V f  
Bowel Sounds fsMMLH 4  L
- “‘“■tluan L,<mi
c
OTHER RELEVANT DATA
Fig. 1.—Proforma sample showing data from 
25-year-old man with acute abdominal pain. 
CAD =  computer-aided diagnosis.
only details of age, sex and symptoms. This 
information was coded and entered into the 
computer system. The system generated a 
diagnostic probability and a print-out of 
the patient’s case history (Fig. 2). The 
computer-aided prediction was then com­
pared with the clinical diagnosis established 
at operation (including the histopathologic 
diagnosis where available).
R e s u l t s
Acute Abdominal Pain
The distribution of cases between the 
disease categories was not equal in this se­
ries of 104 patients (Table I); of the “posi­
tive” diagnoses the commonest disease cate­
gories were appendicitis and cholecystitis. 
This reflects a similar distribution found 
in previous studies to the United Kingdom.
Overall, 82 (78.8%) cases were correct­
ly diagnosed by the computer-aided system, 
but there was considerable variation in the 
accuracy of the system between the various 
disease categories (Table I): the computer 
made 32 diagnoses of appendicitis of which 
31 (97%) were correct, and correctly iden-
C ase r e f -  
M ale
Age 20-29
S i t e  o n s e t - C e n t r a l
S i t e  p resen t-R L Q
R e lie v e d  by ly in g  s t i l l
P a in  g e t t i n g  w orse
D u ra t io n  u n d e r 12 h r s
S e v e re  p a in
N ausea
V om iting
A p p e t i te  d e c re a s e d  
No in d i g e s t i o n  
No ja u n d ic e  
B ow els-C ons t i p  a t io n  
M ic tu r i t io n -F re q u e n c y  
No p r e v io u s  ab d . p a in  
No p r e v .  abdom inal s u r g e r y  
N ot ta k in g  d ru g s
Mood norm al 
C o lo u r-n o rm a l 
A bd. m v t. norm al 
A bdom inal s c a r  a b s e n t  
D is te n s io n  a b s e n t  
Tenderness-R L Q  
Rebound te n d e rn e s s  
G uard in g  p r e s e n t  
R ig i d i ty  a b s e n t 
S w e llin g  a b s e n t  
M u rp h y 's  s ig n  n e g a t iv e  
Bowel sounds norm al 
R e c ta l  ex a m -te n d e r  r .  s i d e
Append D iv e r t  P e r fd u  Nonsap C hole Smbobt P an c re  
9 9 .9 3  .00  .0 0  .06  .0 0  .00  .00
Fig. 2.—Computer print-out from same patient 
as for Fig. 1 showing diagnostic prediction of 
acute appendicitis. Note than computer ignores 
data recorded by clinician as uncertain.
tified 31 (91 %) of the 34 patients with acute 
appendicitis; the computer made 32 diag­
noses of cholelithiasis, of which 29 (91%) 
were correct and correctly identified 29 
(91 %) of the 32 patients who had cholecys­
titis. This represents an accuracy and reli­
ability of over 90% in each case. However, 
of the eight patients with pancreatitis the 
computer correctly identified only two (a 
“pick-up” rate of only 25%).
Dyspepsia
A comparable picture was seen in the 
series of 101 patients with dyspepsia (Ta­
ble II). Overall the diagnostic accuracy (71 
of 101 patients) was modestly encouraging 
(70%) and was higher than the diagnostic 
accuracy of unaided clinicians reported un­
der similar circumstances (50% ).:i However, 
the same differences between diagnostic ac­
curacy by disease categories is evident. The 
computer correctly identified 47 (87%) of 
the 54 patients with peptic ulcer but only 2 
of the 6 patients with proven gastric carci­
noma.
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Fig. 3.—Diagnostic accuracy of computer-aided 
system in Leeds' and in Sherbrooke in cases of 
acute abdomen, compared with percentage accur­
acy of Harvard residents5 and Edinburgh regis­
trars (Gunn A, unpublished data, 1975) and 
Copenhagen registrars (Bjerregaard B, unpublished 
data, 1975).
D iscussion
It has been suggested4 that the potential 
value of any computer-aided system de­
pends on two factors: (a) its performance 
in its place of origin; and (b) transferral to 
a different geographical location without a 
considerable loss of accuracy and reliability. 
It is, therefore, refevant to compare experi­
ence in Leeds and in Sherbrooke.
In some respects precise comparisons 
concerning performance of this system are 
difficult—for example, the cases studied 
in Sherbrooke did not form a consecutive, 
prospective, unselected series. Thus many 
of the categories of data in the case notes 
differed from those that would have been 
collected in a prospective series; also there 
was no attempt to standardize terminology 
in this series. And, although the series was 
unselected there is no guarantee that the 
distribution of cases in this series of 200 
patients will accurately reflect the distribu­
tion in a prospective series.
Despite these problems, it is worth mak­
ing some comparisons between Sherbrooke 
and Leeds— particularly because they bias 
the results against the computer-aided sys­
tem, because there has been no attempt to 
standardize the Sherbrooke and Leeds terms 
and because case histories written in French 
were compared to an English data base. 
(Bias in any series is never desirable but 
when a “new” method or treatment is be­
ing evaluated, any bias should preferably be 
“against” the new method). Moreover, one 
valid comparison that can be made is that 
between the computer’s accuracy in these
patients and its accuracy in similar retro­
spective series of patients studied at the 
inception of the Leeds program. For exam­
ple, the overall accuracy of the computer in 
acute abdominal pain was 79% (Fig. 3), 
which compares well with its 84% accura­
cy in a retrospective group of 300 cases 
studied at the start of the Leeds series. 
Moreover, it is apparent from the failure 
of the system to identify accurately the 
cases of pancreatitis that the diagnostic 
term “pancreatitis” has a different mean­
ing in Leeds and in Sherbrooke. Therefore, 
if we exclude the cases of pancreatitis the 
accuracy of computer prediction is very 
similar in both centres (84% in Leeds, 83% 
in Sherbrooke).
Fig. 4.—Diagnostic accuracy of computer-aided 
system in Leeds, and in Sherbrooke in cases of 
dyspepsia, compared with accuracy of English3 and 
American physicians.3
Results with respect to dyspepsia are also 
comparable (Fig. A'- ’■). In initial attempts 
in Leeds to construct a data base of infor­
mation concerning patients with dyspepsia, 
the diagnostic accuracy overall was 70% . 
In Sherbrooke the diagnostic accuracy over­
all using retrospective case data was 72% .
We have not attempted to make any de­
finite comparisons between diagnoses of 
clinicians and diagnoses of the computer- 
aided system in this series, because it is 
almost impossible in retrospect to assess a 
clinician’s diagnosis in the circumstances 
facing him at the time. We have attempted 
to remedy this drawback by comparing the 
accuracy of the computer-aided predictions 
with that of various groups of clinicians in 
centres where information is available. The 
overall accuracy of the computer-aided sys­
tem in cases of acute abdominal pain (even 
using retrospective case data) is consider­
ably higher than that of the average Euro-
164 TH E CANADIAN JOURNAL OF SURGERY Vol. 19
pean house surgeon (intern) or registrar 
(junior resident), and compares favourably 
with data from North America.** The same 
trend is shown in the patients with dyspep­
sia.
C o n c l u s io n s
Previous studies have shown that appli­
cation of the computer-aided system to 
analysis of data from prospective, conse­
cutive, unselected series has improved the 
diagnostic accuracy over that from retro­
spective series. It seems reasonable, on the 
basis of the present findings, to postulate 
that the same would happen in Sherbrooke, 
but all that can be said as a result of the 
present series of studies is that transfer of 
a small, desk-top, computer-aided system 
for clinical diagnosis from Leeds to Sher­
brooke resulted in little loss of accuracy 
and reliability.
The contrast at Sherbrooke between the 
poor computer diagnosis of pancreatitis and 
the accurate diagnosis of cholecystitis or 
appendicitis is extremely interesting. It is 
reasonable to conclude that cholecystitis and 
appendicitis present in similar fashion in 
Leeds and Sherbrooke, since a computer- 
aided system working on Leeds data correct­
ly diagnosed over 90%  of patients in Sher­
brooke. Preliminary studies from other 
centres indicate that the diseases present in 
comparable fashion elsewhere. One might 
suggest that appendicitis and cholecystitis 
are indeed disease entities, but that “pan­
creatitis” is not yet a sufficiently precise
disease category, and, following from this 
assumption, that the diagnosis of pancreati­
tis should be reviewed and additional ef­
forts should be made towards standardiza­
tion of this diagnosis around the world.
The overall conclusion from the present 
series of studies is that geographical dif­
ferences in disease presentation are not per­
haps as great as might have been thought, 
and there may be in a routine practical 
sense, a place for the wider implementation 
of the type of computer-aided system de­
scribed here. Such an assertion calls for a 
prospective randomized, controlled trial and 
we hope to undertake further studies of this 
nature in the near future as a result of col­
laboration between our two centres.
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FAMILIAL POLYPOSIS COLI AND PERIAMPULLARY CARCINOMA*
ALI H. QIZILBASH, MB, BS, FRCP[C]
An 80-year-old woman with periampullary 
carcinoma was found, at autopsy, to have 
polyposis coli. A brief review of the literature 
indicates that, although the association of Gard­
ner’s syndrome with duodenal and pancreatic 
carcinoma is well established, the patient de­
scribed in this report is only the second with 
polyposis coli in whom a periampullary carcino­
ma developed.
Un cas de polyadenomatose familiale essen- 
tielle a ete decouvert a I'autopsie chez une 
femme de 80 ans atteinte d'un carcinome 
peri-ampullaire. Une breve revue de la littera- 
ture revele que bien que ('association du syn­
drome de Gardner avec le carcinome du duode­
num et du pancreas soit bien reconnue, la 
patiente faisant I'objet de cette communication 
est seulement le deuxieme cas de polyadeno­
matose familiale essentielle chez qui un carci­
nome peri-ampullaire est apparu.
The term polyposis coli is defined as the 
condition of multiple adenomatous polyps 
lining the mucous membrane of the large in­
testine and is used synonymously with 
familial polyposis.1 Polyposis coli may oc­
cur alone or with other extracolonic abnor­
malities. We report a case occurring in 
association with periampullary carcinoma: 
to the best of our knowledge this is only the 
second report of such an association.
Case R eport
A 77-year-old white woman underwent elec­
tive cholecystectomy for a nonfunctioning 
cholesterolotic gallbladder in October 1971. 
Other intra-abdominal organs appeared nor­
mal. She was hospitalized again in August 
1972 because of jaundice, abdominal pain, 
nausea, vomiting and fever. Percutaneous 
transhepatic cholangiography demonstrated 
gross dilatation of the common bile duct and 
intrahepatic biliary radicles with obstruction 
at the lower end of the biliary tract, and lapa­
rotomy revealed a hard nodular head of the 
pancreas and a dilated, thickened common 
bile duct. Carcinoma of the pancreas was diag-
*From the departments of laboratory medicine, 
Henderson General Hospital and McMaster Uni­
versity, Hamilton, Ont.
Reprint requests to: Dr. Ali H. Qizilbash, De­
partment of laboratory medicine, Henderson Gen­
eral Hospital, 711 Concession St., Hamilton, ON 
L8V 1C3.
nosed. The common bile duct and pyloro- 
duodenal junction were anastomosed side-to- 
side and a gastrojejunostomy was performed. 
Despite intra-abdominal abscess formation, 
pulmonary embolization and myocardial in­
farction, the patient recovered satisfactorily.
She was hospitalized once more in August 
1974 because of a 4-day history of recurrent 
chest pain radiating to the right arm and 
shoulder, a 4-month history of severe, watery 
diarrhea (as many as 20 bowel movements 
daily) and weight loss. Abdominal pain with 
occasional nausea and vomiting had persisted 
since August 1972. Pertinent findings were: 
liver, tenderness and enlargement (liver edge, 
4.0 cm below the right costal margin); spleen, 
palpable; hemoglobin concentration, 11.4 g/dl; 
leukocyte count, 10.4 x 107/ (differential, 
normal); total serum bilirubin concentration 
0.6 mg/dl; serum glutamic oxaloacetic trans­
aminase value, 27 IU; alkaline phosphatase 
value, 396 IU; stools, positive for occult blood 
and Salmonella montevideo but negative for 
ova, cysts and parasites; chest radiograph, 1.0- 
cm cavitating lesion in the left upper lobe; 
barium enema examination, diffuse diverticu- 
losis and fecal retention; liver scan, patchy 
distribution of radioactivity within an en­
larged liver and two cold nodules. Results of 
electrocardiography and barium meal exam­
ination were normal. Metastatic pancreatic 
carcinoma was diagnosed. Treatment was 
symptomatic and included antibiotic therapy. 
However, after two episodes of gastrointestinal 
hemorrhage and despite numerous blood 
transfusions she died on Oct. 5, 1974.
Autopsy revealed a well-differentiated ade­
nocarcinoma (in continuity with the head of 
the pancreas) in the region of the ampulla 
of Vater. It involved the entire duodenal wall, 
the peripancreatic tissue, the inferior vena 
cava, and the right retroperitoneal tissues. 
Metastases were present in liver, lungs, pleura 
and intercostal mucles. The common bile duct 
was not involved and the small bowel ap­
peared normal. The large bowel from cecum 
to rectum was carpeted by hundreds of 
polyps (Fig. 1) (diameter, 0.5 to 3.0 cm), ei­
ther pedunculated (Fig. 2) or appearing as 
small nodules on the mucosal surface; the 
largest was a sessile polyp, a villous adenoma, 
in the rectosigmoid area (Fig. 3); the others 
were adenomatous polyps. Numerous diverti­
cula were present in the left colon, and chronic 
cholangitis and obstructive pancreatitis were
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demonstrated histologically. Additional find­
ings included nonbacterial, thrombotic endo­
carditis of mitral valve, small emboli in coro­
nary and splenic arteries, and fresh infarcts 
of brain, myocardium and spleen.
Family History
Further investigation of the family history 
of this patient revealed that other members of 
the family, including the patient’s father, and 
two of five brothers, had died from car­
cinoma of the colon. One of the two brothers 
who died has two daughters, both of whom 
have had carcinoma of the colon. Also, two 
of the patient’s sons have multiple polyposis; 
in one carcinoma of the colon has developed. 
Complete investigation of the entire family is 
now being undertaken.
D iscussion
Our patient is of interest for three rea­
sons; (a) she presented with symptoms of 
periampullary carcinoma 2 years before her 
last admission; (b) diarrhea occurred for 
the first time at the age of 80 years; and (c) 
because of marked fecal retention, the ba­
rium enema was not diagnostic, therefore 
the diagnosis of polyposis coli was not made 
before death. A review of the literature on 
polyposis coli is therefore of value.
The association of polyposis coli with os­
teomas, epidermoid cysts, soft-tissue tu­
mours, abnormal dentition and postoper­
ative desmoid tumours was first recognized 
by Gardner2’ 3 and is now usually referred 
to as Gardner’s syndrome. Polyposis coli 
may be associated also with multiple endo­
crine adenomas4' 5 and tumours of the brain 
(Turcot syndrome).6’ 7
Another interesting association in pa­
tients with Gardner’s syndrome is the find­
ing of carcinoma of the periampullary re­
gion (duodenum, ampulla of Vater and 
pancreas).8 At least seven cases have been 
reported.8' 13 In the case reported by Capps, 
Lewis and Gazzaniga14 carcinoma of the 
ampulla of Vater was found in a patient with 
polyposis coli but without other stigmata of 
Gardner’s syndrome; carcinoma of the colon 
and urinary bladder was also present. Our 
patient also had no extracolonic signs of 
Gardner’s syndrome, but it was difficult to 
decide at autopsy, whether the tumour arose 
in the head of the pancreas, duodenum or 
ampulla of Vater.
Fig. 1.—Portion of colon containing numerous 
small adenomatous polyps.
Fig. 2.—Section of colon showing minute ade­
nomas (hematoxylin and eosin, x 41-
Fig. 3.—Sigmoid colon containing three pe­
dunculated, adenomatous polyps (arrows) and a 
large, sessile, villous papilloma in centre (half had 
been removed for histologic study).
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In most patients with polyposis coli, a 
family history is obtained and evidence of 
the disease can be traced through many 
generations. The condition is transmitted as 
an autosomal dominant.15 Occasionally, 
however, cases of nonfamilial polyposis coli 
are encountered. In Bussey’s view15 non­
familial cases are nearly always attributable 
to new mutation, and transmission of the 
disease is just as likely as in familial cases.
Familial polyposis is generally regarded 
as a disease of youth, but patients may be 
middle-aged or even elderly before symp­
toms appear.15 The polyps usually do not 
appear before 10 years of age though re­
ports of cases as early as 13 months of age 
have been published.16 At St. Mark’s Hos­
pital, London, the oldest patient with mul­
tiple polyposis at the time of diagnosis was 
73 years.17 Our patient who was 80 years 
old at the time of diagnosis appears to be 
the oldest patient reported with this condi­
tion. The mean age of patients with polypo­
sis coli in whom carcinoma subsequently de­
velops is 40 years.17 In the series reported 
by Asman and Pierce,18 in which the mean 
age was 38.8 years, carcinoma was present 
at the time of diagnosis of polyposis coli 
or 2 years thereafter in 49% of their symp­
tomatic patients. However, cancer was de­
tected in only 12% of the asymptomatic 
patients, indicating the importance of symp­
toms in planning surgical treatment. In 
our patient symptoms were only of 4 
months’ duration and no carcinoma of the 
colon was found at autopsy; all of the po­
lyps found in the large bowel were benign, 
adenomatous polyps except for the largest 
one situated in the rectosigmoid region, 
which was a villous papilloma. Most re­
ports refer to the polyps found in familial 
polyposis as adenomas, though rare villous 
tumours have been described.17
Familial polyposis was thought to repre­
sent a disease primarily of the large intes­
tine, but recently it has become apparent 
that many patients with this condition have 
extracolonic signs, supporting the concept 
put forward by Smith19 that there is one 
gene for both Gardner’s syndrome and fa­
milial polyposis, with a variation in pen­
etrance accounting for the different clinical 
pictures. Our case would support such a 
concept.
I thank Dr. W. R. McMillan for permission to 
review the case and to interview members of 
the family.
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CONGENITAL HIP DISLOCATIONS DIAGNOSED AFTER WALKING 
AGE: RESULTS OF TREATMENT*
MICHAEL A. ROSMAN, MD, FRCS[C]
The results of treatment of 64 congenital 
hip dislocations, diagnosed after the children 
were of walking age, were assessed ana­
tomically, using two criteria—general fem­
oral head shape and the C.E. angle of Wiberg. 
Results were also related to age at diagnosis 
and treatment methods. Radiologically 62% of 
the hips had normal or good results, and of 
these, 82% were obtained when the diagnosis 
was made and treatment started before the age 
of 36 months. In this series no correlation ex­
isted between anatomical result and treatment 
method.
Les resultats therapeutiques obtenus dans 
64 cas de dislocation congenitaie de la 
hanche diagnostiques apres que les enfants 
eurent atteints I’age de marcher, ont ete evalues 
selon deux criteres: la forme generale de la 
tete femorale et Tangle C.E. de Wiberg. Les re­
sultats ont aussi ete evalues en fonction de 
I'age au moment du diagnostic et de la methode 
de traitement. A la radiographie, 62% des han­
dles etaient normales ou montraient de bons 
resultats; 82% de ces resultats furent obtenus 
lorsque le diagnostic fut pose et que le traite­
ment commenca avant i'age de 36 mois. Dans 
cette serie il n'y avait aucune correlation entre 
le resultat anatomique et la methode de traite­
ment.
The results of treatment for congenital dis­
location of the hip depend on the age at 
which the diagnosis is made and the treat­
ment initiated.1'4 Generally, the earlier the 
diagnosis is made the better the result, both 
clinically and radiologically. In the few pa­
tients in whom the dislocation is not diag­
nosed until the child begins to walk, results 
are usually less satisfactory.
The purpose of this study was to assess 
the results of treatment in these older chil­
dren and to correlate the results with the 
age of the child at the time of the diagnosis 
and the method of treatment.
*From the department of orthopedic surgery, 
Montreal Children’s Hospital, Montreal, Que.
Presented at the meeting of the Canadian Ortho­
paedic Association, St. John’s, Nfld, June 1974.
Reprint requests to: Dr. M. A. Rosman, Depart­
ment of orthopedic surgery, Montreal Children’s 
Hospital, 2300 Tupper St., Montreal, PQ H3H 1P3.
Details of Patients, Methods
and T reatment
Unilateral or bilateral congenital hip dis­
location was diagnosed after walking age in 
53 children (46 girls) during the 15 years 
1959 through 1973; 64 hips were examined 
(42 unilateral, 11 bilateral). Each hip was 
assessed individually. Initially all patients 
were treated by traction and open adductor 
tenotomy, and, after reduction, with spica- 
cast immobilization.
The age range at the time of diagnosis 
was 11 months to 13 years (average, 3.5 
years). Patients with unilateral dislocation 
were seen earlier than those with bilateral 
dislocation. Follow-up ranged from 5 to 
12.6 years (average, 7.7 years).
Methods used to reduce the hip disloca­
tion were as follows: open reduction, 37 
hips; closed reduction, 26; closed then open 
reduction, 12; open followed by repeat open 
reduction, 4. Fifty-five associated pro­
cedures were done at the time of reduction 
or later (derotational osteotomy, 32 hips; 
innominate osteotomy, 17; varus osteotomy, 
3; other, 3).
Method of A ssessment
The 64 hips were reassessed clinically and 
radiologically. Subjective complaints were 
minimal and objective findings, such as 
limited range of motion, pain on motion, 
awkward gait, shortening and weakness, 
were not grossly abnormal and did not in­
terfere with function.
In the radiologic reassessment of the hips 
we used two criteria: the C.E. angle of 
Wiberg*5 and the general shape of the 
femoral head and acetabulum classified by 
Somerville (normal [radiologically normal], 
good [showing signs of subluxation], fair 
[dysplasia], or poor [deformity]).4
A normal hip has a C.E. angle of over 
35° and appears normal radiologically; a
*A line joining the centre of the femoral head and 
the edge of the acetabulum subtends an angle with 
the centre of the femoral head. A normal hip 
has an angle of 20 to 40°; an angle less than 20° 
represents subluxation and an angle greater than 
40° represents protrusion.
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Fig. la
Fig. lb
Fig. 1.—(a) Congenita! hip dislocation in 2 Vi-year-old girl. Treatment was by closed reduction 
only, (b) Normal result, 9 years later, correlating anatomically normal-shaped femoral head to C E. 
angle of 35 .
March 1976 THE CANADIAN JOURNAL OF SURGERY 171
Fig. 2a
Fig. 2b
Fig. 2.—(a) Initial dislocation in 15-month-old girl. Dislocation was treated by closed reduction 
and derotational osteotomy. Acetabular roof did not develop with abduction splinting; redislocation 
occurred 2 years later and was treated by open reduction, (b) Nine years after initial dislocation, 
anatomical assessment was poor and C.E. angle was 4°.
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good hip has a C.E. angle of 20 to 34° 
either with Shenton’s line intact and slight 
uncovering of the femoral head or with 
Shenton’s line slightly broken and the head 
bulging; fair and poor hips have C.E. angles 
of less than 20° with misshapen and incon­
gruous femoral heads, deformed acetabula 
and broken Shenton’s lines.
R esults
By the anatomic grading of Somerville 
and the C.E. angle of Wiberg, 40 hips were 
reassessed as normal or good (C.E. angle, 
>  35° to 20°) while 24 hips were fair or 
poor (C.E. angle 19° to <  10°). The ana­
tomic grading and the C.E. angle closely 
parallelled each other (Figs. 1 and 2).
TABLE I.—Age at D iagnosis R elated to 
Anatomic R esults
Age at 
diagnosis 
(mo)
Results
Normal Good Fair Poor
11 -2 4 5 9 0 1
25 - 36 14 5 0 0
37 - 48 4 0 12 1
> 48 2 1 2 8
Total 25 15 14 10
Table I illustrates the relationship be­
tween the age at diagnosis and anatomic 
result: 40 (62.5%) of the 64 hips were 
reassessed as normal or good, and of these 
40, 33 (82.5%) resulted when the diag­
nosis was made before 36 months of age. 
When the diagnosis is made later, the re­
sult is often poor—in 23 (96%) of the 24 
hips reassessed as fair or poor the disloca­
tion was diagnosed after 36 months of age.
When the overall number of patients and 
their age at diagnosis (at 6-month intervals) 
were examined in relation to the radiologic 
results of all hips we found that there was 
a greater proportion of more favourable 
radiologic results in patients when the diag­
nosis was made and treatment begun at an 
age under 36 months.
A comparison of two groups of anatomic 
results (normal, good and fair, poor) re­
lated to treatment (Table II), indicates that 
each group had slightly more than one re­
duction per hip, and additional or associated 
procedures averaged close to one per hip. It 
appears, therefore, that the type of reduc­
tion and the associated procedures did not 
affect the anatomic grade in this series.
Complications were recorded for 35 of 
the hips. There were four instances of 
avascular necrosis associated with closed 
reduction.
Discussion
In the treatment of congenital hip dis­
location, the need for preliminary traction, 
usually skeletal, in children of walking age 
has been stressed.6’ 7 In our series it was 
combined with open adductor tenotomy. 
Management of hip dislocation is easier and 
results are better, if the diagnosis is made 
before walking age; in those children whose 
dislocated hips are not diagnosed until after 
they have begun to walk, a greater number 
of reductions, open and closed, and addi­
tional procedures, may be required. Con­
centric reduction is necessary to ensure not 
only stability but also good long-term ana­
tomic results, whether these are achieved by 
open or closed methods.2- 3- 7
Because the response of the acetabular 
roof in children over 18 months of age is 
not uniform or predictable, even after a 
concentric reduction, pelvic osteotomy of 
some type may be required.7 However, in 
the opinion of Somerville4 the acetabular 
roof will respond after 18 months, if the 
femoral head is kept centered, either by 
prolonged abduction splinting or varus 
osteotomy. If reduction is combined with 
acetabular redirection, the forced internal 
rotation that is required to maintain reduc­
tion, and is due to increased anteversion, 
will be unnecessary. Perfect results are 
never expected in any child in whom the 
diagnosis is made and treatment started 
after walking age because operative recon­
struction can never match natural reforma­
tion of the hip joint, but in our series no
TABLE II.—T reatment Related to Anatomic 
R esults
Results
Normal Fair
and good and poor
(n = 40) (n = 24)
Form of reduction:
Closed 24 11
Open 24 20
Other procedures 30 25
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patient or parent was dissatisfied with the 
result.
Our findings suggest that, subjectively and 
functionally, these children do well, but 
that, objectively, the results are less accept­
able. The current treatment of hip disloca­
tions diagnosed after walking age consists 
of gentle preliminary traction following 
open adductor tenotomy, then open reduc­
tion of the hip joint. Innominate osteotomy, 
done at the same time as the open reduction 
or several weeks later, ensures stability and 
coverage by the overlying acetabular roof 
and minimizes immobilization and stiffness.
The age of the child at the time of diag­
nosis was the only factor that appeared to 
influence the overall results in our series: 
if diagnosis was made and treatment begun 
after walking age, there was a 66% chance 
of an acceptable result, and if the patient 
was under 36 months of age, there was an 
80% chance of an acceptable result. The 
findings of this study suggest that a more 
uniform approach to the treatment might 
have produced a greater number of normal 
and good results.
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B O O K  R E V I E W S
COMMON DUCT STONES. Frank Glenn.
135 pp. Illust. Charles C Thomas, Pub­
lisher, Springfield, IL, 1975. $11.50.
The management of common duct stones re­
mains one of the general surgeon’s most dif­
ficult problems. Most surgeons who treat 
biliary tract disease are familiar with the many 
contributions to the literature on this subject 
by Dr. Glenn. This small monograph presents 
an interesting history of the development of 
biliary tract surgery from the earliest obser­
vations in the 5th century to the present. Case 
reports are used to illustrate the advance in 
knowledge and increasing success of treat­
ment; the history of the development of 
radiology as it pertains to biliary tract disease 
is also described. The development of common 
duct surgery and the various clinical syn­
dromes produced by stones in the common 
duct are discussed and then the technique and 
results of common duct drainage and decom­
pression are considered. The various methods 
of dealing with retained common duct stones, 
including the use of various solvents, instru­
mentation and surgical exploration are re­
viewed.
This is not a book on surgical technique 
but an interesting story of the development 
of biliary tract surgery. It contains many ob­
servations (based on a wide experience) that 
are not usually found in a textbook or journal. 
Most general surgeons will find it interesting.
D. E. M orris
Department of surgery,
Victoria General Hospital,
Halifax, NS.
FLUIDS FOR ANESTHESIA AND SUR­
GERY IN THE NEWBORN AND THE 
INFANT. E. J. Bennett and J. P. Payne. 
232 pp. Charles C Thomas, Publisher, 
Springfield, IL, 1975. $18.50.
For the occasional pediatric surgeon or anes­
thetist the management of electrolyte and fluid 
balance of the newborn or infant is often beset 
by problems. This book succinctly (and at 
times dogmatically) sets forth guidelines to 
prevent the occurrence of many of the hazards, 
should they occur, and to indicate treatment.
In the initial chapters renal physiology and 
homeostasis are discussed as they apply to
patients of this age group, and it is on this 
basis that the author, in the ensuing chapters, 
discusses the clinical evaluation of the newborn 
infant and the signs and symptoms of changes 
in homeostasis and presents rational schemes 
for correction of these changes.
Fluid therapy and blood replacement during 
surgery are considered in general terms, and 
specific pathologic entities in more detail. A 
separate chapter is devoted to the evaluation 
and preparation of the infant with pyloric 
stenosis before operation. Short chapters are 
also included on intravenous alimentation and 
fluid balance in infants receiving respiratory 
therapy. Specific examples of the correction of 
various electrolyte and fluid derangements are 
included where appropriate. The references in 
each chapter are complete and plentiful.
This relatively short book is an excellent 
practical guide to current concepts of fluid 
therapy in the pediatric surgical patient.
E. J. R h in e
Department of anesthesia,
Children’s Hospital of Eastern Ontario,
Ottawa, Ont.
MAJOR AMPUTATIONS FOR VASCULAR
SURGERY. Edited by J. M. Little. 114 pp.
Illust. Churchill Livingstone, Edinburgh;
Longman Canada Limited, Toronto, 1975.
$18.00.
In this book, which should interest all medical 
and paramedical personnel responsible for the 
care of amputees, Little stresses the natural 
history and management of the patient and 
relates his personal experience with the am­
putee clinic at the Royal Prince Alfred Hospital 
in Sydney, Australia and he stresses the im­
portance of a rehabilitation program in the 
management of these patients.
Little’s book, in general, is useful but cer­
tain omissions are evident and several other 
points merit comment. For example, I won­
dered why the author does not use delayed 
secondary wound closure of the amputation 
stump, for he discusses the problems of hema­
toma, ischemia, and infection in the stump, 
and reports a wound complication rate in his 
own cases of 30%. I also noted that the 
author failed to report on the two-stage Syme 
amputation, advocated by Wagner.
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In our experience, because of severe pain 
in our patients before amputation, we have 
had little success with preoperative gait train­
ing, and would not approve of the use of ice 
on the skin of ischemic limbs. We still believe 
that the ability to use crutches efficiently is 
the best indicator of the patient’s capabilities 
for prosthetic training. Despite these points, 
this book was a pleasure to review.
G. A. H u n t e r
Department of surgery,
St. Michael’s Hospital,
Toronto, Ont.
RECENT TRENDS IN CARDIOVASCULAR 
AND THORACIC SURGERY. Edited by 
Joseph B. Borman. 222 pp. Illust. Grune & 
Stratton, Inc., New York; Longman Canada 
Limited, Toronto, 1975. $20.25.
What can one really say about a compilation 
of articles by authorities in their respective 
fields in a volume dedicated to Hanoch Mil- 
widsky who, until his untimely death in Feb­
ruary 1970, was director of the division of 
cardiovascular and thoracic surgery at the 
Hadassah University Hospital in Jerusalem? 
To be critical would border on being disre­
spectful! However, virtually all the information 
contained in this book has already been pub­
lished, and republished, in the available surgical 
literature. Yet another operation for esophageal 
stricture is described and several articles em­
phasize that war is bad. On the other hand, 
Lord Brock’s article is like a breath of fresh 
air and should be read by all modern-day 
heart surgeons, who seem incapable of doing 
even a pericardiectomy without “pump sup­
port”.
I can find little reason to recommend this 
book except to those who do not have access 
to a medical library.
R. B. L ynn
Cardiovascular and thoracic surgery,
Queen’s University,
Kingston, Ont.
SALIVARY GLANDS AND THE FACIAL 
NERVE. John Conley. 391 pp. Illust. Grune 
& Stratton, Inc., New York, George Thieme 
Publishers, Stuttgart; Longman Canada 
Limited, Toronto, 1975. $98.00.
The author is congratulated for putting to­
gether an excellent, masterful monograph on 
the salivary glands and facial nerve. In this
text, dealing primarily with diagnosis and 
treatment and based on personal experience, 
he draws on a clinical background of 1210 
cases of salivary gland tumours from the Pack 
Medical Foundation and 1280 tumours from 
the Columbia Presbyterian Medical Center.
The format is pleasing and well or­
ganized, with large, easy-to-read print. It is 
profusely illustrated. The book is divided into 
two sections: The first deals with the anatomy 
of the salivary glands and the pathology, diag­
nosis and treatment of benign and malignant 
tumours; the second refers entirely to the 
facial nerve and its relation to salivary gland 
tumours, its surgical anatomy and the tech­
niques used to restore its function (including 
facial nerve grafting, nerve cross-over, re­
gional flap transpositions, etc.).
Dr. Asher Kleinsasser’s description of epi­
thelial tumours of the parotid gland, based on 
studies conducted at the ear, nose and throat 
clinic at Cologne University, is excellent. In 
these studies, all salivary gland tumours were 
studied microscopically, electronmicroscopical- 
ly and histochemically. Electronmicroscopic 
illustrations of several tumours are beautifully 
shown.
A well-written chapter on non-neoplastic 
diseases of the parotid glands by Walter P. 
Work covers inflammation, metabolic and en­
docrine disorders, embryonic disturbances, 
cysts and trauma and contains an extensive 
bibliography.
The pathology of salivary gland neoplasms, 
outlined by Drs. Marianne Wolff and Raffaele 
Lattes, is disappointingly brief and without 
adequate description of the gross microscopic 
features of benign and malignant lesions.
Three excellent chapters are those on parotid 
gland tumours in children, the gustatory 
sweating syndrome and the role of radiation 
therapy in the management of malignant 
tumours of the salivary gland.
In the final portion of the book, variations 
in facial nerve anatomy together with tech­
niques of facial nerve reconstruction are well 
described and illustrated.
This text is highly recommended for those 
with a particular interest in head and neck 
neoplasms—the otolaryngologist, general sur­
geon, plastic surgeon, maxillofacial surgeon 
and radiotherapist.
E. J. T abah
Central Tumour Registry,
Royal Victoria Hospital,
Montreal, Que.
176 THE CANADIAN JOURNAL OF SURGERY Vol. 19
INDEX TO ADVERTISERS
ARLINGTON LABORATORIES
M .V .I.-1000  ................................... 86
AYERST LABORATORIES
Injectables .......................................... 113
Pyopen .................................................. 91
BOEHRINGER INGELHEIM (CANADA) LTD.
Trasylol .......................... 148, 149, 150
BRISTOL LABORATORIES OF CANADA
Kantrex ..............................................  159
CALMIC LIMITED
Neosporin Irrigating Solution ..........  108
Polybactrin ..............................  114, 115
DAVIS & GECK
Dexon ........................ Outside Back Cover
Surgilon ..............................................  116
EATON LABORATORIES
Vivonex ..............................................  135
ETHICON SUTURES LIMITED
Nurolon .......................  Inside Front Cover
Vicryl ...........................  Inside Back Cover
HARRIS LABORATORIES
Hepalean .........................................  88
HOLLISTER LIMITED
Draining Wound
Management System ........................ 123
MEAD JOHNSON CANADA
Flexical/Isocal/Sustacal ..............  84, 85
PROMED CANADA LIMITED 92
ROBINS COMPANY OF CANADA, LTD., A. H.
AI bee C-550 .....................................  127
SCHERING CORPORATION LIMITED
Garamycin .....................  136, 137, 138
SQUIBB & SONS LIMITED, E. R.
Velosef .......................... 124, 125, 126
SWANN-MORTON LIMITED 165
UPJOHN COMPANY OF CANADA, THE
Dalacin C .....................  100, 101, 102
Solu-Medrol ................. 132, 133, 134
WINTHROP LABORATORIES
82
(Continued from page 173)
Microneurosurgery. International Symposium on 
Microneurosurgery, Kyoto, October 1973. Ed­
ited by Hajime Handa. 201 pp. Illust. Igaku 
Shoin Ltd., Tokyo; University Park Press, Bal­
timore, 1975. Price not stated.
Pediatric Surgical Pathology. Louis P. Dehner. 
882 pp. Illust. The C. V. Mosby Company, St. 
Louis, 1975. $65.60.
Polypoid Lesions of the Gastrointestinal Tract.
2nd ed. Claude E. Welch and Stephen E. Hed- 
berg. Vol. II in Major Problems in Clinical 
Surgery. 220 pp. Illust. W. B. Saunders Com­
pany, Philadelphia; W. B. Saunders Company 
Canada Limited, Toronto, 1975. $13.90. 
Surgical Disorders of the Peripheral Nerves. 2nd 
ed. Sir Herbert Seddon. 336 pp. Illust. Churchill 
Livingstone, Edinburgh; Longman Canada Lim­
ited, Toronto, 1975. $43.25.
Surgical Treatment of Congenital Heart Disease.
2nd ed. Grady L. Hallman and Denton A. 
Cooley. 204 pp. Illust. Lea & Febiger, Phila­
delphia; The Macmillan Company of Canada 
Limited, Toronto, 1975. $19.95.
Vascular Surgery. Edited by William H. Edwards. 
257 pp. Illust. University Park Press, Baltimore, 
1976. $24.50.
Venous Thrombo-Embolic Disease. A Symposium 
held at the William Robertson Building, Uni­
versity of Edinburgh. Edited by C. Vaughan 
Ruckley and Iain M. C. Macintyre. 255 pp. 
Illust. Churchill Livingstone, Edinburgh; Long­
man Canada Limited, Toronto, 1975, $18.00. 
The Year Book of Surgery 1975. Edited by Sey­
mour I. Schwartz. 521 pp. Illust. Year Book 
Medical Publishers, Inc., Chicago, 1975. $19.25. 
The Year Book of Urology 1975. Edited by John 
T. Grayhack. 383 pp. Illust. Year Book Medical 
Publishers, Inc., Chicago, 1975. Price not stated.
NOTICE
HEAD AND NECK SURGERY
The UCLA extension department of con­
tinuing education in health sciences, and the 
division of head and neck surgery, UCLA, 
will present a 5-day short-course program 
on head and neck oncology, June 21 to 25, 
1976. The course will include a combined 
series of didactic lectures, films and cadaver 
dissections as well as diagnostic evaluation 
and therapeutic management of head and 
neck tumours. A series of operations will be 
performed on cadavers by the course partic­
ipants under faculty supervision. The course 
director will be Dr. Thomas Calcaterra. 
For further information write to: Health 
Sciences, UCLA Extension, PO Box 24902, 
Los Angeles, CA 90024.Marcaine
